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Abstract
All mammalian oocytes are surrounded by an acellular, transparent, glycoprotein shell
known as the zona pellucida. This structure plays many important roles during
fertilization and embryogenesis including the mediation of sperm-egg recognition,
induction of the acrosome reaction, development of the block to polyspermy and the
physical protection of the oocyte/zygote throughout the preimplantation stage of
development.
The ability of the zona pellucida to mediate the species specific recognition of
spermatozoa is due to a glycoprotein constituent of this structure, known as ZP3. In
view of its important role in the initiation of fertilization, ZP3 has been identified as a
suitable candidate for the development of a contraceptive vaccine. In order to
determine the validity of the marmoset as an animal model for engineering such a
vaccine, it was important to establish the primary amino acid structure of marmoset
ZP3 and relate this sequence to the human homologue. The strategy employed to
achieve this aim involved the use of the polymerase chain reaction, marmoset ovarian
cDNA, and primers derived from the human ZP3 sequence. The marmoset ZP3 gene
was found to possess an open reading frame of 1272 nucleotides encoding for a
polypeptide core of 424 amino acids. Marmoset (mar) ZP3 was thereby found to be
exactly the same length as human and mouse ZP3 and 2 amino acids longer than the
hamster homologue. The primary amino acid sequence of marZP3 was found to
exhibit a high degree of homology (91%) with the human ZP3 sequence and more
than 60% homology with the hamster and mouse sequences. An additional conserved
feature of the ZP3 molecule was found to be the position of the cysteine residues; the
human marmoset, mouse and hamster all possessing 15 cysteine residues at identical
sites.
Abstract x
In situ hybridization studies indicated that marZP3 was expressed exclusively in
growing oocytes, the ZP3 signal being much greater in secondary and Graafian
follicles than in the primary follicle population and poorly expressed, if at all, by
primordial follicles.
In order to generate recombinant marmoset ZP3 for immunization purposes a
full length 1.3 kb insert encoding for marmoset ZP3 was cloned downstream of the
malE gene to generate a fusion protein containing marZP3 and a maltose binding
domain. This protein was found to be generated in a soluble form in aqueous
solutions and the antigenic integrity of this molecule was demonstrated by its capacity
to be recognized by a monoclonal antibody raised against human ZP3. This full
length fusion protein has been purified by anion exchange chromatography and used
to generate polyclonal antibodies.
In addition to these in vitro studies on the generation of a recombinant marZP3
for active immunization purposes, in vivo studies have also been performed on the
induction of active immunity against porcine ZP3. These studies have demonstrated
that an important side effect of induction of immunity against a heterologous ZP3
antigen involves the depletion of the primordial follicle pool. Moreover this pathology
could be transferred to non-immunized recipients by the passive transfer of antibody.
These data raise the important question as to whether a similar pathology would be
induced if homologous zona antigens were used for the induction of immunity. As a
result of the work described in this thesis, this question can now be addressed in the
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The world's population has more than doubled in the last four decades, from 2.5
billion in 1950 to 5.3 billion in 1990, according to the latest United Nations
estimates. The rate of population growth during the past 40 years, however, has
not been constant. The estimated annual rate of growth increased from 1.79% in
1950 -1955 to 2.06% in 1965 -1975, but then decreased to 1.73% in 1975 - 1980. It
has subsequently remained almost unchanged at that level throughout the 1980s.
Whether the growth rate continues to fall or remains constant makes a considerable
difference in the long run: the world population would have reached zero growth at
6.7 billion in 2030 if the growth rate decline in the 1970s had not stalled in the
1980s and continued linearly; the world population, however, will increase to 10.7
billion in 2030 if the growth rate stays on the current plateau (Horiuchi, 1992).
An important facet of the pattern of population growth is that it is largely
focused on the countries of the developing world. If current trends continue it has
been estimated that approximately 80% of the world's population will be living in
developing countries by the year 2000. Clearly, this pattern of population increase
places a considerable demand on the resources of developing countries and
directly, or indirectly, has a major impact on the prevalence of environmental
damage, famine, disease and poverty. In order to achieve zero population growth,
new methods of contraception will have to be developed and, moreover, methods
of contraception that are appropriate for the problems encountered in the Third
World. In this context, a contraceptive vaccine offers many inherent advantages
since it should provide prolonged protection against fertility and has the potential
to provide a safe and reliable method of birth control. There are three main target
areas for a possible contraceptive vaccine: (1) reproductive endocrine signals, (2)
products of the conceptus and (3) gamete specific antigens. A contraceptive
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vaccine based on the zona pellucida (ZP) or the mammalian sperm receptor (ZP3),
a component of the ZP, offers particular promise since this target should lead to the
development of a vaccine that prevents conception rather than terminate an
ongoing pregnancy, as is the case with the other major approach being researched
at the present time, the anti-hCG vaccine (Raghupathy & Talwar, 1992).
The ideal strategy for the evaluation of a contraceptive vaccine would be
one in which an animal model, such as the marmoset monkey, was immunized
with homologous ZP3 peptides that exhibited perfect sequence homology with
human ZP3. In order to develop such a model the primary amino acid structure of
marmoset ZP3 would have to be elucidated and compared with its human
counterpart. The core of this thesis deals with this issue and presents data on the
primary amino acid sequence of the marmoset ZP3 molecule. Additional parts of
the thesis deal with the expression and translation of the ZP3 gene in the marmoset
ovary and the consequences of inducing active and passive immunity against the
ZP3 molecule, with particular emphasis on the side effects associated with this
treatment in terms of the loss of primordial follicles.
In the course of this work, the PCR technique was employed to clone and
sequence marmoset ZP3 (Chapter 3) using human ZP3 primers. The expression of
the ZP3 gene during follicular development was then investigated using in situ
hybridization procedures (Chapter 4). Prokaryotic expression of recombinant
marmoset ZP3 (Chapter 5) and the purification and characterization of
recombinant marmoset ZP3 are then described in Chapter 6. The effects of active
and passive immunization with porcine ZP3 and the possible mechanisms involved
in ovarian pathogenicity are finally discussed in Chapters 7 and 8.
Each individual chapter has its own introductory section with the purpose
of discussing the literature directly relevant to the work described in that chapter.
Thus, the general introduction provided in Chapter 2 does not set out to review the
entire literature relevant to all the material contained in this thesis. It does
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however attempt to provide a groundwork for accepting and appreciating the
studies summarized in the rest of the thesis. Each chapter also contains a
discussion of the results obtained in the context of those reported by other
investigators and concludes with a short summary of the results reported in that
chapter. The final chapter, Chapter 9, comprises a general discussion of the results
described in the thesis in the context of work by other investigators and emphasises
the areas which may be appropriate for development in the future.
2 Background
2.1 Historical Aspects
Evolution of the complex array of living creatures that inhabit the earth has depended
upon the successful transfer of genetic material from one generation to another through
the process of reproduction. The ancient Greeks believed that menstrual blood and
semen combined to form the embryo and foetal membranes. Aristotle suggested that
the semen contributed in a non-material sense. He regarded embryo development to
be exclusively due to the physiology of the female reproductive tract. At the turn of
the seventeenth century the English physician William Harvey wrote that all creatures
come from an egg (Keynes, 1966), while in 1673 Malpighi, who worked on chick
embryos, suggested that the hen's egg contained the miniature chick and that the
spermatozoa stimulated this to become the mature animal (Cole, 1930). Mammalian
spermatozoa were first observed by van Leeuwenhoek and Hannen (1679) the report
of these authors on the "little animals of sperm" dating back to November 1677. These
observations concerned fresh seminal fluid and showed that the spermatozoa swarmed
as a multitude of "animalcules" propelling themselves about with serpentine
movements.
De Graaf described and illustrated the ovarian vesicles in several species and
fitted the ova into a reasonable scheme, which is substantially what we believe today.
De Graaf used the term vesicles (vesicula) or egg (ovum) for what we now call the
follicle (Setchell, 1974). In 1875 van Beneden observed the male pronucleus inside an
egg cell and correctly concluded that the chromosomes of the first cleavage were
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derived equally from spermatozoa and egg (Gwatkin, 1977). The arrival of phase
contrast microscopy helped investigators to observe living eggs (Austin, 1951).
Initially the major constraint on studying the process of fertilization was the lack of in
vitro culture techniques, however, the subsequent introduction of such procedures
made it possible to dissect the fertilization process in some detail. Dauzier et al.
(1954) pioneered this area by producing the first rabbits derived from in vitro fertilized
ova (Dauzier et al. 1954). During the past two decades significant improvements in
our knowledge of sperm-egg interactions have been made, which have helped promote
further developments in the fields of human in vitro fertilization, animal breeding,
spermatozoa and embryo preservation, transgenic animals and immunocontraception
(Wassarman, 1988a; Henderson et al. 1988; Kinloch et al. 1992).
In the human the act of coitus is associated with the deposition of around 300
(human) million spermatozoa near the cervix. After ejaculation, the spermatozoa have
to pass through cervical mucus, which is mostly composed of macromolecular
glycoprotein filaments and, in the process, many abnormal spermatozoa are excluded
from the female reproductive tract (Hanson & Overstreet, 1981; Katz et al 1990). Of
the 300 million spermatozoa ejaculated only a few hundred actually reach the site of
fertilization, the ampulla of the oviduct (Stone, 1993).
2.2 Fertilization
2.2.1 Capacitation of Spermatozoa
Before fertilization, the spermatozoa must undergo a period of maturation in the
female reproductive tract for several hours; the time required varying in different
species. These post fertilization events were first reported independently by Austin
(1951) and Chang (1951) and the term "capacitation" was coined by Austin in 1952.
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The precise definition of capacitation (Moore & Bedford, 1983) "is the process in the
female reproductive tract (or in situ) that allows the acrosome reaction and the
"activation" of spermatozoa otherwise known as hyper-activation, which promotes
spermatozoa penetration of the zona pellucida" (Yanagimachi & Noda, 1970).
Capacitation is thus a general term encompassing the biochemical and structural
changes that occur in spermatozoa as they progress through the female reproductive
tract. This process is still poorly understood and therefore difficult to define more
precisely (Chang, 1984; Sidhu & Guraya, 1989). The topographical rearrangement of
sperm surface components appears to include loss of a decapacitation factor (Chang,
1993; Eng & Oliphant, 1978) loss or migration of spermatozoa surface antigens
(Myles & Primakoff, 1984), changes in lipid composition (Schwarz & Koehler, 1979)
and the redistribution of lectin binding sites (Schwarz & Koehler, 1979).
Changes in sperm metabolism during capacitation lead to increases in oxygen
uptake and glycolysis, and the expression of hyperactivated motility (Hamner &
Williams, 1963). Before capacitation, spermatozoa swim with linear trajectories
(Yeung & Wooley, 1984), but after hyperactivation, they move in a non-progressive
circular manner (Suarez et al. 1983) as the sperm head traces an erratic trajectory in
response to increases in the amplitude and asymmetry of the flagellar wave form
(Robertson et al. 1988). Sub-fertile human sperm populations exhibit significantly
lower levels of hyperactivation than their fertile counterparts and fewer spermatozoa
bind to hemi-zona pellucida during IVF procedures (Coddington et al. 1991).
In summary, capacitation enables the spermatozoa to undergo changes which
lead to increased metabolism, the initiation of the acrosome reaction and the onset of
hyperactivation. These processes enhance the ability of spermatozoa to bind to and
penetrate the zona pellucida (Wassarman, 1987a; Sidhu & Guraya, 1989).
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2.2.2 Acrosome Reaction (AR)
The name has a Greek origin meaning "sharp body" Popa, in 1927, first noticed that
droplets of a 'sticky substance' were extruded from the tip of sea urchin spermatozoa
when they were treated 'with egg water' (Popa, 1927 cited in Austin, 1968).The
acrosome is a membrane-bound organelle that occupies the anterior region of the
spermatozoa head, just above the nucleus and beneath the plasma membrane
(Wassarman, 1987a). The acrosomal membrane that is nearest to the nuclear
membrane is referred to as the inner acrosomal membrane and the one underlying the
plasma membrane is called the outer acrosomal membrane. The AR is an exocytotic
event involving focal fusion of the sperm plasma membrane with the outer acrosomal
membranes at different sites and the formation of hybrid membrane vesicles. Initially
the acrosomal matrix partially decondenses and the outer acrosomal membrane, alone
or in combination with the plasma membrane, invaginates to form many vesicles in the
acrosomal cap, many of which fuse with the plasma membrane leading to the
fenestration of this structure. The membrane vesicles are finally discharged from the
sperm head, thereby exposing the acrosomal contents and the inner acrosomal
membrane (Wassarman et al. 1986). The acrosomal vesicle is similar to a lysosome,
and contains numerous hydrolases, such as hyaluronidase, proteinases, glycosidases,
lipases and phosphatases (Allison & Hartree, 1970; McRorie & Williams, 1974;
Morton, 1977). The AR requires extracellular calcium and is triggered by an influx of
sodium and calcium and an efflux of hydrogen ions through the plasma membrane.
The increase in intracellular pH appears to be due to an ATP-dependent H+ pump
(Endo etalA99\\ Yanagimachi, 1981).
The place where the spermatozoa undergo the acrosome reaction remains
controversial subject. Some workers have suggested that spermatozoa which
spontaneously acrosome react in vitro are inferior cells which could be unable to
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fertilize an egg in vivo (Schill et al. 1988; White et al. 1990). Infertile men who are
polyzoospermic (with an increased number of spermatozoa in their ejaculates, usually
> 350xl()6/ml) have an abnormally high rate of spontaneously occurring acrosome
reactions. This suggests that the place and timing of the acrosome reaction are
important factors in determining the fertilizing ability of spermatozoa (Schill et
al. 1988; Tesarik, 1989). Some investigators have suggested that only capacitated
acrosome-intact spermatozoa can penetrate the cumulus and bind to the zona pellucida
(Storey et al. 1984; Cherr et al. 1986) and that both uncapacitated and acrosome-reacted
spermatozoa are incapable of entering this extracellular matrix (Cherr et al. 1986).
This general concept of the mechanisms regulating fertilization, in which
capacitated spermatozoa with an intact acrosome penetrate the cumulus matrix, bind to
the ZP, and only then undergo the AR, has received considerable attention (Florman et
al. 1984b; Wassarman, 1987a; Bleil & Wassarman, 1986; Leyton & Saling, 1989b).
An interesting exception to this general rule is the guinea pig in which only acrosome
reacted spermatozoa can bind to the ZP (Huang et al. 1981), the acrosome intact
spermatozoa lacking any affinity for the ZP even when capacitated. For most
mammalian species the observations of Anderson et al (1975) seems to pertain: that
both acrosome-intact spermatozoa and those that had undergone the acrosome reaction
can penetrate the cumulus matrix but only the acrosome intact spermatozoa are able to
bind to the ZP and fertilize the eggs. Other investigators (Storey et a/. 1984; Saling &
Storey, 1979) have observed the same phenomenon using the chlortetracycline
fluorescence procedure to score acrosome-intact and acrosome-reacted spermatozoa
during in vitro fertilization procedures. Spermatozoa of the sea urchin, frog and other
motile cells lacking hyaluronidase have been found to pass through the cumulus
matrix of hamster eggs but were unable to bind to the ZP raising doubts about whether
spermatozoa release hyaluronidase in order to penetrate the egg cumulus matrix.
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Moreover, marsupial spermatozoa contain acrosomal hyaluronidase but their ovulated
eggs are not surrounded by cumulus matrix (Morton, 1977; Talbot & DiCarlantonio,
1984), again indicating that it is not necessary for these cells to undergo the AR in
order to reach the surface of the zona pellucida.
In most studies, the failure of spermatozoa to interact with the ZP appears to be
at the level of ZP binding. If the ZP is removed from the oocytes, even spontaneously
acrosome-reacted spermatozoa are able to fertilize an egg leading to the birth of
normal young (Naito et al. 1992). Under in vitro conditions, when cumulus-free
(denuded) eggs were used, only acrosome-intact spermatozoa (Wolf & Inoue, 1976;
Saling etal. 1978; Saling & Storey, 1979; Phillips & Shalgi, 1980; Bleil & Wassarman,
1983) bound to the ZP and, after binding, the ZP induced the acrosome reaction
(Saling et al. 1979; Florman & Storey, 1982; Bleil & Wassarman, 1983). Using the
scanning electron microscopy technique, Phillips & Shalgi (1980) observed that only
acrosome-intact spermatozoa could be mechanically isolated from unfertilized hamster
eggs, but the spermatozoa that had spontaneously undergone the AR failed to bind to
ZP. In another study, using transmission electron microscopy, Florman & Storey
(1982) showed that the percentage of acrosome-reacted spermatozoa on the zona
surface reached 80% after 240 minutes post-insemination. Strong experimental
evidence for an important biological role for the ZP has come from experiments in
which acid or heat-solubilized ZP added to the spermatozoa are found to successfully
induce the acrosome reaction (Florman & Storey, 1982; Bleil & Wassarman, 1983;
Cherr et al. 1986). In contrast acid-solublized embryos ZP failed to induce the
spermatozoa to undergo the acrosome reaction (Florman et al. 1984b). Similarly,
pronase-treated ZP3 loses its ability to induce the acrosome reaction (Florman et
al. 1984b) suggesting that the intact polypeptide is essential for this function.
Wassarman (1987a&b) subsequently indicated that both the polypeptide core and the
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oligosaccharide side chains of ZP3 were required for the induction of the acrosome
reaction, the peptide backbone forming a bridge, cros linking adjacent carbohydrate
structures. The mechanism by which the sperm receptor ZP3 induces spermatozoa to
undergo the acrosome reaction is thought to be a signal transduced exocytosis event
involving guanine nucleotide binding proteins (Florman et al. 1989; Endo et al. 1987a;
Leyton & Saling, 1989a). Activation of tyrosine kinase receptors as a consequence of
ligand-induced aggregation is a widely known phenomenon and is in keeping with the
apparent mechanism of action of ZP3. It is thought that ZP3 binding leads to
clustering of receptors on the spermatozoa, which triggers acrosomal exocytosis. The
signal transduction mechanism requires the involvement of a G protein to effect fusion
between the plasma membrane and outer acrosomal membranes. A 95 kD protein
present on the spermatozoa plasma membrane is involved in binding to ZP3, and
appears to undergo an autophosphorylation event on binding the zona glycoprotein
which, in turn, sets in motion a cascade of biochemical changes leading to exocytosis
(Leyton & Saling, 1989a). A more detailed discussion can be seen later in chapter
2.3.12. A similar protein has been observed in human spermatozoa, the
phosphorylation of which is enhanced by exposure to human and porcine zona
proteins (Naz et al. 1991a). Recently it has also been observed in the mouse that Gal-
transferase on the sperm head mediates fertilization by binding oligosaccharide
residues in the egg coat or zona pellucida. After the acrosome reaction the transferase
relocalizes to a new membrane domain where it can no longer bind to ZP3, which is
consistent with the inability of acrosome-reacted sperm to bind ZP3 or to initiate
binding to the zona pellucida (Miller et al. 1992). In view of the incidence supporting
the involvement of both glycosyltransferases and tyrosin kinases in mediating sperm-
zona interaction, we may conclude that the later is a highly complex event, which may
involve several alternative pathways of gamete recognition and signal transduction.
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2.2.3 Spermatozoa - Zona Pellucida Binding
The initial association between spermatozoa and the ZP is loose and is referred to as
"attachment" (Hartmann et al. 1972). The attached spermatozoa can be removed either
by repeatedly pipetting the eggs (Hartmann et al. 1972; Bleil & Wassarman, 1980a) or
by dextran sulphate gradient centrifugation assays (Berger et al. 1989). Later is the
process of fertilization the spermatozoa become strongly bound to the zona pellucida,
and are difficult to detach after repeated pipetting or gradient centrifugation, and this is
called "binding" (Hartmann et al. 1972).
2.2.4 Species Specificity
Lilly (Wassarman, 1990) was the first to observe that the interaction of complementary
molecules on the surface of spermatozoa and eggs is essential for the process of
fertilization. Fertilization is the most important event in the propagation of living
beings and represents the co-ordinated process whereby haploid spermatozoa and egg
fuse to form a diploid zygote which, in turn, is destined to become an adult organism.
Specificity is essential, particularly where fertilization is external, for example in the
sea, where the process takes place in an environment in which gametes from a number
of different species are present. Sea urchin spermatozoa possess a lectin-like protein,
called bindin, that interacts specifically with a glycoprotein receptor in the vitelline
envelope of the sea urchin egg. Similar mechanisms also operate in ascidians and
amphibians, as well as in plants. Mammalian fertilization takes place within the
female reproductive tract, and in this situation, phenotype and behaviour help to
maintain the species specificity of fertilization (Yanagimachi, 1978; quoted in Gulyas
& Schmell, 1981) while gamete-specific receptor molecules resist cross-fertilization
between closely related mammals. Fertilization involving heterologous gametes has
occasionally been observed (Schmell & Gulyas, 1980; Bedford, 1977), for example,
Background 12
mammalian hybrids such as the mule are created by cross-fertilization. Thus, it is
generally accepted that mammalian fertilization is relatively, but not absolutely
species-specific (Schmell & Gulyas, 1980). At the cellular level, the ZP plays a major
role in preventing inter-species fertilization (Yanagimachi, 1977; Yanagimachi, 1984;
Gulyas & Schmell, 1981; Adams, 1974). The most profound expression of this
activity being in the golden hamster to oocytes of which will fuse with the acrosome
reacted spermatozoa from a wide variety of species providing the zona pellucida has
been removed (Yanagimachi, 1984).
2.2.5 Spermatozoa-Zona Pellucida Interaction
Once spermatozoa have traversed the cumulus matrix, the acrosome-intact cells bind
to the zona pellucida. The sperm receptor molecule on the ZP is a glycoprotein,
termed ZP3. This ZP3 glycoprotein not only serves as a recognition site for
spermatozoa but also induces these cells to undergo the acrosome reaction (Mortillo &
Wassarman, 1991). It is thought that O-linked oligosaccharides associated with the
ZP3 molecule possess the sperm receptor activity (Bleil & Wassarman, 1988). Recent
evidence involving the use of cross-linking agents in conjunction with mouse ZP3
have succeeded in identifying an Mr= 56000 sperm surface constituent which has been
proposed as primary mouse-egg binding protein (Bleil & Wassarman, 1990). This
protein (sp56) is located in the plasma membrane overlying the acrosomal region of
acrosome intact mouse spermatozoa but is lost following the acrosome reaction.
Proteolytic enzymes, particularly acrosin, released from the acrosome during
exocytosis are thought to aid zona penetration (Gaddum & Blandau, 1970; McRorie &
Williams, 1974; Gwatkin & Williams, 1977; Stambaugh & Smith, 1978).
Specifically, acrosin aids the digestion of ZP1, a glycoprotein which serves a cross-
linking function within the zona pellucida. The propulsive forces generated by sperm
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movement also help spermatozoa to penetrate the ZP (Bedford & Roger, 1983). After
the acrosome reaction has been induced the penetrating spermatozoa bind to another
ZP glycoprotein, ZP2, which acts as a secondary binding site for spermatozoa (Bleil &
Wassarman, 1986; Bleil etal. 1988).
2.2.6 Spermatozoa-Egg Fusion
It is believed that an influx of Ca^+ ions into the acrosomal region during the
acrosome reaction, is one of the changes that helps to modify the spermatozoa plasma
membrane (Monroy, 1985) in preparation for sperm-oocyte fusion. In addition, local
dehydration at the site of sperm-oolemma contact and other hydrophobic interactions
might help mediate the fusion of the spermatozoa with the vitelline membrane of the
eggs (Wilschut & Hoekstna, 1984). Once the fertilizing spermatozoon fuses with the
egg plasma membrane, the sperm tail ceases to move (Yanagimachi, 1966; Gaddum
Rosse, 1985) and the microvillous projections present on the egg, cluster tightly
around and interdigitate over the sperm head (Schatten & Mazia, 1976). The cortex of
the egg contains numerous cytoskeletal proteins such as actin and myosin, which
produce contractile movements which help to draw the spermatozoon into the egg
cytoplasm (Wassarman, 1987a).
Entry of more than one spermatozoa is lethal to the embryo and specific
mechanisms have evolved for the prevention of polyspermy (Wassarman, 1987a;
Bedford & Roger, 1983). One component of this process involves the discharge of the
contents of the cortical granules into the perivitelline space (Gwatkin et al. 1976;
Whitaker & Steinhart, 1985) via mechanisms that are poorly understood. The contents
of the granules induce both a 'zona reaction', leading to loss of sperm binding activity,
and a hardening process, which makes this structure resistant to sperm penetration (ZP
hardening). The zona reaction involves a modification of the sperm receptor ZP3, to a
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less receptive form ZP3f, and a cros linking of the ZP, such that it becomes difficult to
dissolve with reagents like proteinases and reducing agents (Bleil et al. 1981;
Wassarman et al. 1986). Following fusion with the oocyte, the sperm head
decondenses, the male pronucleus is formed, and the activated egg completes meiosis
and the second polar body is released (Bedford & Roger, 1983). The entire sequence
of oocyte growth and follicular maturation depends upon primary stimulation of the
ovary by gonadotrophins, underpinned by local (paracrine and autocrine) levels of
control emanating from within the follicle itself (Hillier, 1991).
2.3 Zona Pellucida
All mammalian eggs are surrounded by a 2-5 (im thick, transparent, extracellular
matrix called the zona pellucida (ZP) which plays many roles during fertilization and
early embryogenesis. As already discussed, the ZP contains species specific sperm
receptors, furthermore, it induces the acrosome reaction and, following a signal
transduced exocytotic event in the oocyte, blocks the entry of more than one
spermatozoon (polyspermy) into the ooplasm. It also offers mechanical protection to
the embryo during the preimplantation stages of pregnancy. Recent advances in
biochemistry and molecular biology have helped us to understand the mechanisms by
which the zona pellucida plays its many roles.
The mouse ovary has 10,000 to 15,000 primordial oocytes at birth and these
non-growing oocytes do not have a visible ZP. During the oocyte growth phase (20-
40p.m diameter) the ZP first appears as a thin, diffuse envelope after about 2 weeks
and later as a thick, dense coat when the oocytes have reached 60-85 Jim in diameter
(Wassarman & Josefowicz, 1978). In the following section, we shall examine the
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information that is available on the structure and composition of this important
biological (ZP) structure.
2.3.1 Zona Pellucida Synthesis
The site of production of the ZP has been a controversial issue for a long time. Many
of the non-mammalian egg coats are not synthesized by oocytes but by their
surrounding follicle cells or nurse cells (Dumont & Brummet, 1985). Under in vitro
conditions, when denuded mouse oocytes (free of follicular cells) are cultured with
either 35s-methionine or ^H-fucose, the oocytes can synthesise all the major ZP
glycoproteins, in contrast the follicular cells are not able to synthesise any ZP
components (Wassarman, 1988b; Bleil & Wassarman, 1980b). In vitro culture
experiments also suggest that three of the sulphated glycoproteins of the ZP are
synthesized by the oocytes (Shimizu et al. 1983). A specific antiserum directed against
mouse ZP2 could precipitate ZP2 from the oocytes only, not from the follicular cells
(Greve et al. 1982). On the contrary, Wolgemuth et al (1984) used an anti-ZP
antiserum to immunolocalize ZP synthesis, and have reported immunostaining of ZP
in the cytoplasm of oocytes and within the cytoplasm of the follicular cells. With the
arrival of molecular probes, in situ hybridisation studies have clearly shown that, ZP3
mRNA is only expressed in oocytes and not in follicular cells (Wassarman, 1989;
Liang et al. 1990; Philpott et al. 1987).
2.3.2 ZP Biochemical Characteristics
The ZP of mouse oocytes consists of three different glycoproteins namely ZP1 with
apparent molecular, mass (Mr) of 200,000, ZP2 (Mr=120,000) and ZP3 (Mr=83,000)
(Wassarman, 1987a; Wassarman, 1988a; Wassarman, 1990). Like other secreted
glycoproteins, the zona pellucida shows considerable micro heterogeneity expressed in
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the presence of multiple charge isomers. The isoelectric point of ZP1 is 4.1; ZP2 5.2;
and ZP3, 4.2-5.2, so that all three glycoproteins are acidic in nature (Greve et al. 1982;
Salzmann et al. 1983). All of the mouse glycoproteins contain sulphated
oligosaccharide complexes. When run on SDS-PAGE, ZP2 and ZP3 migrate as
monomers but ZP1 behaves as a dimer (Wassarman, 1988b; Wassarman, 1990).
Under reducing conditions ZP1 co-migrates with ZP2 on a one dimensional gel with
molecular mass of 120,000 whereas ZP3 is slightly retarded, suggesting that the native
form of ZP3 possesses intramolecular disulphide bonds. Endo-B-N-
acetyglucosaminidase has been used to digest the mouse glycoproteins although this
enzyme was found to be inefficient, implying that all ZP glycoproteins have aspargine-
linked (N-linked) complex type oligosaccharides. Under in vitro culture conditions,
mouse oocytes fail to "core" glycosylate all of the mouse zona proteins, in the
presence of the antibiotic tunicamycin an inhibitor which prevents N-linked
glycosylation (Roller & Wassarman, 1983). The molecular mass of ZP2 and ZP3
decreases if alkaline-G-elimination is carried out in the presence of ^H-NaBH/).. This
is due to the removal of oligosaccharides that have ^H-N-acetylgalactosaminitol at the
reducing termini (Bleil & Wassarman, 1988). The relatively low isoelectric points of
the mouse ZP glycoproteins are due to the presence of the oligosaccharide side chains,
such that these molecules are acidic in the glycosylated form but become more basic if
treated with endo F or neuraminadase. The sialic acids on the glycosaccharides of the
ZP glycoproteins are the major contributors to their acidic nature. In vitro studies have
shown that ZP from oocytes grown in the presence of tunicamycin and subsequently
digested with EndoH yielded ZP3 species of Mr=81,000 and 44,000 (Salzmann et
al. 1983). Similar molecular masses were obtained after complete deglycosylation
with trifluoromethane sulphonic acid (TFMS), a reagent that removes both N-and O-
linked oligosaccharides from glycoproteins. All ZP glycoproteins are N-glycosylated
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posttranslationally in the endoplasmic reticulum to give rise to 160,000, 91,000,
56,000 and 53,000 molecular weight species, all of which possess high mannose-type
N-linked oligosaccharides. ZP2 has six N-linked and ZP3 either three or four re¬
linked oligosaccharides per molecule (Greve et al. 1982). Successful secretion of ZP2
requires addition of N-linked oligosaccharides but these are not required for ZP3
secretion, under in vitro culture conditions. The nascent N-linked oligosaccharides of
the ZP are converted to complex-type oligosaccharides, and, at the same time nascent
ZP2 and ZP3 obtain their O-linked oligosaccharides and these mature ZP
glycoproteins are secreted into the extracellular space (Salzmann etal. 1983).
2.3.3 Porcine ZP Glycoproteins
Porcine ZP is composed of four glycoprotein families of molecular mass 80,000-
90,000 (ZP1), 60,000-65,000 (ZP2), 55,000 (ZP3), 20,000-25,000 (ZP4) (Hedrick &
Wardrip, 1986; Yurewicz et al. 1987; Dunbar & Raynor, 1980; Henderson et
al. 1987b). Like the mouse, porcine ZP glycoproteins are acidic in nature, with pis in
the range 5.2 to 5.6 pH units. Work from different laboratories suggests that ZP2 and
ZP4 are derived from ZP1 by proteolysis and reduction of its intermolecular
disulphide bonds. Evidence for this comes from the fact that the total sum of the
amino acids and carbohydrates in ZP2 and ZP4 is equal to those in ZP1 (Hedrick &
Wardrip, 1987). ZP1 and ZP2 have similar peptide domains and some peptide
segments share an identical primary structure. ZP1 is immunologically related to ZP2
and ZP4, but ZP2 and ZP4 are not immunologically related to one another (Hedrick &
Wardrip, 1987). On one-dimensional gels under non-reducing conditions, porcine ZP
gives rise to 80,000-90,000 and 55,000 molecular mass components. The porcine ZP3
band contains two distinct glycoprotein species namely ZP3a and ZP315. The 80,000-
90,000 species corresponds to ZP1 and the heterodimer of ZP2 and ZP4.
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Deglycosylation of porcine ZP3 with TFMS yields two polypeptides of Mr=34,000
and 36,000 and these polypeptides differ from one another in their primary structure as
determined by amino-terminal sequence analyses and peptide mapping experiments, as
well as immunologically (Yurewicz et al. 1987). The average amino acid composition
of these two polypeptides is identical to that of purified ZP3. Partial deglycosylation
of ZP3 with endo-B-galactosidase yields two glycoprotein types of Mr=42,000 and
46,000. They differ in their amino acid and carbohydrate composition, peptide map
amino-terminus analyses, and immunoreactivity. This implies that porcine ZP3 is
composed of two structurally and immunologically different lactoseaminoglycan-
containing glycoproteins, representing different genes (Yurewicz et al. 1987).
Henderson et al (1987b) have demonstrated that chemical deglycosylation of porcine
ZP using trifluoromethanesulphonic acid (TFMS) resulted in the production of five
discrete protein bands on one-dimensional sodium dodecyl sulphate/polyacrylamide
gel electrophoresis (SDS/PAGE) with molecular masses of 66(ZP1), 52(ZP2), 36(ZP3
a) 32(ZP3I3), and 16 kD. All the above porcine ZP components were purified to
homogeneity using one-dimensional SDS-PAGE and the antibodies generated to the
32 kD deglycosylated polypeptide inhibited human gamete interaction (Henderson et
al. 1987a).
2.3.4 Hamster ZP
Under non-reducing SDS-PAGE the hamster ZP migrates as two bands having
Mr=208, 000 (range, 127-288,000) and 56,000 (range 54-58,000) (Moller et al. 1990).
HPLC analysis also reveals two bands of similar size, but when these HPLC-
fractionated samples are analysed by SDS-PAGE a further band of Mr=103,000 is
revealed (range 92-113,000). Hamster ZP1 consists of two polypeptides of 103,000,
held together by intermolecular disulphide bonds and cannot be distinguished from
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hamster ZP3 on the basis of size (Moller et al. 1990). In the presence of reducing
agents, the Mr= 200,000 hZPl molecule migrates on SDS-PAGE with an apparent
Mr=103,000. This suggests that hZPl, like mouse ZP1, is composed of two
polypeptides held together by intermolecular disulphides.
2.3.5 Human ZP
Less information is available on human ZP because of the paucity ofmaterial. Human
ZP after heat solublization, and iodination and SDS-PAGE under non-reducing
conditions yields bands migrating in the range 92-12,000 (ZP1, 2) and 57-73,000
(ZP3). In the presence of a reducing agent human ZP separates into molecules of
Mr=97,000 (ZP1), 82,000 (ZP2), and 70,000 (ZP3). It has also been noticed that there
is also a substantial disappearance of ZP1 from fertilised eggs, when compared with
unfertilised eggs under reducing condition (Shabanowitz & O'Rand, 1988b).
2.3.6 Structure of the Zona Pellucida
Using a variety of techniques including light and electron microscopy and different
probes such as lectins, antibodies and ruthenium red it is possible to gain a limited
understanding of the structure of the ZP. The ZP appears a meshwork of randomly
arranged fibrillogranular strands. The binding sites for ruthenium red, lectins and
antibodies lie at the exterior rather than at the interior of the ZP. Some of the reagents
used could not penetrate the interior of the ZP. However, some evidence suggests that
the strands, or fibres, are more densely packed on the internal surface of the ZP (Dietl
& Czuppon, 1984). Isolated ZP solubilized with elastase at pH 5.5 produce primarily
large complexes consisting of interconnected or branched filaments in which
heterologous interactions between ZP1, ZP2, and ZP3 are observed. Treatment with
chymotrypsin and dithiothreitol reveals primarily individual or unbranched filaments
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in which heterologous interactions, at least between ZP2 and ZP3, are maintained. ZP
filaments exhibit a structural repeat of about 14-15nm in the electron microscope.
ZP2:ZP3 is present as a heterodimer every 14 nm and this was demonstrated in both
isolated filaments and intact ZP by SDS-PAGE and by electron microscopy using
monoclonal antibodies specific to ZP2 and ZP3. The SDS-PAGE experiments also
revealed that the ZP2:ZP3 dimer has a Mr of approximately 180, 000. Treatment of
ZP with dithiothreitol and chymotrypsin results in reduction and limited proteolysis of
ZP1 and the solubilized preparation contained filaments that were no longer
interconnected. This suggests that ZP1 serves as an interconnection between ZP2:ZP3
giving rise to a three-dimensional matrix (Greve & Wassarman, 1985).
2.3.7 Zona Pellucida Genes (Mouse)
Analysis of genomic DNA (Kinloch et al. 1988; Chamberlin & Dean, 1989) has
revealed that the mouse ZP3 gene is lOkb in length with 8 exons and is located on
mouse chromosome number 6. The sizes of the mouse exons are 338 bp, 119 bp, 104
bp, 184 bp, 118 bp, 92 bp, 137 bp, and 225 bp for exons 1-8, respectively. The introns
range from 2520 bp to 195 bp. In the 5' flanking upstream region there is a TATA box
29 nt from the transcription start site. Also in the upstream region there is a short
region of internal homology at approximately -220 to -320 from the first exon. Many
copies of a 54 consensus sequence are found as tandem arrays in the 5'-flanking
regions and the cis-acting elements in mouse ZP3. Another tandem array is also
present beginning 43 bp, 3' to the polyadenylation site at the 3' end of the gene. This
sequence contains 12 nucleotides (GGTGGGATTGGT) perfectly repeated 11 times.
A startling feature of the ZP3 gene is that the stop codon, TAA, is buried in the
polyadenylation signal, AATAAA (Chamberlin & Dean, 1989; Kinloch et al. 1990).
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Mouse ZP3 cDNA is 1317 nt in length and has a poly(A) tail of 200-300nt (Ringuette
et al. 1986; Ringuette et al. 1988). There is a 29 nt 5' untranslated region followed by a
single open reading frame, giving rise to a nascent polypeptide ofMr= 46,307. The N-
terminus has a 22 amino acid signal sequence, leaving a core polypeptide of
Mr=43,943. It has 13 cysteine, 29 proline, 70 serine plus threonine, 13 histidine, 6
tryptophan, and 2 methionine residues (Kinloch et al. 1988; Ringuette et al. 1986;
Ringuette et al. 1988). ZP3 contains a high number of proline and serine plus
threonine residues. There are 6 potential glycosylation sites for N-linked
oligosaccharides, 3 or 4 of which are of the complex-type. The hydrophobicity plot
shows that ZP3 is neither strongly hydrophobic nor hydrophilic, except for 2 small
domains near the carboxyl terminus (Dean et al. 1989). The ZP3 gene is expressed
exclusively in actively growing oocytes. Zona transcripts cannot be detected in the
oocytes (10-15pm) of primordial follicles, and maximum levels are observed in 50(im-
diameter oocytes that contain 1 ng of ZP2 transcripts and 0.4 ng of ZP3 transcripts
representing 1 and 80%, respectively, of total poly(A+) RNA (Testart & Mendoza
Oltras, 1986; Philpott et al. 1987; Roller et al. 1989; Schickler et al. 1992). Upon
meiotic maturation the levels of ZP2 and ZP3 mRNA drop to 5% of the peak levels of
ZP transcripts (Liang et al. 1990). Secondary structure prediction methods indicate
that ZP3 contains little a-helical-forming potential. All the N-linked glycosylation
sites are situated in the hydrophilic stretches, which are predicted to form reverse turns
or coils.
In female, mammals zona pellucida genes are the only known oocyte and
therefore sex-specific genes expressed in mammals. ZP3 gene expression is found in
growing oocytes of 2-3 weeks of age in the mouse. The cis-acting element that
governs expression of the ZP3 gene in oocytes is reported to be present within 6.5 kb
in the upstream region (Lira et al. 1990). This has been demonstrated in transgenic
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mice by introducing the firefly reporter gene along with the 6.5 kb upstream of the
ZP3 gene. Recently, it has been demonstrated that the cis-acting element responsible
for oocyte-specific expression in transgenic mice is located within the first 470 bp of
the mouse ZP3 (mZP3) promoter. Extracts of mouse ovaries contain a Mr=~60,000
protein, that binds specifically to the sequence 5'—GATAA-3' located within the first
lOObp of the mZP3 promoter. This protein is known as OSP-1, and is present only in
growing oocytes but not in ovulated eggs or two-cell embryos (Schickler et al. 1992).
The mouse and human ZP2 and ZP3 genes 5'—flanking region contains five short
DNA sequences I, HA, IIB, III, and IV (4 to 12 bp) that are 60-100% identical and are
approximately equidistant upstream of the TATAA box in the four genes. Deletion
and mutational analysis of the five short 5'-flanking regions of ZP3 revealed that
element IV is a 12-bp sequence that plays a crucial role in directing expression in
oocytes. The element IV (CACG/CTG) forms protein-DNA complexes of
indistinguishable mobility with lysates from oocytes and not from any other tissues
(Millar et al. 1991).
2.3.8 Human ZP3 Gene
The human genomic DNA is a 18.3 kb transcription unit, which is double the size
(8.6-kb) of the mouse gene. The human ZP3 gene is composed of 8 exons spanning a
length of 18.3 kb. The exons range from 92 to 312 bp, which is almost identical in
size to the eight exons of mouse ZP3 and the nucleotide sequence is 74% similar to
the mouse. There are at least 16 human Alu repeat sequences present at the locus of
the human ZP3 homologue. The human and mouse ZP3, in the first 250 bp upstream
region has four similar elements of 8-15 bp, which are 82-90% conserved. Like the
mouse the human ZP3 has short untranslated regions in the 5' and 3' regions. The
tandem repeat found upstream of the transcription start site of mouse ZP3 and the
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perfect 12-bp repeat found 3' to the gene are not present in the human gene
(Chamberlin & Dean, 1989) Human ZP3 involves a single open reading frame of
1272 nt that encodes a 424 amino acid protein. The amino acid sequence is 67%
similar to the mouse ZP3 and the predicted secondary structure is also conserved. The
human ZP3 polypeptide chain contains four potential N-linked glycosylation sites,
three of which are conserved in the mouse, and 66 potential O-linked glycosylation
sites in human ZP3, 71% of which are conserved in the mouse. All of the 13 cysteine
residues found in the human ZP3 are conserved in the mouse protein, suggesting that
the secondary structures of these proteins are preserved. The region that is very
dissimilar from the mouse ZP3 lies in the carboxyl region and corresponds to the
hydrophilic peaks that presumably lie on the surface of the protein (Chamberlin &
Dean, 1990). Interestingly the human ZP3 is not a single-copy gene in that human
genome has second polymorphic locus which, due to an extra G residue in exon 8, has
the potential to encode a truncated protein of 372 amino acids. Direct sequence
analysis of polymerase chain reaction-amplified exon 8 DNA of 56 individuals of
various human populations revealed three different sequence patterns: one containing
only ZP3-424-coding sequences and two containing ZP3-424- and ZP3-372-coding
DNA (van Duin et al. 1992).
2.3.9 Hamster ZP3 Gene
The hamster genomic DNA is 7900 bp in length and consists of eight exons and seven
introns. Hamster mRNA contains 1266 nt of coding sequence, 6 nt less than mouse
RNA (Kinloch et al. 1990). Like the mouse and human ZP3 mRNAs the hamster ZP3
mRNA 5'- and 3'-noncoding regions are very short, compared with most eukaryotic
mRNAs (Kozak, 1984). Ten nucleotides around the ATG initiation codon of hamster
(hZP3) match those of a consensus sequence (GCCGCCA/GCCATGG) reported to be
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involved in translation initiation in vertebrates (Kozak, 1987) and the termination
codon TAA forms part of the poly(A) addition signals, AATAAA (Proudfoot &
Brownlee, 1976). Many copies of a 54 consensus sequence are found as tandem arrays
in the 5'-flanking regions and the cis-acting elements known to be present in mouse
ZP3 are also present in hZP3, which is approximately 85% similar (Kinloch et
al. 1990). The predicted amino acid sequence of hZP3 is 81% identical to mouse ZP3,
and hZP3 is similarly characterised by a high number of serine plus threonine residues.
Hamster ZP3 also has 13 cysteine residues, as has the mouse ZP3, in conserved
locations. Hamster ZP3 has four potential N-glycosylation sites and, three of which
are conserved between hZP3 and mZP3. Secondary structure prediction methods
indicate little a-helix-forming potential; rather, it consists of reverse turns or coils
(Kinloch et al. 1990) and the hydropathicity plot is virtually identical with that
generated by mouse ZP3 (Kyte & Doolittle, 1982).
2.3.10 Recombinant ZP Proteins
The hamster and the mouse ZP3 genomic DNA has been cloned in pKJ-1, which
contains the bacterial neomycin resistance gene placed between the mouse
phosphoglycerate kinase-1 (pgk-1) 5'- and 3'- regions. The mouse and the hamster
genomic DNA was therefore under the control of the phosphoglycerate kinase-1
promoter (Kinloch et al. 1991). The embryo carcinoma cell lines transfected with a
genomic construct of mZP3 and hZP3 secreted large amounts of recombinant ZP3
glycoproteins. The molecular mass of the secreted mZP3 and hZP3 glycoproteins
were Mr=83,000 and Mr=49,000 respectively. The embryonic cell line of mouse
origin produced recombinant mouse ZP3 of the right size (Mr=83,000), whereas the
recombinant hamster protein was Mr=49,000 as compared to the wild type, which has
a Mr value of 56,000. Kinloch et al (1991) also demonstrated that the recombinant
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mZP3 is biologically active as a sperm receptor in vitro, but hZP3 is not. Similarly the
mZP3 could induce the acrosome reaction in murine spermatozoa, but the hZP3 could
not. It has also been demonstrated that the embryonic cell line transfected with mZP3
can bind murine spermatozoa in vitro (Kinloch et al. 1991). Beebe et al (1992) have
shown that the full length mouse ZP3 cDNA construct cloned in cytomegalo virus and
transfected into the mouse L-929 cell line, produced recombinant mouse ZP3 with a
relative molecular mass of 60,000-70,000. Another construct cloned into the vaccinia
virus promotor and transfected into the green monkey CV-1 cell line, also produced
mouse recombinant ZP3 of the same size. The recombinant glycoproteins were
biologically active since they inhibited spermatozoa binding and induced the acrosome
reaction (Beebe et al. 1992).
2.3.11 ZP3 : the Sperm Receptor
Respective complementarity between molecules on the surface of gametes ensures
species specific interactions during fertilization. At present there appears to be a
number of different candidates for a sperm zona-binding protein that interacts with
zona pellucida. These comprise enzymatic molecules like galactosyltransferase
(Lopez et al. 1985; Lopez & Shur, 1987; Miller et al. 1992; Fayrer Hosken et al. 1991)
the acrosomal enzyme acrosin (Moos et al. 1990; Topfer Petersen et al. 1990; Aitken et
al. 1990; Jones, 1991) and a trypsin-like protease in the mouse (Leyton & Saling,
1989a). The egg's receptor, on the other hand, appears to be one or more carbohydrate
moieties of the ZP molecules, ZP3 and ZP2, at least in the mouse (Wassarman et
al. 1986; Bleil & Wassarman, 1986; Bleil & Wassarman, 1990; Bleil et al. 1988;
Vazquez et al. 1989; Wassarman, 1989; Florman & Wassarman, 1985). In the pig,
ZP3 of Mr=55,000 has been identified as the boar sperm receptor (Sacco et al. 1989;
Peterson et al. 1991; Peterson & Hunt, 1989). Further research has shown that
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Mr=90,000 and Mr=55,000 (a) components have the capacity to bind to sperm
populations (Berger et al. 1989), whereas in the rabbit ZP2 and ZP3 have been shown
to interact with spermatozoa (O'Rand et al. 1988). Impressive studies by Bleil and
Wassarman (1986) have shown that in the mouse, purified ZP3 binds exclusively to
the sperm head only and not to any other parts of spermatozoa and even at low
concentration, ZP3 prevents the binding of spermatozoa to ova in vitro, whereas a
variety of other non-specific glycoproteins have no effect on this process (Bleil &
Wassarman, 1980d; Florman & Wassarman, 1985; Bleil & Wassarman, 1988; Leyton
et al. 1989). Only acrosome intact spermatozoa are able to bind to the unfertilised egg
ZP (Bleil & Wassarman, 1986; Mortillo & Wassarman, 1991). It has been shown that
acrosome-intact spermatozoa bind to silica beads coated with ZP3 and undergo the
acrosome reaction but spermatozoa do not bind to other zona glycoproteins such as
ZP2 coupled to the silica beads (Vazquez et al. 1989). In the mouse, ZP3 at a very low
concentration is able to induce the AR (spermatozoa exocytosis) in vitro but no other
ZP glycoproteins can (Kopf, 1989; Leyton & Saling, 1989b; Leyton et al. 1989; Endo
et al. 1987b; Endo et a/.1987c). ZP3 from fertilised eggs is unable to bind to
spermatozoa (Bleil & Wassarman, 1986) or to induce the acrosome reaction (Bleil &
Wassarman, 1983) suggesting that ZP3 undergoes biochemical changes once
spermatozoa is bound and thus prevents further entry of spermatozoa (block to
polyspermy).
Over the past decade, the detailed biochemical structure of the sperm receptor
has been studied extensively (Florman & Wassarman, 1985; Oikawa et al. 1973;
Huang et al. 1982; Ahuja, 1982; Ahuja, 1985; Shur & Hall, 1982). In the mouse zona,
Florman and Wassarman (1985) identified a glycopeptide from the ZP3 molecule with
an O-linked carbohydrate moiety that was responsible for the binding of the
spermatozoa to the zona pellucida. After extensive digestion with pronase, ZP3
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generated a population of relatively small glycopeptides (about Mr= 1500-6000) which
still retained their sperm receptor activity but were unable to induce the acrosome
reaction (Florman et al. 1984a; Wassarman, 1989; Leyton & Saling, 1989b). ZP3 loses
its sperm receptor activity when chemically deglycosylated with trifluoromethane
sulphonic acid which removes both N-linked and O-linked oligosaccharides (Edge et
al. 1981) or when O-linked oligosaccharides are selectively removed from ZP3 by mild
alkaline hydrolysis (B-elimination; Sharon, 1975; Wassarman et al. 1985; Wassarman
et al. 1989). On the contrary, selective removal of N-linked oligosaccharides from ZP3
had no significant effect on ZP3's ability to serve as a sperm receptor (Wassarman et
al. 1985; Wassarman, 1989). When ZP3 was subjected to B-elimination in the presence
of sodium borohydride, the result was the release of O-linked oligosaccharides having
N-acetyl-D-galactosaminitol at their reducing termini (Florman & Wassarman, 1985).
Furthermore, O-linked oligosaccharides fractionated by HPLC having an apparent
molecular mass between 3400-4600, possessed sperm receptor activity. Studies have
shown that when such O-linked oligosaccharides were treated with different
exoglycosidases only a-galactosidase and a-fucosidase have a significant effect (Bleil
& Wassarman, 1988; Wassarman, 1989). The involvement of a terminal galactose has
also been suggested to be important for sperm receptor activity. Sperm receptor
activity was lost when ZP3 was treated with galactose oxidase which converts the C-6
position alcohol of terminal galactose and N-acetylgalactosamine residues of ZP3
oligosaccharides to an aldehyde. The sperm receptor activity was restored by
regeneration of a C-6 position alcohol on galactose by reduction with sodium
borohydride (Bleil & Wassarman, 1988).
A new concept has been put forward for sperm-zona interaction in the mouse
involving a sperm surface B-,l,4-galatosyl transferase (Gal-transferace) that behaves
like a lectin, binding to a specific glycoside substrate on ZP3 (Miller et al. 1992). The
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specificity of this interaction is remarkable since the sperm galactosyl transferase
binds to ZP3 but not to any of the other zona pellucida glycoproteins. If the Gal-
transferase binding sites on ZP3 are blocked by incubation with purified Gal-
transferase and UDP-galactose, then ZP3 loses its biological activity. Removal of the
Gal-transferase binding sites with N-acetyl hexoseaminidase was also found to destroy
the ability of ZP3 to behave as a sperm receptor, while treatment with a-galactosidase
had no effect, in contrast to the report of Bleil and Wassarman (1988). After the
acrosome reaction, spermatozoa lose their affinity for ZP3 and the Gal-transferase
becomes relocated to a new membrane domain and loses its reactivity towards ZP3
(Miller et al. 1992). In contrast to the above results Noguchi et al.{ 1992) have shown
that neutral carbohydrate chains derived from the N-linked ZP oligosaccharides are
responsible for the sperm receptor activity expressed by porcine ZP3. Fucoidin,
blocks fertilization in a number of species like hamster, human, boar, rat and mouse
and disrupts the binding of acrosome-reacted guinea pig spermatozoa to homologous
zonae pellucidae(Huang et al. 1982; Ahuja, 1982). Fucoidin and ZP glycoproteins are
both known to bind to acid-extracted proteins from guinea pig spermatozoa in the
western blot detection system (Jones & Lancaster, 1988).
In the porcine model, a 55kD (ZP3) glycoprotein was found to possess sperm
receptor activity (Sacco et al. 1984). Digestion of ZP3 with endo-B-galactosidase
yields two glycoprotein species of 42,000 (B)and 46,000 (a)molecular mass, which
differ in their amino acid and carbohydrate composition, and have immunologically
distinct lactosaminoglycans (Yurewicz et al. 1987). Sacco et al (1989) have presented
evidence that the ZP3a (46,000 kD) glycoproteins of MR=55,000 protein possess
sperm receptor activity and have shown that the carbohydrate residue plays a critical
role in sperm receptor function. In the porcine model purified O-glycans inhibited
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sperm binding, but was 2-3 orders of magnitude less effective than ZP3 as a
competitive ligand (Yurewicz et al. 1991).
It has been reported that mouse ZP2 serves as a secondary sperm receptor and
that it binds exclusively to the inner acrosomal membrane of acrosome-reacted
spermatozoa and that acrosin might be its ligand (Bleil & Wassarman, 1986; Bleil et
al. 1988; Mortillo & Wassarman, 1991). Since the sperm Gal-transferase possesses no
affinity for ZP2 it is unlikely that this particular sperm surface entity is involved in
secondary binding phenomena. The most likely candidate for the ZP2 receptor at the
present time is (pro) acrosin, an acrosomal constituent than expresses, in addition to its
inherent proteolytic activity, a fucose binding domain that is capable of interaction
with the zona pellucida. During the acrosome reaction, the alkalinization of the
acrosomal contents leads to the autoactivation of proacrosin to generate acrosin
through the modification of both the N-terminal and C-terminal ends of the protein
(Fock-Nuzel et al. 1984; Cechova et al. 1988; Baba et al. 1989; Topfer Petersen et
al. 1990). Acrosin is liberated from the acrosomal vesicle during a very early stage of
the acrosome reaction and apparently becomes bound to the outer surface of the
plasma membrane, at least in the human (Tesarik et al. 1988). The relocation of
proacrosin/acrosin on the sperm surface places this molecule in an ideal position to
mediate the secondary phase of sperm-zona interaction following the initial attachment
of the sperm plasma membrane to the zona surface through the mediation of ZP3. The
pig has been used as an animal model for these studies and the results indicate that, as
long as protease inhibitors are present in the incubation medium, then the major zona-
binding entity in porcine spermatozoa is an Mr=53000 molecule with all the features
of proacrosin (Topfer Petersen & Henschen, 1987). The evidence for ZP2 binding on
proacrosin/acrosin is not very strong, but studies have suggested that basic residues
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like sulphate groups along the polymer backbone on proacrosin/acrosin are likely
determinants (Jones, 1990).
2.3.12 ZP3 as Acrosome Inducer
For successful fertilization to occur, spermatozoa must recognize and bind to the ZP.
ZP-binding triggers exocytosis in the acrosomal region of the sperm head, which is
mandatory for sperm passage through the ZP and access to the plasma membrane
where gamete fusion occurs (Bunch et al. 1992). Purified ZP3 induces mouse
spermatozoa to undergo the AR in vitro. However, a higher concentration of ZP3 is
needed for acrosome induction than for prevention of sperm-zona binding (Bleil &
Wassarman, 1983). Proteolytic fragments of ZP3 are known to retain the specific
binding, but not the acrosome reaction-inducing capacity of native ZP3, suggesting
that the polypeptide core of ZP3 is necessary for the acrosome reaction induction
(Florman et al. 1984a; Wassarman, 1989). Recently it has been confirmed, using gold-
labelled zona pellucida glycoproteins under the transmission electron microscope, that
mouse ZP2 and ZP3 bind preferentially to the sperm head of acrosome reacted and
acrosome intact spermatozoa, respectively(Mortillo & Wassarman, 1991). Recent
studies suggest that induction of the AR by ZP3 could depend on multivalent
interactions with the sperm surface leading to aggregation of receptors for ZP3 in the
sperm plasma membrane. This was demonstrated by incubating mouse spermatozoa
with small ZP3 glycopeptides that were unable to induce these cells to undergo the AR
in vitro until the glycopeptides had been cross-linked on the sperm surface with
specific antibodies (Leyton & Saling, 1989b). Investigators have (Leyton & Saling,
1989a) identified a Mr=95000 protein (p95) as a putative ZP3 receptor. According to
these authors bound multivalent ZP3 facilitates the oligomerization of p95 and leading
to the autophosphorylation of this putative receptor on tyrosine residues, initiating the
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intracellular cascade that finally results in acrosomal exocytosis. To date, no
experiments have been performed with tyrosine kinase inhibitors to determine whether
such reagents have the capacity to interfere with zona-induced acrosome reactions.
2.4 Immunocontraception
People of diverse religion and culture regard immunology with high esteem, so that
they willingly accept vaccination and other immunological treatments (Tyler, 1961).
In that context, immunocontraception may be an alternative to the existing methods of
contraception. An ideal immunocontraceptive must be one that is specific to a
particular antigen, is without any untoward effects, is cheap enough to produce, and
possibly, though not necessarily, reversible in nature.
Metchnikoff (1899) injected guinea pigs with the semen or the macerated testes
of man, bulls, guinea pigs and rabbits. He found that the serum of these different
animals agglutinated and immobilized the spermatozoa of all these various species.
There are a number of investigators who have actively immunized women with intact
spermatozoa or extracts of human, bull or ram spermatozoa, and all have obtained
positive results (Baskin, 1935; Laffont & Theron, 1934; Escuder, 1936). The
contraceptive potential of antibodies against fertilisin, prepared from the surface of the
sea-urchin egg, has also been demonstrated to block further development of treated
eggs (Tyler, 1957). There are primarily three potential candidate antigens which are
currently under development for immunocontraceptive purposes 1) human chorionic
gonadotrophin (hCG), 2) the zona pellucida and 3) sperm surface antigens.
Human chorionic gonadotrophin is secreted by the early embryo and can be
detected as early as 72 hours post implantation. This hormone is involved in the
maternal recognition of pregnancy through the rescue of corpus luteum function
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during the earliest stages of pregnancy. In this way, the embryo prevents the cyclical
demise of the corpus luteum that precipitates menstruation. There is considerable
homology in the primary amino acid structure of hCG and the pituitary gonadotrophin
LH (luteinizing hormone). The a-subunits of the two hormones are identical and the
G-subunit, has an additional short sequence of 37 amino acid at the carboxyl terminus
of hCG (Mitchison, 1990). Stevens and Crystle (1973) actively immunized post¬
menopausal and sterilized pre-menopausal women with sulphonic derivatives of whole
hCG and suggested that hCG could be made immunogenic in humans. Vaccines
incorporating the carboxyl sequence, conjugated to immunogenic carriers such as
diptheria toxoid have been used in phase I clinical trials and have shown to produce
antibody titres in the absence of any detectable side effects (Stevens et al. 1990). An
alternative approach employed the whole G-subunit of the hCG molecule as the
antigen. Initial studies were based on the conjugation of the G-subunit of hCG to
tetanus toxoid. This study had demonstrated that it was possible to raise antibodies
against hCG and that the response was reversible and free from any harmful side-
effects (Talwar et al. 1988; Talwar et al. 1990). In order to enhance the
immunogenicity of hCG, a chimeric hCG molecule has been created, in which the G-
subunit has been annealed to the a-subunit of ovine LH. This approach had generated
high anti-hCG antibody titres in many of the women involved in phase 1 clinical trials
in India, without any untoward side effects (Gaur et al. 1990).
Studies have shown that 5% of patients attending infertility clinics appear to be
infertile as a result of auto- or iso-antibodies against spermatozoa (Aitken et al. 1992).
These patients appear to suffer no other consequence of their immunity apart from
their infertility, the feasibility of developing a safe, effective contraceptive vaccine
based on sperm surface antigens would appear to have been demonstrated. It has also
been shown that patients having antisperm antibodies according to the conventional
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sperm-agglutination assays appear to generate a broad spectrum of antibodies directed
against multiple antigenic targets, and not to single dominant surface determinants
(Aitken et al. 1987). Surface antigens might not be integral components of plasma
membranes or acrosomal enzymes, since they may be lost during capacitation. The
ideal antigen should perhaps be present on the spermatozoa surface as well as inside
the cell (Kurpisz, 1990). A sperm surface antigen of internal origin which had
received wide attention is SP10. A monoclonal antibody against this antigen cross
reacts only with testicular germ cells and mature spermatozoa and not with somatic
cells (Herr et al. 1990). A 95 kD antigen has also been reported (Moore et al. 1987)
which is located intracellularly and when targeted by a monoclonal antibody disrupts
the attachment of human spermatozoa to the zona pellucida. Other antigens derived
from the acrosomal region of spermatozoa, termed HS-11 and HS-63 with Mr=35,000-
50,000 and Mr=40,000-50,000 respectively, have also demonstrated contraceptive
potential since antibodies against them interfere with the acrosome reaction induced by
either the ionophore, A23187, or ZP. A well characterised sperm surface antigen of
guinea pig origin called PH20 consistently produces a contraceptive effect in active
immunization studies and, furthermore, the contraceptive effects are reversible in both
males and females (Primakoff et al. 1988).
2.4.1 ZP3 Antigen for Immunological Contraception
In the past two decades various candidate antigens have been extensively studied for
immunologic contraceptives. These include spermatozoa antigens (Naz et al. 1991b;
Aitken et al. 1987) hormonal antigens (Stevens et al. 1990; Talwar etal. 1988) and zona
pellucida antigens (Yurewicz etal. 1986; Dean & East, 1986; Isojima etal. 1986; Sacco
et al. 1986; Paterson & Aitken, 1989; Mahi Brown et al. 1988; Paterson et al. 1992).
ZP3 emerges as a strong contestant for contraceptive vaccine development for the
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following reasons, 1) it possesses sperm receptor activity, 2) the antigens of which it is
comprised are not expressed in any other tissue, 3) small amounts of antibodies are
enough to block spermatozoa binding to single ovulated oocytes, 4) it is highly
immunogenic in most of the animals studied so far 5) it prevents rather than terminates
pregnancy, and 6) it can be purified by chromatographic methods.
Porter (1965) showed that when female guinea pigs were immunized with
guinea pig ovaries, inhibition of ovulation resulted. Later Shahani et al (1969)
prepared a rabbit antibody against mouse ovarian tissue and reported that this antibody
greatly inhibited fertility in vivo. Gonad specific antigens localizing to the sperm
acrosome and zona pellucida have been demonstrated by a fluorescent antibody
technique with rabbit anti-guinea-pig ovary and anti-guinea pig testis antisera (Porter
et al. 1970). Rabbit antibody against golden hamster ovary, when absorbed with
hamster small intestine and lung and then allowed to react in Oucterlony plates
produced one precipitin band against hamster ovary and no other bands against eleven
other hamster tissues tested (Ownby & Shivers, 1972). Sacco and Shivers (1973a)
studied the ovarian specific antigens by an indirect fluorescent antibody technique and
localized two major ovarian antigens in the zona pellucida, theca interna and atretic
follicles.
The notion of using zona pellucida as the target for a contraceptive vaccine was
first put forward by Shivers et al (1972) two decades ago. These workers
demonstrated the inhibition of sperm-egg interaction by an anti-ovarian antibody that
specifically targeted the zona pellucida. Sperm attachment was prevented due to the
formation of a precipitate on the outer surface of the zona pellucida. A number of
laboratories from different parts of the world have subsequently confirmed the
powerful immunogenecity and contraceptive potential of antibodies generated against
the zona pellucida. In vitro isolated oocytes treated with antibodies against ovarian
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extract inhibited sperm attachment to and penetration through the zona pellucida
(Ownby & Shivers, 1972; Sacco & Shivers, 1973b; Metchnikoff, 1899). Similarly,
antibodies against ovarian extract blocked the fertilization of golden hamster eggs in
vitro by binding to the zona pellucida and preventing sperm attachment and the same
antibody also rendered the animal sterile for 12 days when given as an intraperitoneal
injection (Oikawa & Yanagimachi, 1975). Rabbit antibodies produced against
hamster ovarian antigens blocked fertilization in vitro and in vivo and the formation of
a clear precipitate around the zona pellucida was responsible for this effect. The
specificity of the antizona antibodies used in such experiments was indicated when
radiolabeled antibody against hamster ovarian antigens was given in vivo was found
localized in the ovary to a higher degree than in any other tissue tested (Yanagimachi
etal. 1976).
2.4.2 Active Immunization
Practically all the initial immunization studies were done with crude ovarian extracts.
Heterologous, heat-solubilized hamster zonae pellucidae was employed for the first
time in active immunization studies by Gwatkin et al (1977) and the infertility induced
was found to be reversible and without any side effects. However, the ova recovered
from these immunized animals were found to have lost their shape and were fragile.
Anti-rat ovary antisera prepared in rabbits significantly inhibited fertilization of rat
eggs in vitro but also inhibited fertilization in the mouse and hamster indicating cross
reactivity between the zona antigens expressed by these respective species (Tsunoda &
Chang, 1976b). The observations of cross reactivity between rat and mouse zonae
pellucidae by indirect immunofluorescence, complement fixation and
immunoprecipitation tests facilitated the use of heterologous ZP in active
immunization experiments involving the rat and mouse (Aitken & Richardson, 1980).
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Rats were actively immunized with mouse ovarian antigen, and antibody titres were
monitored by immunofluorescence, immunoprecipitation and spermatozoa binding
assays. The antibody titre correlated with the onset and duration of infertility in the
rats during the course of the study period. Most of the animals remained infertile
without any side effects (Aitken & Richardson, 198Id). Further studies demonstrated
that rabbit anti-hamster ovarian antibody could block sperm-egg binding in a
homologous systems and that the antibody was effective when passively administered
in vivo without affecting the oestrous cycle and ovulation. In addition, anti-hamster
ovarian antibody when added to embryos at different stages (2, 4, 8, 16 cell and
morula stage) in vitro failed to implant when subsequently transferred to the uterus,
suggesting that the antibodies prevented zona shedding before implantation
(Dudkiewicz et al. 1975). Similar findings in the mouse have been reported using
rabbit anti-mouse ZP antibodies (Tsunoda & Chang, 1978). The cross linking induced
by the anti-ovarian antibodies rendered the ZP resistant to trypsin and pronase, both of
which are normally able to dissolve the zona pellucida without difficulty. Canine
ovarian antibodies also prevented in vitro fertilization of canine oocytes and the
implication of these findings for canine birth control has been discussed (Mahi &
Yanagimachi, 1979). Rats immunized with cross reactive mouse zonae pellucidae
showed a complete block of fertility without any side effects. After a decline in
antibody titres there was an uncomplicated return of fertility (Aitken & Richardson,
1981a). It has been suggested that the anti-zona antibodies can inhibit fertility even
after fertilization, in view of evidence produced by post mortem examination of
immunized animals, demonstrating the presence of fertilised ova surrounded by
fragile, fractured zonae (Aitken & Richardson, 1981a). In subsequent studies, the
duration of infertility following active immunization with heterologous pure ZP was
correlated with antibody titres measured by complement fixation, immunofluorescence
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and immunoprecipitation (Aitken & Richardson, 1981c). Similarly bitches immunized
with isolated porcine zonae pellucidae developed high antibody titres and expressed
prolonged infertility. In contrast, an animal immunized with homologous canine
zonae and one control immunised with adjuvant alone did become pregnant. The
bitches immunized with porcine zonae did however experience somewhat abnormal
cycles although the reason for this was not clear (Mahi Brown et al. 1982).
The development of large scale isolation methods has enabled the production
of useful quantities of zonae from various species such as the pig, (Dunbar et al. 1978;
Dunbar et al. 1980) rabbit (Dunbar, 1980) and cow (Gwatkin et al. 1980) for production
of antisera and biochemical characterization. Mice immunized with hamster zonae
(Gwatkin et al. 1977) and rabbits immunized with bovine (Gwatkin & Williams, 1978),
porcine (Gwatkin et al. 1980; Wood et al. 1981), or rabbit zonae (Wood et al. 1981) had
significantly reduced fertility. Immunization of rabbits with intact or heat-solubilized
porcine zonae pellucidae completely prevented term pregnancies. No eggs were found
after ovulation in the former group while ovulation had not occurred in rabbits
immunized with heat-treated ZP (Wood et al. 1981). Detergent-dissociated porcine
zonae or intact rabbit ZP used as immunogen produced variable reductions in fertility,
ranging from 30-70%. The antibody titres measured by radioimmunoassay were
maximal after the first booster and remained high throughout the experiment (Skinner
et al. 1984). Additional experiments involving the active immunization of rabbits with
heat-solubilized porcine ZP revealed that the rabbits had abnormal follicular
development, did not ovulate in response to hCG and had elevated serum
concentrations of gonadotrophins suggesting disruption of negative feedback control
by steroids of ovarian origin. Histological examination of the follicles showed only a
few growing follicles after 23 weeks of immunization and the follicles did not contain
oocytes (Skinner et al. 1984).
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The cross-reactivity exhibited between primate and porcine zonae pellucidae
(Sacco et al. 1981; Sacco et al. 1983) has also led to the use of primate models in
different active immunization studies. For example studies that have been carried out
in cynomolgus monkeys using heat-solubilized porcine ZP (Gulyas et al. 1983) in 1%
Alhydrogel, with monthly boosters. Six of the twelve monkeys became pregnant
between six to ten weeks after the first immunization, whereas the remaining monkeys
did not conceive, despite regular matings until their antibody titres fell after boosters
were stopped. The cycles of five monkeys were irregular and histological examination
of the ovaries showed some with developing follicles and some without. The authors
suggested that the impurity of the zona preparation may have caused the impairment of
ovarian function since repeated injections of contaminating proteins from eggs or
follicle cells could raise antisera to those structures. Active immunization studies
involving squirrel monkeys using purified porcine zona antigen (PPZA) of 60 kD,
which was shown to be free of the other two major glycoprotein families contained in
ZP, produced significant antibody titres. Laparoscopic examination of the monkeys
revealed that the ovaries of the immunized monkeys were smaller and had fewer
follicles than those of control animals. Only two oocytes could be recovered after
hCG injection to induce ovulation. The oocytes had evidence of antibodies bound to
the ZP suggesting that antibodies can reach the follicles in situ (Sacco et al. 1983).
Studies in bonnet monkeys immunized with 200|ig of intact pig zonae
pellucidae in Freund's adjuvant indicated that both progesterone and oestradiol
concentrations fell following the generation of high anti-zona antibody titres, but
normal cyclicity returned when the antibody titres fell to basal level (Bamezai et
al. 1986). A more elaborate study was done using 50 squirrel monkeys with a purified
porcine zona pellucida antigen possessing sperm receptor activity (Sacco et al. 1984).
After active immunization, high antibody titres were induced in the monkeys for as
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long as 18 months, and the animals experienced infertility. Disturbances in hormonal
status along with histological changes were observed in these animals suggesting
interference with folliculogenesis, although the initial disturbance was followed by a
recovery back to normal ovarian function, as indicated by laparoscopic and hormonal
data, despite the presence of high titres of anti-zona antibodies (Sacco et al. 1987).
Dunbar et al. (1989) have used muramyl dipeptide, a synthetic adjuvant, together with
purified porcine pig zona pellucida antigen (ZP1) to immunize baboons. These
animals showed decreased levels of oestrogen throughout the menstrual cycle, and two
of the animals ceased ovulation. Furthermore ovarian sections from these animals
revealed changes in the number and normality of ovarian follicles.
The ovarian pathology evident from the active immunization experiments
involving primates and rabbits has also been observed in bitches actively immunized
with crude or partially purified porcine zonae pellucidae. In such cases an elevation of
oestradiol levels and a reduction in plasma progesterone concentrations was observed
(Skinner et al. 1984; Sacco et al. 1991; Paterson et al. 1992). However when purified
porcine zonae pellucidae was used as an immunogen there was an inhibition of
fertility without loss of ovarian function, in all animals except one. All three different
adjuvants (Freund's, CP 20-961, and alum) produced antibody titres sufficient to
suppress fertility (Mahi Brown et al. 1985). Other reports indicated no observable
adverse effects following active immunization (Shivers et al. 1981). However, recent
studies in the marmoset have provided further evidence of ovarian dysfunction even in
animals that have ben actively immunized with highly purified porcine ZP3 antigens.
Active immunization studies employing of porcine ZP3 preparations such as
the deglycosylated polypeptide core of Mr=32,000 (DGZP-32) and the fully
glycosylated 55,000 (ZP3) have been used to actively immunize marmoset monkeys in
order to investigate the contraceptive efficacy and safety of such preparation (Paterson
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et al. 1992). The DGZP-32 with non-ulcerative Freund's adjuvant was not able to
generate antibody titres of the same magnitude as glycosylated ZP3. However, despite
the difference in immunogenicity between the native glycoprotein and the core DGZP-
32, both antigen sources exhibited contraceptive potential in vivo. Nevertheless,
during the course of these active immunization studies, animals exhibited abnormal
ovarian cyclicity. Ovarian histopathology in the high antibody titre animals was
associated with severe follicular atrophy, absence of primordial follicles and the
presence of a large number of follicular clusters with no evidence of active
folliculogenesis. When the immunogen consists of deglycosylated peptide, the onset
of this pathology was delayed and took about 2 years to manifest itself. Moreover,
when the cessation of ovarian cyclicity did become apparent, the pathology did not
reverse as antibody titres decline; it was permanent. It is important to note that there
was a considerable lag time before the onset of these pathological changes (Paterson et
al. 1992).
Progress towards the development of anti-zona vaccines that are free from
detrimental effects on the ovary has been made using the mouse as a model. A mouse
monoclonal antibody known to block fertilization in mice after passive immunization
was used to screen a cDNA encoding ZP3, which was randomly cleaved to 200-1000
base pair fragments. A synthetic peptide was synthesized based on the sequence
derived from the epitope library screening. The synthetic peptide, containing a B cell
epitope, was conjugated to a macromolecular carrier protein known to provide helper
T cell epitopes. This study demonstrated that repeated immunization of female mice
with a mouse ZP3 peptide-KLH conjugate can induce long term infertility without any
ovarian histopathology. It was suggested that the absence of ovarian histopathology
was due to a lack of ZP3 T cell epitopes which could otherwise have a cytotoxic effect
on the primordial follicles (Millar et al. 1989).
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2.4.3 In Vitro Studies
Anti-ovarian antibodies have been shown to block fertilization in vitro in a number of
mammalian species tested so far (Shahani et al. 1969; Porter, 1965; Shivers et al. 1972;
Tsunoda & Chang, 1976b). The inhibition of sperm attachment to the zona pellucida
is achieved through the occlusion of sperm binding sites on the zona surface by the
cross-linking activities of the anti-ZP antibodies, which result in the formation of a
precipitate on the ZP surface (Aitken et al. 1981; Aitken & Richardson, 1981b).
However, when the cross-linking activity of such antibodies is destroyed through the
preparation of Fab fragments, neither immunoprecipitate formation nor the inhibition
of sperm-zona interactions was observed (Aitken et al. 1982; Ahuja & Tzartos, 1981).
Monoclonal antibodies specific for either ZP-2 or ZP-3 also completely block in vitro
fertilization at relatively low concentrations ranging from 0.4 to 75 micrograms/ml.
The contraceptive effect requires the presence of the zona and appears to involve the
inhibition of zona penetration by the spermatozoa rather than the occlusion of sperm
binding sites (East et al. 1985). Monoclonal antibodies have also been described that,
while directed against single epitopes, can block sperm binding to the ZP even though
there is no immunoprecipitate formation (Isojima et al. 1984; Koyama et al. 1985; East
et al. 1985). In such cases, the antibody is not being effective through steric hindrance
mechanism but must be targeting on antigenic determinant in close proximity to the
binding site itself. Bamezai et al. (1988) have identified a mouse monoclonal antibody
against porcine ZP that inhibits sperm penetration in dogs. Some of the monoclonal
antibodies developed against porcine and rabbit ZP fail to block sperm binding,
although they react with the antigenic determinants present on the ZP (Drell &
Dunbar, 1984). Such antibodies must presumably be targeting antigenic determinants
distant from the sperm binding site. In general, most of the monoclonal antibodies
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generated against the ZP are not effective in disrupting fertilization by blocking sperm-
zona interaction, either at the level of sperm binding to the zona surface or by
preventing penetration of the zona matrix, even though immunological cross-reactivity
may be demonstrable (Isojima et al. 1984; Koyama et al. 1985). The addition of a
second, polyclonal antiserum directed against mouse immunoglobulin can generate
bioactivity by facilitating immunoprecipitate formation and masking the sperm
receptor sites by steric hindrance (Koyama et al. 1985). An important exception, in
terms of this need for a second cross linking antibody is the work of Mori et al (1985)
who generated two monoclonal antibodies; one of them formed an immunoprecipitate
during immunoelectrophoresis while the other did not. However, both antibodies
block human sperm-zona interactions without a need for a second, cross-linking
antibody (Mori et al. 1985). Such results emphasise that immunoprecipitation
formation is not an absolute requirement of the contraceptive action of antibodies
directed.
Recently, a different ZP antigen, identified in the porcine ZP and termed ZP4,
was purified by SDS-PAGE, and used to raise monoclonal antibodies. Five of these
monoclonal antibodies reacted with intact ZP of porcine, human and rabbit oocytes
and all five of them showed a strong blocking effect on the human spermatozoa-zona
interaction without the need for a second antibody. These antibodies appeared to
recognize a key epitope on the ZP, although it is not known whether their inhibiting
activity might have been due to steric hindrance of the sperm receptor through the
formation of immune complexes or due to direct interference with the receptor site
itself. The investigators have observed that the monoclonal antibody to ZP4 does not
block the initial spermatozoa binding to human ZP; instead, most of the spermatozoa
attached to ZP gradually dissociated within a few hours of the subsequent incubation
period. As a result, the number of spermatozoa bound and penetrating the ZP at the
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final stage of the incubation was markedly reduced (Koyama et al. 1991). It is
therefore possible that antibodies directed against ZP4 are effective in suppressing the
secondary binding of acrosome-reacted spermatozoa to the ZP, rather than the
disruption of the primary recognition event.
2.4.4 Passive Immunization Studies
Antisera against ovarian antigens could induce infertility in a variety of species such as
hamster (Oikawa & Yanagimachi, 1975), mice (Jivek & Pavlok, 1975), and rats
(Tsunoda & Chang, 1976b) by passive immunization. Fertilisation of golden hamster
eggs was blocked both in vitro and in vivo by antibodies produced in rabbits against
specific hamster ovarian antigens. Anti-hamster ovarian antigen antibody, when
injected into animals, bound to the ZP and blocked fertility for four oestrous cycles
and thereafter fertility returned to normal levels. These results suggested that the
antibodies did not cause destruction of the female reproductive organs. Passive
immunization with radiolabelled anti-hamster ovarian antigen antibodies indicated that
the antibodies were concentrated in the ovary during the period of infertility
(Yanagimachi et al. 1976). A single intraperitoneal injection of rabbit antisera against
denuded mouse eggs and isolated ZP inhibited fertilization in mice for 25-30 days.
After fertilization the antibodies did not affect the embryonic development of foetuses
(Tsunoda & Chang, 1978).
A single passive immunization of anti-zona antibodies in mice was found to
provide protection against conception for 24-30 days (Sacco, 1979). Dean and East
(1986) have demonstrated that passive immunization of mice with antibodies specific
for either ZP-2 or ZP-3 inhibited fertilization in vivo and in vitro. This effect was
observed with ng/ml quantities of antibody. It appeared that the antibodies did not
preclude sperm binding but rather prevented sperm penetration of the zona through
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their cross linking activity. The contraceptive effect of passive immunization is fully
reversible and this reversibility is associated with a loss of antibody binding to the
zona pellucida. Antibodies to ZP-2 or ZP-3 had no other adverse effects on either in
vivo or in vitro pre-implantation development (Dean & East, 1986). The prolonged
periods of infertility observed following the induction of passive immunity appear to
be due to the ability of these antibodies to bind to the zonae pellucidae of follicular as
well as ovulated oocytes. As a result, the ova liberated from the ovary over six or
seven successive cycles will have been affected by the anti-zona antibodies. Ova
recovered from passively immunized animals possess an immunoprecipitate on the
outer surface of the zona pellucida and an increased resistance to solublization
(Tsunoda & Chang, 1976b; Tsunoda & Chang, 1976a; Tsunoda & Chang, 1978).
Most interestingly, monoclonal antibodies developed against ZP2, which is the
secondary sperm receptor, are effective in blocking the formation of 2-cell embryos
(East et al. 1984b). Thus, antibody binding to the proposed primary sperm receptor
(ZP3) does not appear necessary to prevent fertilization.
2.4.5 Ovarian Pathogenicity
Experimental results obtained to date reveal that after active immunization of female
rabbits or primates with porcine ZP glycoprotein, there is an interruption of follicular
development, which coincides with the stage at which the ZP first appears as an
extracellular matrix between the oocyte and follicular cells. In actively immunized
rabbits there was a noticeable reduction in ovarian size and weight as early as 7 weeks
after primary immunization. Progesterone secretion in response to hCG was
completely absent within 20 weeks of immunization and FSH and LH secretion was
strikingly increased over control values. The alteration in ovarian function was
associated with the presence of serum antibodies to the three major porcine ZP
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glycoproteins. Histopathological analysis demonstrated that there was an increase in
the number of follicles with atretic oocytes and the complete disappearance of growing
follicles as well as corpora lutea within 30 weeks post immunization. The number of
primordial follicles present in the long-term (40-48 weeks) immunized animals was
reduced. This decrease was accompanied by an increase in the number of oocyte-free
follicular cell clusters. This whole effect appeared to be due to a humoral immune
response rather than a cell-mediated response, since there was no sign of macrophage
or leucocyte infiltration or inflammation in the ovaries even at early time points (e.g.
2-21 days) after the primary immunization (Skinner et al. 1984).
Immunisation with crude porcine ZP caused abnormal oestrous cycles and
infertility in bitches with high antibody titres against crude porcine ZP. In such
animals histological examination and steroid hormone profiles strongly supported a
failure of ovulation. In contrast bitches with low antibody titres against crude porcine
ZP seemed to have ovulated, as indicated by elevated serum progesterone levels. The
bitches immunized with purified porcine ZP had moderate titres and their cycles were
normal. Thus, in general, purified porcine ZP preparations did not affect the steroid
profile of bitches during their first cycle after immunization, but by the time of the
second cycle one animal which had received 6 injections, exhibited an abnormal cycle
associated with an abnormal steroid profile, similar to that in the bitches exhibiting
high antibody titres following immunization with crude porcine ZP material (Mahi
Brown et al. 1985). In some actively immunized bitches, oocytes did not ovulate or
might have ovulated in a degenerated condition. In some bitches, ovulation did not
occur because of a failure of follicles to survive beyond the primordial stage. In
bitches immunised with ZP, the most common histological finding in the ovaries was
follicular cysts and, in some cases, loss of oocytes from the follicles. It was suggested
that the condition observed seemed to reflect premature ovarian failure in women. It
Background 46
has been postulated that the loss of oocytes in actively immunized animals might result
from the interruption of communication between oocytes and the granulosa cells
because of interference with the cytoplasmic processes that pass from the corona cells
through the ZP, as a result of anti-zona antibody precipitation on the ZP surface (Mahi
Brown et al. 1988).
Bamezai et al (1986) have reported that bonnet monkeys immunized with
porcine ZP were infertile. Steroid secretion and ovarian cycles were disturbed during
the period of high anti-zona antibody activity, but returned to normal once antibody
levels had dropped. A reduction in the development of ovarian follicles and a decrease
in oocyte survival, along with reduced levels of oestrogen and variable levels of
progesterone secretion were observed in squirrel monkeys immunized with purified
porcine ZP3. After 10 months of immunization, there appeared to be a recovery in the
ovarian steroid response, despite the presence of high antibody titres, but fewer
oocytes were recovered from ZP3 injected monkeys (Sacco et al. 1987).
On the other hand, active immunization of bonnet monkeys with purified ZP3
showed adverse effects on the ovary depending upon the type of adjuvant used.
Animals immunized with complete Freund's adjuvant showed profound ovarian
follicular atrophy, and an absence of Graafian follicles and corpora lutea in the
ovaries. The secondary follicles were reduced in size and appeared as cellular
aggregates bound by a continual basal lamina but the primordial follicles continued to
survive. No leucocytic infiltration was noticed at any stage of follicular atrophy or
resorption. Bonnet monkeys immunised with ZP3 using sodium phthalyated
lipopolysaccharide as adjuvant did not show any noticeable histological changes in the
ovaries. The primordial follicles were abundant and present all along the periphery of
the ovarian cortex. The secondary follicles and large antral follicles displayed normal
morphology and signs of ovulation as indicated by the presence of corpora lutea
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(Upadhyay et al. 1989). It has been suggested that mycobacterial antigens present in
CFA could trigger autoimmunity against auto-antigens or might activate cytotoxic T
cells that could possibly react with certain ovarian antigens (Shoenfeld & Isenberg,
1988). Similar observations have also been made in control animals receiving CFA
alone which showed altered cyclic ovarian activities (Aitken et al. 1984; Sacco et
al. 1987; Sacco et al. 1986), whereas injection of pertussis toxin as an additional
adjuvant did not significantly alter the severity or prevalence of ovarian disease (Rhim
et al. 1992). In a further study, a synthetic mouse ZP peptide containing the B cell but
not T-cell epitope coupled to a carrier protein produced long-lasting contraception
without any ovarian histopathology (Millar et al. 1989).
The hormonal impact of immunization with solubilized ZP and ZP3 has been
recorded in rabbits. Both native ZP3B and ZP3B/endo-B-galactosidase-digested
(EBGD) immunogen produced elevated levels of LH and FSH and loss of hCG-
induced progesterone secretion. Whereas the rabbits immunised with ZP3a/EBGD,
ZPa/DG and ZP3B/DG showed no significant elevations of gonadotrophins and
continued to display cyclic progesterone secretion in response to hCG (Keenan et
al. 1991). Recently, a study was undertaken to analyse the importance of the
carbohydrate moiety in the aetiology of impaired ovarian function by comparing the
consequences of inducing immunity in the marmoset against porcine ZP3 and a
peptide derived from this molecule, DGZP32, the chemically deglycosylated core of
ZP3B. Regardless of the nature of ZP antigens used for the induction of immunity, all
animals showed signs of profound follicular atrophy. The ovaries appeared small with
no primordial follicles and contained a large number of follicular clusters with no
evidence of folliculogenesis. The plasma progesterone profiles indicated no initial
disturbance to the ovaries, but the presence of antibody for a prolonged period of time
(>18 months) led to a complete fall in progesterone levels. Such results suggested that
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it is not only the oligosaccharide side chains that might bear the epitopes responsible
for the induction of pathological changes in the ovaries of actively immunized animals
(Paterson et al. 1992).
In another study, immunization of mice with rat ZP had a significant effect on
small antral follicles suggesting that the pre-antral stage was most sensitive to the
effects of immunization. The percentage of all large follicles (pre-antral to large
antral) with visible oocytes was significantly less in the immunized mice (Mahi Brown
et al. 1992). Furthermore, this study demonstrated that a significant cellular response
can be generated by measuring the proliferation of T cells in response to ZP in vitro,
although this study was not extended to determine whether the ovarian pathogenicity
was due to a cellular immune response to ZP (Mahi Brown et al. 1992). The
importance of cellular immune responses in the aetiology of ovarian pathology was
emphasised by an experiment using a synthetic 15 amino acid mouse ZP3 peptide 328-
342, which could elicit oophoritis in B6AF1, BALBc/By, and A/J mice. This
synthetic peptide contained both B and T cell epitopes, suggesting that both epitopes
might be involved in autoimmune oophoritis in mice. However, adoptive transfer of
the disease by lymph node cells and two CD4+ T cell lines derived from mice
immunized with peptides ZP3 330-342 and ZP3 328-340 strongly suggested that T
cells were involved in ovarian atrophy. This study also further demonstrated in
actively immunised mice the presence of infiltrating inflammatory cells as early as day
6 post immunization with a maximum effect on day 21 (Rhim et al. 1992). Additional
experiments have been carried out in rabbits with different forms of ZP preparations
like solubilized porcine ZP (SIZP), purified porcine ZP3a and ZP36, purified endo-8-
galactosidase (EBGD) digested glycoproteins ZP3a-(EBGD), ZP3B-(EBGD)(each
about 30% deglycosylated), chemically deglycosylated (DG) core proteins ZP3a-DG
and ZP3B-DG. Rabbits immunised with SIZP and ZP3 showed greatest follicular
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growth disruption as early as 6 and 12 weeks after initial immunization. These
animals showed significantly fewer primary, secondary and tertiary follicles up to 36
weeks of this study (Keenan et al. 1991). Histopathological examination of ovaries
from ZP3G-EBGD-immunized rabbits showed a reduction in all stages of follicle
development, whereas ZP3B-DG showed a significant decrease in primary follicles
after 18 weeks of immunization but no significant follicular reduction of secondary
and tertiary follicles. On the contrary, rabbits immunised with ZP3a-EBGD and ZP3a-
DG showed normal follicular development of all stages with normal ovarian
morphology (Jones et al. 1992a). When a different antigen (porcine ZP4) was used as
a immunogen, there was a milder degenerative change in hamster ovarian sections,
which returned to normality during the subsequent decline of antibody titres
(Hasegawa et al. 1992).
2.5 Summary
The molecules of which the zona pellucida is comprised are thought to play many
important roles during the process of fertilization. Molecular cloning of the sperm
receptor has helped to understand the structure and function of ZP3. Also recombinant
technology has helped to produce abundant quantities of this material for further
research on contraceptive vaccine development, including the mechanism by which
the anti-fertility effects are achieved and the pathophysiology of ovarian dysfunction.
3 Cloning and Sequencing
ofMarmoset ZP3 Gene
3.1 Introduction
The discovery of the double helix structure ofDNA by Watson and Crick (1953) was a
significant breakthrough in molecular biology. In the 1970s, the advent of techniques
for the in vitro manipulation of DNA like subcloning and sequencing, completely
changed our understanding of the biology of living organisms. These new techniques
allowed the introduction of manipulated genetic material into an organism in such a
way as to replicate and be passed on to the progeny (Gingold, 1988). In order for the
foreign gene to replicate, it must be attached to a molecule that is capable of
replicating in a bacterial cell. A bacterial species such as E. coli will not recognize a
foreign gene; so it is essential to clone the foreign DNA into a carrier molecule that is
capable of integrating into the bacterium and replicating. Carrier molecules composed
of extrachromosomal DNA, termed plasmids, found in the bacterial species serve this
purpose (Broda, 1979). To clone a foreign gene into a vector the DNA has to be cut at
a particular site in order to ligate it into the vector sequence. It was found that bacteria
could cut up phage DNA on entry into the cell and the properties of these cutting
enzymes, called restriction enzymes or endonucleases, provided an invaluable tool for
cutting DNA at defined sites (Dussoix & Arber, 1962). The enzyme DNA ligase helps
to form covalent bonds between the cut ends of the DNA.
Many of the problems associated with protein sequencing have been solved by
DNA sequencing procedures (Sanger et al. 1977; Maxmam & Gilbert, 1977). The
chain termination technique using dideoxynucleotides has proven extremely valuable
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for rapid DNA sequencing. The polymerase chain reaction (PCR) has also speeded up
many molecular biology procedures like amplification of DNA from a single DNA
molecule, rapid sequencing, amplification of small amounts of mRNA by reverse PCR
or cDNA amplification, and cloning. The purpose of this section of the research was
to use such molecular biology techniques to clone and sequence the marmoset ZP3
gene and thence determine the primary amino acid structure of this molecule.
The importance of ZP3 stems from the role this proteins play during
fertilization: the binding of spermatozoa to the egg, the induction of the acrosome
reaction and the prevention of polyspermy. All earlier studies on the structure and
function of ZP3 utilised material manually isolated from the ovaries of a particular
species. Under such circumstances, it was rather difficult to obtain sufficient material
to determine the primary amino acid sequence of ZP3 or the structure of the gene
encoding this protein. This is particularly true of the ZP from primates, including
man, which are extremely difficult to obtain in appreciable quantities. As a
consequence, molecular biology techniques have been used to clone and sequence the
genes encoding for the ZP3 protein in a variety of different mammalian species. Thus,
the primary amino acid structure of human, mouse and hamster ZP3 have been
elucidated through gene cloning and sequence analysis (Kinloch et al. 1988; Kinloch et
al. 1990; Ringuette et al. 1988; Chamberlin & Dean, 1990). The results indicate that
ZP3 has no homology with other proteins; it is a sex-specific gene that is expressed
uniquely in growing oocytes during active folliculogenesis and is apparently
undetectable in the primordial follicle population. Comparison of the mouse and
hamster ZP3 proteins has revealed an 81% sequence homology, whereas the similarity
between these amino acid sequences and human ZP3 is around 60% (Figure 3.8). The
polypeptide core of all three proteins is approximately 420 amino acid residues in
length, in which two potential N-linked glycosylation sites are conserved. Additional
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N-linked carbohydrate addition sites and numerous positions for O-linked sugars
probably provide the protein with the structural information that is essential for the
species specificity of sperm-zona interaction. Thus, despite the conserved primary
amino acid structures of the polypeptide core, differential glycosylation leads to
considerable heterogeneity in the molecular mass of the secreted product giving an
apparent Mr of 83kD for the mouse ZP3 and a spectrum of charge isomers ranging
from 50 to 60 kD for human and hamster ZP3 (Moller et al. 1990; Shabanowitz,
1990).
Conservation and elucidation of the primary structure of human ZP3 have been
particularly important in the context of contraceptive vaccine development.
Antibodies against the deglycosylated peptide core of porcine ZP3 have been shown to
block the fertilization of human ova in vitro and, moreover, to disrupt the fertility of
actively immunised marmosets in vivo (Paterson et al. 1992). Such active
immunization experiments have been particularly informative since they have revealed
important side effects of anti-ZP3 immunity, involving the depletion of the primordial
follicle population and the onset of a premature menopause. While the induction of
immunity against heterologous zona antigens has generated interesting information,
such studies may not accurately reflect the consequences of developing immunity
against a homologous peptide.
The ideal protocol for the evaluation of a contraceptive vaccine would be one
in which an animal model, such as the marmoset monkey, was immunized with
homologous ZP3 peptides that exhibited perfect sequence homology with human ZP3.
In order to develop such a model the primary amino acid structure of marmoset ZP3
would have to be elucidated and compared with its human counterpart. The present
study was designed to achieve this objective.
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Figure 3.1 Schematic diagram of the marmoset ZP3 cloning and sequencing
procedure (A). PCR 1000 Vector employed for cloning the mar ZP3 cDNAs (B).
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3 2 Materials and Methods
3.2.1 Poly(A)-mRNA Isolation
Marmoset ovarian material was collected from the Medical Research Council, Primate
Colony, Edinburgh for the purpose ofmRNA isolation. The ovarian tissue was frozen
in liquid nitrogen and transported to the laboratory and stored at -80°C until use where
the tissue was homogenised using a glass hand-homogenizer (Kontes Biotechnology,
Vineland, NJ, USA). For the mRNA isolation, Dynabeads, mRNA purification kit
(Dynal (UK) Ltd, New Ferry, Wirral, UK) was used. 1ml lysis/binding buffer [100
mM Tris-HCl, pH 8.0; 500 mM LiCl; 10 mM EDTA, pH 8.0; 1% lithium
dodecylsulphate (LiDS); 5 mM dithiothreitol (DTT)] was added to the homogenizer
and homogenised manually for 1-2 min. The lysate was transferred to a microfuge
tube and spun for 30 seconds. The supernatant was mixed with 1.5 mg of Dynabeads
Oligo (dt) in 100 |il lysis/binding buffer and allowed to anneal for 3-5 minutes on ice.
The tube was placed in the Dynal MPC-E-1 magnetic stand and the supernatant
removed. The bound oligo (dt) was washed 3 times with 0.5 ml washing buffer (10
mM Tris-HCl, pH 7.5; 0.15 M lithium chloride; ImM EDTA; 0.1-0.3% SDS) using
the Dynal MPC-E-1 separator. The bound Poly (A)-mRNA was eluted with 20|il of
elution buffer (2 mM EDTA, pH 7.5) by incubating the tube in a 65°C water bath for 2
minutes.
3.2.2 Marmoset Ovarian cDNA Synthesis
The Poly (A)+RNA of marmoset ovary was used to synthesize the cDNA by using
Amersham's cDNA synthesis system plus (Amersham, UK). The first strand cDNA
synthesis was made as follows, 4|il of 5x 1st strand synthesis reaction buffer, 1 |nl of
sodium pyrophosphate solution, 2|il of human placental ribonuclease inhibitor,
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deoxynucleoside triphosphate mix, l(il of Oligo dt, 2|il ofmarmoset ovarian poly (A)+
RNA (2 |ig), 9|il of water and reverse transcriptase, 1.5|_l1 containing 40 units of
activity and then incubated at 42°C for 40 minutes.
3.2.3 Second Strand cDNA Synthesis
To the above first strand cDNA mixture, was added 37.5fil of second strand synthesis
reaction buffer, lpl (0.8 units) of E.coli ribonuclease H, 6jil (23 units) of E.coli DNA
polymerase 1, and 34jil of water. The above reaction was carried out at 12°C for 60
minutes; 22°C for 60 minutes and 70°C for 10 minutes. After a brief spun, 2[il
containing 2 units of T4 DNA polymerase was added and incubated at 37°C for 10
minutes. The reaction was stopped by adding 2|il of 0.5M EDTA pH 8.0. The cDNA
reaction mixture was extracted using 1 volume of 1:1 phenol chloroform (1 part TE
buffer-saturated phenol, pH 7.8; 1 part chloroform). The solution was vortexed for 1
minute and then microcentrifuged at 12 000 x g for 5 minutes. The upper aqueous
phase was transferred to a new tube and an equal volume of chloroform added. After
vortexing for 1 minute, this was spun at 12 000 x g for 5 minutes. The upper aqueous
phase was again transferred to a new tube and an equal volume of 4M ammonium
acetate was added together with twice the combined volume of cold (-20°C) ethanol
which had been cooled at -20°C for a minimum of 30 minutes. After centrifuging at
12 000 x g for 5 minutes, the supernatant was carefully removed and the pellet
resuspended in 1 ml of 70% ethanol. This was spun again, the supernatant carefully
aspirated and the cDNA pellet dried under vacuum. The pellet was resuspended in
10|il of TE buffer (lOmM Tris-HCl, pH 8.0, ImM EDTA, pH 8.0).
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3.2.4 Primer Synthesis
Oligonucleotide primers were made using an Oligonucleotide synthesizer (Applied
Biosystems, Warrington, Cheshire, UK). The primers were removed from the column
using 2ml ice-cold ammonia and deprotected by incubating overnight in a 55°C water
bath. The deprotected primers were ethanol precipitated and stored at -20°C as
aliquots.
3.2.5 Agarose Gel Electrophoresis
Agarose gels were run using a Mini submarine agarose gel unit (Model HE33; Hoefer
Scientific Instruments, Newcastle, Staffs, UK). 1% agarose gels (SeaKem GTG
Agarose; FMC Bioproducts, High Wycombe, Bucks, UK) in 0.5 x TBE containing
0.3(ig/ml ethidium bromide (EtBr; Sigma, Poole, Dorset, UK) were run at a constant
voltage of 80V for 1-2 hours using 0.5 x TBE as the electrode buffer. Low melting
point 2% agarose gels in (Nusieve GTG agarose; FMC Bioproducts) 1 x TAE
containing 0.3(tg/ml EtBr were run at a constant voltage of 45V for 2 hours at 4°C
using 1 x TAE as the electrode buffer.
3.2.6 Polymerase Chain Reaction
The marmoset ovarian cDNA was used as template to amplify marmoset cDNA 1-6
using the polymerase chain reaction (PCR; Saiki et al, 1985, 1988; Mullis & Faloona,
1987). PCR was performed using a GeneAMP PCR Reagent kit with AmpliTaq DNA
Polymerase (Perkin Elmer Cetus, Norwalk, CT, USA) using two primers synthesized
as described in Section 3.2.4 and a programmable heating block (Hybaid, Teddington,
Middlesex, UK). Marmoset ZP3, exon 1-6 corresponding to human ZP3 (Chamberlin
& Dean, 1990) was amplified with oligonucleotide primers 1, 5'-
TGCAGGGTACCATGGAGCTATAGGC-3' and primer 2, 5'-
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ATCACACCATCGTGGAC-3' in 35 cycles of PCR. The final concentrations of the
components in the lOOfil reaction mixture were AmpliTaq DNA Polymerase, 2.5
Units; dNTPs each 200pM; lx reaction buffer (lOmM Tris-HCl pH 8.3, 50mM KC1,
1.5 mM MgCl2, and 0.001% (w/v) gelatin); 0.5|iM primer 1, 0.5fiM primer 2, The
PCR reaction involved 35 cycles of incubation at 94°C for 2 minutes to achieve the
initial melt, then 94°C for 1 minute, 60°C for 2 minutes, and 72°C for 3 minutes
followed by a final extension at 72°C for 15 minutes. The PCR reaction products were
checked by electrophoresis in a submerged 1% agarose gel in 0.5 x TBE buffer run at
a constant voltage of 80V for 1 hour.
Marmoset ZP3, exon 4-8 corresponding to human ZP3 (Chamberlin & Dean,
1990) was amplified with oligonucleotide primers 3, 5'-
CAGGTGGCAGGTGATGTA-3' and primer 4, 5'-
CTTCTTTTATTCGGAAGCAGACACAGG-3' in 30 cycles of PCR. The final
concentrations of the components in the 100|il reaction mixture were AmpliTaq DNA
Polymerase, 2.5 Units; dNTPs, each 2()0(iM; lx reaction buffer (lOmM Tris-HCl pH
8.3, 50mM KC1, 1.5 mM MgCl2, and 0.001% (w/v) gelatin), 0.5|TM primer 3, and
0.5|iM primer 4. The PCR reaction involved 30 cycles incubation at 94°C for 2
minutes to achieve the initial melt, then 94°C for 1 minute, 55°C for 2 minutes, and
72°C for 3 minutes followed by a final extension at 72°C for 15 minutes. The PCR
reaction products were checked by electrophoresis in a submerged 1% agarose gel in
0.5 x TBE buffer run at a constant voltage of 80V for 1 hour.
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3.2.7 Cloning into PCR 1000 Vector
The products of 12 independent PCR runs were pooled and the amplified cDNA
fragments of marmoset ZP3 exons 1-6 and 4-8 (0.8 and 0.6kb respectively) so
generated were purified by agarose gel electrophoresis using Geneclean II kit
(Geneclean II kit, Bio 101 Inc. La Jolla, USA) for cloning into the vector. The
marmoset ZP3 exon 1-6 fragment was ligated with PCR 1000 vector (TA cloning kit,
Invitrogen, Burford, UK). The ligation mixture contained 2(il of PCR™ vector
(25ng/[il), 2(il of marmoset ZP3 exon 1-6 DNA (50ng/pl), l|il of 10 x ligation buffer,
5|il of water, and l|il of T4 DNA ligase. Ligation was carried out at 12°C, overnight.
The following day, frozen competent E. coli cells (INVaF') (TA cloning kit,
Invitrogen, Burford, UK) were used for transformation. l|il of the ligation mixture
was added to the competent cells and mixed by tapping gently. The tube was placed
on ice for 30 minutes and then incubated for exactly 60 seconds in a 42°C water bath
followed by a 2 minute storage on ice. The cells were immediately resuspended in
lml of prewarmed (37°C) SOC medium (2% Bacto tryptone, 0.5% Bacto yeast extract,
lOmM NaCl, 2.5mM KC1, lOmM MgCl2, 10mM MgS04, 20mM glucose) and
incubated at 37°C for 1 hour with shaking in 17 x 100mm polypropylene tubes. The
cells were then plated on LB plates containing 50|J,g/ml kanamycin, 40|ig/ml X-gal
and 0.5mM IPTG (Isopropyl B-D-thiogalactoside) and grown overnight at 37°C. E.
Coli cells transformed with recombinant plasmids resulted in the formation of white
colonies. Several white (putative positive) colonies were grown up in LB medium
containing 50fig/ml kanamycin, at 37°C, overnight and the plasmids purified using
Magic Mini-Prep columns (Promega, Southampton,UK). To identify positive clones,
the purified plasmid was restriction map analysed by digesting with Ncol restriction
enzyme (Section 3.2.8), and a band of the appropriate size resolved on a 1% agarose
gel before being isolated and subjected to DNA sequencing.
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The marmoset ZP3 exon 4-8 PCR fragments were also cloned in the PCR 1000 vector
as described in section 3.2.7. To identify positive clones, the purified plasmid was
digested with Ncol and Sacl restriction enzyme as described in section 3.2.9,
identified as a band of the appropriate size of 600 nt resolved on a 1% agarose gel and
finally isolated and subjected to DNA sequencing.
3.2.8 Digestion of Plasmid with Ncol
The restriction enzyme Ncol was purchased from Promega and used with the
restriction enzyme buffer supplied with it. The reaction mixture contained plasmid
DNA of marZP3 exon 1-6, 25|il (1.5|ig), 3|il of restriction enzyme buffer, 2|il (20
units) of restriction enzyme Ncol, and the reaction was carried out at 37°C for 1-2
hours.
3.2.9 Digestion of Plasmid with Ncol and Sacl
The restriction enzyme Ncol and Sacl were purchased from Promega and used in
conjunction with the restriction enzyme buffer from Pharmacia 'One-Phor-All'. The
reaction mixture contained plasmid DNA of mar ZP3 exon 4-8, 25jil (1.5|ig), 4|il of
restriction enzyme buffer, 3|il (30 units) of restriction enzyme Ncol, 3|il, (30 units) of
restriction enzyme Sacl, 5|il of water, and the reaction was carried out at 37°C for 1-2
hours.
3.2.10 Alkaline Denaturation of DNA
The plasmid DNA was denatured using alkaline treatment. The DNA was denatured
in 0.2M NaOH, 0.2mM EDTA for 30 minutes at 37°C and was neutralised by adding
0.1 volumes of 3M sodium acetate, pH 5. The DNA was precipitated with 4 volumes
of ethanol for 15 minutes at -70°C and then pelleted by centrifugation at 14 000 x g for
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10 minutes. The pelleted DNA was washed with 70% ethanol and after a second
centrifugation, the pellet was dried under vacuum. The DNA was then redissolved in
water to be used for sequencing analysis (Section 3.2.11).
3.2.11 Sequencing
The nucleotide sequence of the subcloned insert was determined according to the
dideoxynucleotide chain termination method of Sanger et al (1977) using a
commercially available sequencing kit (Sequenase; United States Biochemical
Corporation, Cambridge, UK) and 35S-dATP (Amersham). The annealing reaction
comprised 7|il of denatured plasmid DNA, 2ptl of Sequenase reaction buffer and l|il
primer (approximately 300ng). The tubes were warmed to 65°C for 2 minutes then
allowed to cool slowly to <30°C. Dimethyl sulphoxide (DMSO) was added to the
termination mixes at a ratio of 9:1 (mixrDMSO) and also to the dilute labelling mix in
the same ratio (Winship, 1989). The labelling reaction was carried out by adding lp.1
dithiothreitol (DTT, 0.1M), 2jil diluted labelling mix (1:4), 0.5|il 35S-ATP and 2 til
diluted Sequenase enzyme (1:8) to the annealed template-primer mix and this was
incubated at room temperature for 5 minutes. The reactions were terminated by
adding 3.5|il of the sequencing reaction mixture to each of the prewarmed (37°C)
termination mixes containing a dideoxynucleotide (ddA, ddC, ddG and ddT; 2.5(il)
and incubated for 5 minutes at 37 °C. The reactions were finally stopped by adding 4|il
of formamide stop dye to each termination mix and the vials placed on ice until the gel
was prepared. The sequencing reaction products were run on a Hydrolink Long
Ranger sequencing gel (AT Biochem, Newcastle, Staffs, UK) prepared according to
the manufacturer's instructions. Gels were run using an LKB power supply at 35 W
constant power for 3 hours. The gel was transferred to Whatman 3MM
chromatography filter paper and carefully covered with cling film. The gel was dried
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under vacuum at 80°C for 30 minutes (slab Gel Dryer, Hoefer Scientific Instruments,
Newcastle, Staffs, UK) after which the cling film was removed and the gel exposed to
X-ray film (Kodak X-OMAT AR; Kodak, Liverpool, UK) overnight. The X-ray film
was developed after 24-48 hours using X-ray film developer and fixer (Kodak
liverpool, UK). Analysis of human and marmoset polypeptide sequence was done by
GeneJockey software (Medical Research Council, UK) while the hydropathicity
profile of marmoset ZP3 polypeptide chain was created by Kyte-Doolittle computer
analysis (Kyte and Doolittle, 1982).
3.2.12 Restriction Map Analysis
The sequenced marmoset ZP3 gene was restriction map analysed using Genejockey
software (Medical Research Council, UK).
3.3 Results
The marmoset poly(A)+ RNA isolated from marmoset ovarian tissue was used to
create marmoset ovarian cDNA which, in turn, served as a substrate for the
amplification of ZP3 cDNA. Due to the difficulty in obtaining larger PCR fragments,
we chose to amplify marmoset ZP3 exon 1-6 and exon 4-8 separately using primers
based on the human ZP3 sequence (Chamberlin & Dean, 1990). The PCR products
were electrophoresed on an 0.8 % agarose gel (Figure 3. 2) which indicated that the
PCR product containing marmoset ZP3 exon 1-6 was approximately 0.8 kb in size.
Marmoset ZP3 exon 4-8 PCR products were electrophoresed on an 0.8 % agarose gel
(Figure 3. 3) which indicated that the PCR product was approximately 0.6 kb in size.
Both cDNA fragments, encoding exon 1-6 and 4-8 respectively were cloned into the
PCR 1000 vector. Positive white colonies containing marmoset ZP3 exon 1-6 in PCR
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1000 vector were identified by restriction enzyme digestion with Ncol restriction
enzyme. The positive plasmid contained approximately a 750nt band of marmoset
exon 1-6 and a PCR 1000 vector band of 600nt (Figure 3. 4). Positive white colonies
containing marmoset exon 4-8 in PCR 1000 vector were identified by restriction
enzyme digestion with Ncol and Sacl. The positive plasmid released 550 nt bands are
shown in Figure 3.5. The plasmids containing marmoset ZP3 exons 1-6 and 4-8 were
sequenced in both directions to exclude the possibility of PCR-induced mutations.
Moreover, the validity of the sequence data was confirmed on 4 independent analyses.
The entire cloned marmoset ZP3 cDNA sequence is presented in Figure 3.7.
MarZP3 possesses an open reading frame of 1272 nucleotides, which is identical in
length to the published human ZP3 sequence (Chamberlin & Dean, 1990). Similarities
to the human ZP3 sequence also exist in that the marmoset ZP3 mRNA does not have
a 3'untranslated region, since the translational stop codon TAA coincides with the
RNA polyadenylation signal (Chamberlin & Dean, 1990). A partial restriction map of
mar ZP3 cDNA is presented in Figure 3.6.
The predicted polypeptide consists of 424 amino acids, with a calculated
molecular mass of 46815. An alignment with the human, mouse and hamster
sequences is presented in Figure 3.8. The primary amino acid structure revealed a
significant similarity between the marZP3 and huZP3 (Chamberlin & Dean, 1990),
giving an overall homology of about 91% (Figure 3.8). The disparity between these
proteins is confined to widely dispersed changes in one or two amino acids with the
exception of the polypeptide chain spanning residues 322-352 in which the homology
was reduced to 45%. Comparison of marZP3 with the murine and hamster ZP3
sequences indicated an overall homology of 68% and 61% respectively.








Figure 3.2 Electrophoresis in 0.8% agarose gel showing PCR products. Lane 1, DNA
size markers, an EcoRI and Hind III digest of lamda DNA producing bands of sizes 21
227bp, 5148bp, 4973bp, 4268bp, 3530bp, 2027bp, 1904bp, 1584bp, 1375bp, 975bp,
831bp, 564bp and 125bp; Lane 2, PCR fragment of mar ZP3 exon 1-6, which is
indicated by an arrow; Lane 3, same as lane 2 but no substrate was added. The gel was
run at 80V for 1-2 hour in 0.5 x TBE.








rs«„re 3 3 Electrophoresis in 0.8% agarose gel showing PCR products. Lane 1, DNAiT^J'TecoRI and Hind III digest of lamda DNA; Lane 2, PCR fragment of











™ * d FlectroDhoresis in 0.8% agarose gel. Positive white colonies containingngure 3.4 Electiop
1000 vector digested with Ncol restriction enzyme. Lane 1,nar ZP3 exon 1-6 inPCR1000^ ^ ^diSstedwith Ncol showing release of exon 1-6 insert of approximately 750 bpindicated by an arrow and PCR 1000 vector bandof size 600 bp. Lane 3, same as lane
2. The gel was run at 80V for 1-2 hour in 0.5 x TBE.









Figure 3.5 Electrophoresis in 0.8% agarose gel. Positive white colonies containing
mar ZP3 exon 4-8 in PCR 1000 vector digested with Sacl and Ncol restriction
enzymes. Lane 1, DNA size markers, an EcoRI and Hind III digest of lamda DNA;
Lane 2, positive PCR 1000 vector digested with Sacl and Ncol showing release of
exon 4-8 insert of approximately 550bp indicated by an arrow and the PCR 1000 vector
band of 3000bp, which is also indicated by an arrow. The gel was run at 80V for 1-2
hour in 0.5 x TBE.
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Human, marmoset, hamster and mouse ZP3 contain 4, 5, 4, and 6 potential sites for re¬
linked glycosylation respectively (Struck & Lennarz, 1980; Kornfeld & Kornfeld,
1985) of which two positions are conserved between all species (Figure 3.8) while the
marmoset and human ZP3 share 4 sites for the addition of N-linked carbohydrate side
chains.
As in the other species for which the amino acid sequence is known, marZP3 is
characterized by an abundance of serine and threonine residues, 90% of which are
conserved in the human ZP3 protein. All 15 cysteine residues (Chamberlin & Dean,
1990) present in both human and marmoset ZP3 molecules are located in the same
positions, where they may participate in the formation of disulphide bonds to maintain
the secondary structure of the ZP3 proteins. Proline residues (29) were also unusually
common in both marZP3 and huZP3 and were conserved with the exception of residue
305 in the human and residue 347 in the marmoset sequence. A hydrophobicity plot
(Figure 3.9) of marZP3 showed the presence of one hydrophobic sequence at the
amino terminus and two hydrophobic segments at the carboxyl terminal of the protein
sequence. Comparison of huZP3 and marZP3 hydropathicity plots generated similar
profiles (Figure 3 9). On the basis of protein sequence homology and hydrophobicity
profile, a 22 amino acid signal peptide was predicted at the amino terminus of marZP3
(Von Heijne, 1986) giving a secreted peptide of 402 amino acids with a molecular
mass of 44182 D and an N-terminal glutamine.
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Figure 3.6 Partial restriction map of marmoset ZP3 cDNA analysed using
Genejockey software (Medical Research Council, UK). Sal 1 restriction enzyme site
is indicated in bold letters, which was employed in subcloning and creating a full
length mar ZP3 cDNA.
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1 5'-TGCAGGTACC
Met Glu Leu Ser Tyr Arg Leu Phe lie Cys Leu Leu Leu Trp Gly Ser 16
11 ATG GAG CTG AGC TAT AGG CTA TTC ATC TGC CTC CTG CTC TGG GGT AGT
Thr Glu Leu cys Tyr Pro Gin Pro Leu Arg Leu Leu Gin Gly Gly Thr 32
60 ACT GAG CTG TGC TAC CCC CAA CCC CTC AGG CTC TTA CAG GGT GGA ACC
Ser His Pro Glu Thr Ala Leu Gin Pro Val Val Val Glu Cys Gin Glu 48
108 AGC CAC CCT GAG ACC GCT CTG CAG CCC GTA GTG GTG GAG TGT CAG GAA
Ala Thr Leu Val Val Thr Val Ser Lys Asp Leu Phe Gly Thr Arg Lys 64
156 GCC ACC CTA GTG GTC ACA GTC AGT AAA GAC CTT TTT GGC ACC AGG AAG
Leu He Arg Ala Val Asp Leu Thr Leu Gly Pro Glu Gly Cys Glu Pro 80
204 CTT ATC AGG GCT GTT GAT CTC ACC CTG GGC CCA GAG GGC TGT GAG CCC
Leu Val Ser Thr Asp Thr Glu Asp Val Val Arg Phe Glu Val Gly Leu 96
252 CTG GTC TCC ACG GAC ACA GAG GAT GTG GTC AGG TTT GAG GTT GGA CTC
His Glu Cys Gly Asn Ser Met Gin Val Thr Asp Asp Ala Leu Val Tyr 112
300 CAT GAG TGT GGT AAC AGC ATG CAG GTG ACC GAC GAT GCC CTG GTG TAC
Ser Thr Phe Leu Leu His Asp Pro Arg Pro Val Gly Asn Leu Ser lie 128
348 AGC ACC TTC CTG CTT CAC GAC CCC CGC CCT GTG GGA AAC CTG TCC ATC
Val Arg Thr Asn Arg Ala Glu lie Pro lie Glu Cys Arg Tyr Pro Arg 144
396 GTG AGG ACT AAC CGC GCA GAG ATT CCC ATC GAG TGC CGC TAC CCC AGG
Arg Gly A?n Val Ser Ser Gin Ala lie Leu Pro Thr Trp Leu Pro Phe 160
444 CGG GGC AAT GTG AGC AGC CAG GCC ATC CTT CCC ACC TGG CTG CCC TTC
Arg Thr Thr Val Phe Ser Glu Glu Lys Leu Thr Phe Ser Leu Arg Leu 17 6
492 AGG ACC ACG GTG TTC TCA GAG GAG AAG CTG ACT TTC TCT CTG CGC CTG
Met Glu Glu A?n Trp Ser Thr Glu Lys Arg Thr Pro Thr Phe His Leu 192
540 ATG GAG GAG AAC TGG AGC ACT GAG AAG AGG ACC CCT ACC TTC CAC CTG
Gly Asp Val Ala His Leu Gin Ala Glu lie nis Thr Gly Ser His Val 208
588 GGA GAT GTG GCC CAC CTC CAG GCA GAA ATC CAC ACT GGC AGC CAC GTG
Pro Leu Arg Leu Phe Val Asp His Cys Val Ala Thr Pro Thr Pro Asp 224
636 CCA CTG CGG CTA TTT GTG GAC CAC TGT GTG GCC ACG CCA ACA CCA GAC
Gin Assn Ala Ser Pro Tyr His Thr lie Val Asp Phe His Gly Cys Leu 240
684 CAG AAT GCC TCC CCT TAT CAC ACC ATC GTG GAC TTC CAT GGC TGT CTT
Val Asp Gly Leu Thr Asp Ala Ser Ser Ala Phe Gin Ala Pro Arg Pro 256
732 GTC GAC GGT CTC ACT GAT GCC TCT TCT GCA TTC CAA GCT CCC AGA CCC
Arg Pro Asp Thr Leu Gin Phe Thr Val Asp Val Phe His Phe Ala Asn 272
780 AGG CCA GAT ACA CTC CAG TTC ACG GTG GAT GTG TTT CAT TTT GCT AAT
Asd s<?r Arg Asn Met lie Tyr lie Thr Cys His Leu Lys Val Thr Leu 288
828 GAC TCC AGA AAT ATG ATA TAC ATC ACC TGC CAC CTG AAG GTC ACC CTA
Ala Glu Gin Asp Pro Asp Glu Leu Asn Lys Ala Cys Ser Phe Ser Lys 304
876 GCT GAG CAG GAC CCA GAT GAA CTG AAC AAA GCC TGT TCC TTC AGC AAG
Ala Ser Asn Ser Trp Phe Pro Val Glu Gly Pro Ala Asp lie Cys Gin 320
924 GCT TCC AAC AGC TGG TTC CCG GTG GAA GGC CCG GCT GAC ATC TGC CAG
Cys Cys Ser Lys Gly Asp Cys Gly Thr Pro Ser His Ala Arg Arg Gin 336
972 TGC TGT AGC AAG GGT GAC TGT GGC ACT CCA AGC CAT GCC AGG AGG CAG
Pro His Val Val Ser Leu Gly Ser Gly Ser Pro Ala Arg Asp Arg Arg 352
1020 CCC CAT GTC GTG AGC CTG GGG TCG GGT TCT CCT GCC CGT GAC CGC AGG
His Val Thr Glu Glu Ala Asp Val Thr Val Gly Pro Leu lie Phe Leu 368
1068 CAT GTG ACA GAA GAA GCA GAC GTC ACC GTG GGA CCG CTG ATC TTC CTG
Asp Arg Thr Gly Asp His Glu Met Glu Gin Trp Ala Leu Pro Ala Asp 384
1116 GAC AGG ACT GGT GAC CAC GAA ATG GAG CAG TGG GCC TTG CCG GCT GAC
Thr Ser Leu Leu Leu Leu Gly Thr Gly Leu Ala Val Val Ala Leu Leu 400
1164 ACC TCC TTG CTG CTG CTG GGC ACA GGC CTG GCT GTT GTG GCG CTC CTG
Thr Leu Thr Ala Val lie Leu Val Leu Thr Arg Arg Cys Arg Thr Ala 416
1212 ACT CTG ACC GCT GTT ATC CTG GTT CTC ACC AGG AGG TGT CGC ACT GCC
Ser Leu Pro Val Ser Ala Ser Glu Stop 424
1260 TCC CTC CCT GTG TCT GCT TCC GAA TAA AAGAAGAAAGCAAT-3'
Figure 3.7 The top line is the marmoset mRNA from marmoset cDNA sequences and
the bottom line is the aminoacid sequences translated from the single open reading
frame. The signal peptide sequence (1-22 amino acids) is italicized and the potential
N-linked glycosylation sites are underlined. The primers used for the PCR are
indicated in bold letters.
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Figure 3.8 Comparison of the primary amino acid sequence of ZP3 for the four
species. Asterisks indicate conserved amino acids and dots indicate highly conserved
amino acids. Potential N-linked glycosylation sites (NXT or NXS1 are underlined.
Cloning and sequencing of Marmoset ZP3 Gene 71
3.4 Discussion
In this study we have succeeded in elucidating the primary amino acid sequence of
marmoset ZP3 employing a PCR strategy to amplify marZP3 cDNA, which has then
been cloned and sequenced. Mar ZP3 has a single open reading frame 1272
nucleotides in length, which gives rise to a polypeptide core of 424 amino acids. This
is exactly the same size as human and mouse ZP3 (Chamberlin & Dean, 1990) and 2
amino acids longer than the hamster homologue (Kinloch et al. 1990). On the basis of
the hydrophobicity plot (Kyte & Doolittle, 1982) and amino acid homology, a signal
peptide of 22 amino acids could be identified, the four amino acids near the cleavage
site sharing the "-3, -1 rule" for predicting signal sequence cleavage sites (Von Heijne,
1986). In this respect marmoset ZP3 is identical to the other species in which the
primary amino acid structure is known including the mouse (Kinloch et al. 1988;
Ringuette et al. 1988; Chamberlin and Dean, 1989) hamster (Kinloch et al. 1990;
Moller et al. 1990) and human (Chamberlin and Dean, 1990; Van Duin et al., 1992).
The marZP3 also shared with the other species in which this molecule has been
sequenced, a second broad hydrophobic domain near the carboxyl terminus, the
function of which is currently unknown.
The primary amino acid structure of marZP3 was found to exhibit a high
degree of homology (91%) with the huZP3 sequence and more than 60% homology
with the mouse and hamster sequences. Intriguingly, the most significant differences
between the human and marmoset sequences were confined to a short stretch of amino
acids spanning residues 322-352, over which the level of homology was reduced to
45%. A region of the ZP3 sequence covering residues 318 to 352, was also found to
house the greatest sequence disparity when the mouse and hamster ZP3 sequences
were compared (Kinloch et al. 1990). The existence of such a highly variable region
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within an otherwise conserved ZP3 primary structure, might suggest a role for this
domain in determining the species specificity of sperm-zona interaction.
Other characteristic features of the ZP3 molecule that were retained by the
marZP3 molecule included the unusually high frequency of serine/threonine and
proline residues, which have been found in all ZP3s sequenced to date. The latter
comprised: (i) a region spanning amino acid 119 to 158 that contained 7 proline
residues in the mouse and hamster and 6 in human and marmoset ZP3 and (ii) a
second proline rich domain spanning residues 208-257 and containing 7 proline
residues in the mouse and hamster and 5 in human and marmoset ZP3. An additional
conserved feature of the ZP3 molecule is the number and location of the cysteine
residues; the human, marmoset, mouse and hamster ZP3 sequences all possessing 15
cysteine residues at identical sites. Such a high level of conservation suggests a key
role for intramolecular disulphide bonds in preserving the structural features of the
polypeptide chain that are involved in the expression of biological activity.
Elucidation of the primary structure of marZP3 has not only been of value in
emphasizing the way in which the structural features of this molecule have evolved in
different species but will also be of considerable importance in the development of
contraceptive vaccines. By demonstrating the considerable sequence homology that
exists between the human and marmoset ZP3, the way is now open to develop a
clinically-relevant active immunization model for evaluating the influence of anti-zona
antibodies on reproductive function, employing antigens based on homologous regions
of the ZP3 polypeptide chain.
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Figure 3.9 Hydropathicity profiles of marmoset and human ZP3 determined by the Kyte and
Doolittle (1982) algorithm, showing the conserved nature of the two ZP3 proteins.
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3.5 Summary
A PCR strategy was used to amplify, clone and sequence marmoset ZP3 cDNA. The
primary amino acid structure of marZP3 was found to exhibit a high degree of
homology (91%) with the huZP3 sequence and more than 60% homology with the
mouse and hamster sequences. An additional conserved feature of the ZP3 molecule is
the number and location of the cysteine residues; the human, marmoset, mouse and
hamster ZP3 sequences all possessing 15 cysteine residues at identical sites.
Elucidation of mar ZP3 primary amino acid sequence has been of value in





At birth the mouse ovary contains 10,000 to 15,000 primordial oocytes (Jones &
Krohn, 1961), many of which are in the prophase of the first meiotic division, the
resting condition known as dictyate. At recruitment, resting oocytes of 10 to 15 |im in
diameter enter into a 2-week growth phase which culminates in meiotic maturation
and subsequent ovulation (Baker, 1972; Brambell, 1928). The completion of meiosis
as evidenced by the exclusion of the second polar body does not occur until the oocyte
has been fertilized in the oviduct (Eppig, 1985; Bachvarova, 1985). Nothing is known
about the regulatory elements, and their signals, that might induce the growth and
differentiation of oocytes, although secretion of the ZP is thought to be an important
sign that activation of the oocyte has occurred on recruitment to the primary follicle
pool (Philpott etal. 1987; Liang etal. 1990; Roller etal. 1989; Lira etal. 1990).
Although the biochemical constituents of the ZP have been well characterized
(Wassarman, 1987b; Wassarman, 1988a; Wassarman, 1988b; Shimizu et al. 1983),
controversy has arisen as to whether the ZP proteins are synthesised by the oocytes
and/or by the granulosa cells. Some of the early studies suggested that ZP proteins
were synthesised by growing oocytes as well as the granulosa cells of the ovary
(Wolgemuth et al. 1984). Antibodies developed against total ZP proteins were
employed to localise the formation of ZP proteins in the ovary. The ZP proteins were
first observed in the cytoplasm and at the periphery of the oocytes, surrounded by a
thin squamous follicular cell layer. As the ZP matrix was assembled extracellularly,
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the intensity of staining of the outer and inner regions could be distinguished.
(Wolgemuth et al. 1984). Radiolabeled antibodies or immunofluorescence techniques
have been employed to monitor the distribution of anti-zona monoclonal antibodies in
ovarian tissue sections and in all cases the immunoreactivity has been found to target
the ZP exclusively (Dean & East, 1986; East et al. 1984a; East & Dean, 1984).
Furthermore, biosynthetic studies of the mouse ZP using an in vitro culture system
clearly revealed that the ZP proteins were synthesised in growing oocytes (Shimizu et
al. 1983; Bleil & Wassarman, 1980c). These findings have been reinforced by the use
of powerful tools like in situ hybridisation (Philpott et al 1987) Thus a DNA construct
that placed the hZP3 gene under the control of mZP3 gene 5'-flanking sequence was
used to produce two lines of transgenic mice that harboured the foreign sperm receptor
transgene. The transgene was expressed only by growing oocytes, at a level
comparable to that of the endogenous mZP3 gene, and the developmental pattern of
transgene expression resembled that of the mZP3 gene (Lira et al. 1990).
In situ hybridisation has become a powerful tool in biology. The basis of in
situ hybridisation is that a piece of labelled ribonucleic acid (RNA) or complementary
deoxyribonucleic acid (cDNA) from a gene of interest can be hybridised to a section of
tissue, permitting identification of the cells transcribing that particular gene. In situ
hybridisation studies were initially performed to detect DNA targets and amplified
ribosomal RNA within cell nuclei (Gall & Pardue, 1969; John et al. 1969; Buongiorno-
Nardelli & Amaldi, 1970). However recent improvements in cloning techniques have
made available probes for a large and rapidly increasing number of mRNA species.
Work by Angerer and Angerer (1981) dealing with sea urchin embryo
development using RNA probes, has given us the methodology for conducting in situ
hybridization experiments. One significant problem is that the greater the size of the
probe the more difficulties are encountered in achieving penetration of the tissue to be
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examined. This problem could be circumvented either using hydrolysed shorter
probes or oligonucleotide probes. Coghlan et al (1985) solved this difficulty by using
synthetic oligonucleotide probes. Introduction of biotinylated probes in in situ
hybridisation has been an additional advance which has made the approach safe from
the danger of handling radioactivity (Singer & Ward, 1982).
The purpose of this study was to use the information we had gained on the
structure of the marmoset ZP3 gene to design probes that could be labelled and used to
examine the cellular distribution ofmar ZP3 transcripts in the marmoset ovary.
4.2 Materials and Methods
4.2.1 Marmoset Genomic DNA Isolation
Marmoset liver DNA was collected for genomic DNA isolation from the Medical
Research Council Primate Colony, Edinburgh. The marmoset liver was collected in
liquid nitrogen and transported to the laboratory and stored at -80°C. Approximately
lOg marmoset liver was crushed with a glass homogenizer in 40ml of extraction buffer
(TE Buffer; lOmM Tris-HCl, 0.1M EDTA, pH 8.0; 20|ig/ml Pancreatic-RNAse; 0.5%
SDS). After one hour proteinase K (100|ig/ml) was added and then kept at 50°C in a
water bath for 3 hours. An equal volume of phenokchloroform pH 8.0 was then
added and the solution mixed to form an emulsion, then centrifuged at 4000 rpm for
15 minutes. The aqueous phase was withdrawn and the phenokchloroform extraction
was repeated twice as before. 2ml, 10M ammonium acetate and 44ml cold ethanol
was then added to the 20ml aqueous phase . The DNA separated as a cloudy
precipitate and was removed with a glass rod, washed with 70% ethanol and then
pelleted by centrifugation. The DNA was left at room temperature to dry and then
dissolved with TE buffer, pH 8.0.
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4.2.2 PCR Amplification ofMarmoset ZP3 Exon 8
The marmoset genomic DNA was used as a template to amplify marmoset ZP3 exon 8
using the polymerase chain reaction (PCR; Saiki etal, 1985, 1988; Mullis & Faloona,
1987). PCR was performed using a GeneAMP PCR Reagent kit with AmpliTaq DNA
Polymerase (Perkin Elmer Cetus, Norwalk, CT, USA) using two primers synthesised
as described in Section 3.2.4 and a programmable heating block (Hybaid, Teddington,
Middlesex, UK). Marmoset ZP3 exon 8, corresponding to the equivalent exon in
human ZP3 (Chamberlin & Dean, 1990), was amplified with oligonucleotide primer 5,
5'-CACAGTGACAGAAGAAGCAG-3' and primer 6, 5'-
AGATCTGAGCTCATTGCTTTCTTCTTTTATTCGGAAG-3' in 25 cycles of PCR.
The final concentrations of the components in the lOOptl reaction mixture were 2.5
Units of AmpliTaq DNA Polymerase, dNTPs, each 200|iM; 1 x reaction buffer
(lOmM Tris-HCl, pH 8.3, 50mM KC1, 1.5 mM MgCh, 0.001% (w/v) gelatin); 0.5 |iM
primer 1 and 0.5|iM primer 2. The PCR reaction involved 25 cycles of incubation at
94°C for 2 minutes to achieve the initial melt, then 94°C for 1 minute, 60°C for 2
minutes, and 72°C for 3 minutes, followed by a final extension at 72°C for 15 minutes.
The PCR reaction products were checked by electrophoresis in a submerged 1%
agarose gel in 0.5 x TBE buffer run at a constant voltage of 80V for 1 hour.
4.2.3 Modification of Ragged Ends of PCR DNA
Based on the observation that Taq polymerase can add a single non template-directed
deoxyadenosine residue to the 3'end of duplex PCR products, this non-template
directed 3' end overhangs (ragged end) has to be blunt ended to clone the PCR DNA.
The marmoset ZP3 exon 8 PCR product was sliced from the agarose gel and was
purified from agarose gel electrophoresis using the Geneclean II kit (Geneclean II kit,
Bio 101 Inc. La Jolla, USA). Approximately 500ng of a 230nt fragment of exon 8
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marZP3, were dissolved in lOpl of 10 x kinase buffer lOjil (0.5 M Tris pH 7.5, 0.1 M
MgCl2, lOmM DTT, 0.5 mg/ml BSA, 200jiM dNTPs), and to this mixture were added
ATP 1 mM, and about 10 units each of T4 polynucleotide kinase and DNA
polymerase (Clark, 1988; Aslanidis & de Jong, 1990). The final volume was adjusted
to 100|il with water and incubated at 37°C for 1 hour, stopped with 1 jil of 0.5 M
EDTA pH 8.0 and the blunt ended PCR amplified DNA purified using the Geneclean
Hkit.
4.2.4 Sub-cloning into Bluescript SK-
Bluescript SK- was digested with Smal restriction enzyme at 30°C for 3 hours. The
reaction mixture consisted of 3(ig of Bluescript SK- in 3ptl, 5p.l of BSA (lmg/ml), 5(_tl
restriction buffer (10 x), restriction enzyme Smal (20 units) and the volume adjusted
to 50|il with water. After 3 hours the Sma I cut plasmid was dephosphorylated to
prevent self-ligation. The Smal cut plasmid DNA was mixed with 5jil, (10 x) calf
intestine alkaline phosphate buffer, and calf intestine alkaline phosphatase (4 units)
and the reaction was carried out at 37 °C for 60 minutes. The reaction was stopped
with l|il of 0.5M EDTA and then the calf intestine alkaline phosphatase activity was
heat-destroyed at 75°C for 10 minutes. The dephosphorylated plasmid DNA was
phenolichloroform extracted twice and then ethanol precipitated.
The ligation of Bluescript SK- with marmoset ZP3 exon 8 was carried out at
14°C overnight. The reaction mix contained lOOng Smal cut vector DNA, lOOng
marmoset ZP3 exon 8 DNA, 4fil (5 x) ligase buffer, T4 DNA ligase (10 units), and
water to make up the 20|il final volume. The following day, XL1-B competent cells
(Section 4.2.5) were electrotransformed with this ligation mixture using a Gene Pulser
(BioRad, Hemel Hempstead, Hertfordshire, UK) as follows. Aliquots of competent
cells (40|il) were thawed at room temperature and then immediately placed on ice. 2|il
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of the ligation mix was added to each cell suspension, mixed well and incubated on ice
for 0.5-1 minute. The DNA-cell mixture was transferred to a cold 0.2 cm sterile
electroporation cuvette and pulsed for 15 seconds. The Gene Pulser apparatus was set
at 25|iF and 2.5 kV and the Pulse Controller at 200 ohms. The cells were
immediately resuspended in prewarmed (37°C) 1ml SOC medium (2% Bacto tryptone,
0.5% Bacto yeast extract, lOmM NaCl, 2.5mM KC1, lOmM MgCh, lOmM MgSC>4,
20mM glucose) and the cells incubated at 37°C for 1 hour with shaking in 17 x
100mm polypropylene tubes. The cells were then plated on LB plates containing
50(1g/ml ampicillin, 40(1g/ml X-gal and 0.5M IPTG (LAX plates) and grown overnight
at 37°C. Cells transformed with recombinant plasmid result in white colonies.
Several white (putative positive) colonies were grown up and plasmid DNA purified
using Magic Mini-Prep columns (Promega, Southampton,UK). The purified DNA
was checked by PCR (Section 4.2.2) and sequencing (3.2.11) to verify the presence of
positive marmoset ZP3 exon 8.
4.2.5 Preparation of Competent Cells
E. coli XLl-Blue competent cells were prepared as follows. One litre of L broth was
inoculated with 1/100 volume of a fresh overnight culture of XL1-B cells. The cells
were grown at 37°C with vigorous shaking till the absorbency at 600nm was between
0.5 and 0.8. The cells were harvested by chilling the flask on ice for 15-30 minutes
followed by centrifugation in a cold rotor at 4000 x g for 15 minutes. The supernatant
was removed and the pellet resuspended in 1 litre of ice-cold water. The suspension
was then centrifuged as before and the pellet resuspended in 0.5 litre of ice-cold water.
After a third centrifugation, the pellet was resuspended in approximately 20ml of ice
cold 10% glycerol. A final centrifugation step was performed and the cells
resuspended in 2-3ml of ice-cold 10% glycerol so that the final concentration was
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approximately 1-3 x 106 cells/ml. This suspension was frozen as 40|ll aliquots on dry
ice and stored at -70°C until required.
4.2.6 Riboprobe Preparation
DNA from Marmoset ZP3 exon 8 cloned in the Bluescript SK- was used for riboprobe
preparation. DNA was digested with restriction enzyme BamHI to prepare the
antisense probe, and restriction enzyme EcoRI for sense strand preparation. The
digested DNA was phenol:chloroform extracted and then ethanol precipitated. BamHI
digested DNA (l|xg) was used for antisense riboprobe preparation, rATP, rGTP and
rCTP each at 2.5mM, 2|il of 10 x transcription buffer, ribonuclease inhibitor (lunit),
rUTP (a35S 50pCi), T7 polymerase (20units) and water added to make the volume up
to 20|il. The reaction was carried out at 37°C for 2 hours. EcoRI digested (l|ig )DNA
was used for sense strand DNA preparation and the reaction mix contained the same as
the above antisense strand preparation, except that the transcription enzyme was T3
polymerase (20 units). After two hours of incubation, yeast tRNA, 2(_il containing
lOmg/ml, was added with RNAse-free DNAse (lunit) and incubated at 37°C for 10
minutes. The reaction was stopped with 1 jj.1 of 0.5M ETDA and the volume was
increased to lOOptl with the addition of 50mM DTT in TE buffer. The sense and
antisense probe mix was phenolxhloroform extracted and then ethanol precipitated
overnight.
4.2.7 Slide Preparation
Glass slides were washed and then baked in a hot air oven to destroy the RNAse
enzyme. Washed slides were dipped in 2%, 3-aminopropyltriethoxysilane (Sigma,
MO) in acetone and allowed to dry and the same procedure was repeated once again.
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The slides were then rinsed in acetone and distilled water and the dried slides stored in
boxes until use.
4.2.8 In situ Hybridization
Marmoset ovaries, stored at -80°C were used and lOjim sections were cut using a
Cryostat. The sections were mounted on 3-aminopropyltriethoxysilane (Sigma, MO)
coated slides (Van prooijen-Knegt et al. 1982) for in situ hybridization as described
above (Section 4.2.7). Ovarian sections were fixed in 4% paraformaldehyde, pH 7.4
for 5 minutes, washed in PBS (Flow Laboratories, Irvine, UK), pH 7.4 for 2 x 5
minutes, rinsed in water for 2 minutes, washed in 0.1 M triethanolamine pH 8.0, and
incubated in 0.25% acetic anhydride in 0.1 M triethanolamine, pH 8.0 for 10 minutes
(Angerer & Angerer, 1981). The RNA probes were added to a hybridization solution
(50% deionised formamide, 10% dextran sulphate, 4x SSC (20x SSC = 3M sodium
chloride/0.3M sodium citrate), lx Denhardt's (lx Denhardt's solution = 0.02% Bovine
serum albumin / 0.02% Ficoll / 0.02% Polyvinylpyrrolidone), 100 mM dithiothreitol,
125|ig/ml yeast RNA, 125qg /ml salmon spermatozoa DNA) and 1 x 106 cpm/slide
was applied to each tissue section before being overlaid with a coverslip. Slides were
hybridized at 50°C for 16-18 hours and then the coverslips were removed and washed
with 4 x SSC containing 4 mM dithiothreitol for 2 x 5 minutes. The slides were
subsequently treated with RNAseA (30|lg/ml) in 0.5M NaCl/lOmM Tris-HCl/lmM
EDTA, pH 8.0 at 37°C for 30 minutes. This wash was repeated without RNAse-A but
containing 2mM dithiothreitol at 37°C for 30 min. The slides were then washed at
50°C in 50% formamide, 2 x SSC, lOmM dithiothreitol for one hour (Philpott et
al. 1987) followed by O.lx SSC for 2 x 15 minutes at room temperature. Finally, the
slides were dehydrated through a series of ethyl alcohols, air dried, dipped in Kodak
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NTB-2 emulsion and stored at 4°C. After 10 days exposure, the slides were developed,
counterstained with haematoxylin and photographed.
4.3 Results
Marmoset ovary contains a variety of different cell types such as granulosa cells, theca
cells, primordial follicles, secondary, growing and antral follicle types and corpus
luteum. Whether ZP transcripts are to be found in oocytes or whether they may also
be found in granulosa cells is a controversial issue. The selective detection of ZP3
transcripts by in situ hybridisation has enabled us to investigate individual oocytes and
follicular cells and determine both the cellular location of the ZP3 transcript and the
way in which these signals changed with the stage of oocyte development. Because of
the difficulty in using longer length RNA probes in in situ hybridisation techniques, a
small DNA probe was made using the PCR technique (Figure 4.1). For this purpose
marmoset exon 8 was successfully subcloned into the plasmid BluscriptSK- (Figure
4.2). Using plasmid BluscriptSK- containing the marmoset ZP3 exon 8, and T3 and
T7 promotors, riboprobes were made in both the sense and antisense orientations.
Marmoset ovaries, stored at -80°C were used and 10p.m sections were cut using a
Cryostat and were hybridized with the sense and antisense probe. The RNA
transcripts of marZP3 exon 8 were found hybridize strongly only with oocytes and not
with granulosa or corona cells, confirming previous reports in other species (Figure
4.3) (Philpott et al. 1987; Lira et al. 1990).








Figure 4.1 Electrophoresis in 0.8% agarose gel showing PCR product of mar ZP3
exon 8. Lane 1, DNA size markers, an EcoRI and Hind III digest of lamda DNA- Lane
2, PCR fragment ofmar ZP3 exon 8, which is indicated by an arrow The eel was run
at 80V for 1-2 hour in 0.5 xTBE. 6








Figure 4.2 Electrophoresis in 0.8% agarose gel showing mar ZP3 exon 8 PCR
product. Lane 1, DNA size markers, an EcoRI and Hind III digest of lamda DNA;
Lane 2, Positive clones of mar ZP3 exon-8 in plasmid BluscriptSK- were identified by
PCR (fragment of mar ZP3 exon 8 indicated by an arrow); Lane 3, same as lane 2.
The gel was run at 80V for 1-2 hour in 0.5 x TBE.
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Figure 4.3 In situ hybridization of marmoset ovarian tissue. [35S]UTP-labelled
antisense RNA transcripts derived from marmoset exon 8 DNA. (A) Haematoxylin
stained section after hybridization with antisense RNA transcripts. (B) Darkfield of
(A). The RNA transcripts of marZP3 exon 8 strongly hybridized only with secondary
follicle (S) and does not involve granulosa or corona cells of the ovary. (100 x)
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Figure 4.4 In situ hybridization of marmoset ovarian tissue. [35S]UTP-labelled
antisense RNA transcripts derived from marmoset exon 8 DNA. (A) Haematoxylin
stained section after hybridization with antisense RNA transcripts. (B) Darkfield of
(A). No ZP3 transcripts were detected in the primordial follicles (P), but ZP3
transcripts could be detected in secondary follicles (S). (62 5 x)
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Figure 4.5 In situ hybridization of marmoset ovarian tissue. [35S]UTP-labelled
antisense RNA transcripts derived from marmoset exon 8 DNA. (A) Haematoxylin
stained section after hybridization with antisense RNA transcripts. (B) Darkfield of
(A). The ZP3 transcripts are first seen in primary follicles (P) and the intensity of ZP3
transcripts signal increases to a maximum in secondary follicles (S). (lOOx)




p: „lire 4 6 Insitu hybridization of marmoset ovarian tissue. [35S]UTP-labelled
antisense RNA transcripts derived from marmoset exon 8 DNA. (A) Hematoxylin
stained section after hybridization with antisense RNA tiwscripts. (B) Darkfield of
(A) The ZP3 transcripts could be detected in growing follicles (G) more abundantly
than in any other types of oocytes. (100 x)
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Since all the in situ experiments were done under identical conditions, it is possible to
compare the quantity of ZP3 transcripts observed in individual oocytes during
oogenesis. No ZP3 transcripts were detected in primordial follicles, but ZP3
transcripts could be detected in primary follicles (Figure 4.4.). The ZP3 transcripts are
first seen in primary follicles and the intensity of the ZP3-transcript signals increasesd
to a maximum level in secondary follicles (Figure 4.5). The ZP3 transcripts could also
be readily detected in the rapidly growing tertiary follicles (Figure 4.6).
To determine whether this expression could be localised to other cells,
granulosa and thecal cells of the ovary were examined for the presence of ZP3
transcripts, but no specific signals were present. ZP3 transcripts signals could not be
detected in the coipus luteum. Control hybridization experiments involving the sense
probe did not give a positive signal with any cells in the ovarian sections.
4.4 Discussion
In situ hybridization was employed to investigate the expression of ZP3 transcripts
during oogenesis. The evidence suggests that the ZP3 gene is transcribed exclusively
in growing oocytes and not in the surrounding granulosa cells (Liang et al. 1990;
Philpott et al. 1987). The site of ZP protein synthesis has remained controversial for
some time. Earlier studies have pointed out that granulosa cells, which surround the
oocytes during folliculogenesis, also produced ZP proteins. The evidence was based
upon morphological studies in rodents (Chiquoine, 1960; Hadek, 1965) or on
immunoperoxidase staining using an antizona polyclonal antibody in rabbits
(Wolgemuth et al. 1984). The immunostaining appeared to indicate the presence of ZP
proteins within the cytoplasm of the inner layer of follicular cells. More recent studies
in the rabbit have employed a cDNA encoding for a full-length ZP protein with a
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calculated molecular weight of 57,185 (rec55) and a specific antibody to the
corresponding native rabbit ZP proteins (R55) (Lee and Dunbar, 1993).
Immunohistochemical analysis of ovaries demonstrated that R55 was localized in the
follicles of animals 2 weeks and older. R55 was localized in the oocytes of primordial
follicles and the oocytes and granulosa cells of primary follicles. Northern blot
analysis with the cDNA probe rec55 revealed that cultured granulosa cells contained a
mRNA for R55 and that there was stage-specific expression of the R55 mRNA in
developing rabbit ovaries (Lee & Dunbar, 1993).
Radiolabeled antibodies or immunofluorescence techniques have also been
extensively used to monitor the distribution of monoclonal ZP antigens and, in all
cases, the reactivity was found to be directed towards the ZP and not to any other cells
of the ovary (Dean & East, 1986; East et al. 1984a; East & Dean, 1984). In the mouse,
these reagents have clearly suggested that the oocyte is the exclusive source of ZP
proteins, particularly ZP3. Furthermore, biosynthetic studies involving mouse ZP in
an in vitro culture system have clearly revealed that the ZP proteins are synthesized in
growing oocytes (Shimizu et al. 1983; Bleil & Wassarman, 1980c). Cis-acting
sequences located in the mouse ZP3 gene 5' flanking region, together with oocyte-
specific proteins, apparently are responsible for the pattern of expression during
development. It has been demonstrated that either 6.5 kb or 0.47 kb of the mouse ZP3
gene 5'-flanking sequence can target expression of the firefly luciferase gene
exclusively to growing oocytes in transgenic mice (Lira et al. 1990; Schickler et
al. 1992).
During the oocyte growth phase, each mouse oocyte was found to produce >1
ng of ZP3 for assembly into the ZP (Wassarman, 1988b). It has been reported that
mouse oocytes synthesise a significant store of RNA during oogenesis and fully grown
oocytes contain 90 pg of poly(A+) RNA (Bachvarova, 1985; Brower et al. 1981).
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However, fifty percent of poly(A+) is lost during meiotic maturation and fertilization
such that two-cell embryos contain less than 10% of the original maternal poly(A+)
(Levey et al. 1978; Piko & Clegg, 1982). The level of ZP3 mRNA generation declines
dramatically (approximately 98%) during ovulation, from approximately 240,000
copies per oocyte to approximately 5000 copies per ovulated egg. ZP3 mRNA is
undetectable in fertilised eggs (less than 1000 copies per fertilised egg), and remains
undetectable (less than 1000 copies per embryo) throughout the preimplantation stages
of development (Roller et al. 1989). The results from this study also suggest a similar
pattern, where, in the primordial follicle, no ZP3 transcripts can be detected, but in
secondary and growing follicles the ZP3 transcripts signals are abundant. It has been
observed that in ovulated eggs, that the size of the ZP3 mRNA is approximately 200 nt
shorter than it is in the growing oocytes. Since the poly(A) tail length of ZP3 is 200 nt
this has led to the notion that the zona mRNAs, like other maternal messages, undergo
deadenylation and degradation during meiotic maturation and ovulation. Though the
amount of ZP3 mRNA transcripts decline dramatically at the time of ovulation, the ZP
itself persists as an extracellular matrix up to the early blastocyst stage and because of
its stable configuration serves an important function up to the time of implantation
(Wassarman, 1988b). The fact that the expression of the ZP3 genes is restricted to the
growth phase of oogenesis in the marmoset suggests that this molecule could be used
as a marker for investigating the molecular mechanisms responsible for gene
activation in the oocyte.
Oocyte-Specific Expression of Marmoset ZP3 93
4.5 Summary
The mar ZP3 transcripts hybridized strongly to oocytes and not to the surrounding
granulosa cells. Primordial follicles did not contain detectable amounts of marmoset
ZP3 transcripts. The mar ZP3 transcripts were detected in primary oocytes and the
accumulation of ZP3 message continued in secondary and tertiary follicles. This study
has clarified the controversy over the site of ZP3 synthesis as least as far as the
marmoset is concerned. The oocyte-specific accumulation of ZP3 transcripts could be
used as a marker to study other factors involved in the activation of the oocyte
following the recruitment into the growing follicle pool
5 Cloning and Expression
ofMarmoset ZP3
5.1 Introduction
The development of techniques to manipulate DNA in vitro in the 1970s has had a
major impact on the production of key proteins, of limited natural availability, in
abundant quantity. The expectation that foreign DNA should be expressed in
unrelated organisms is based on the assumption that the genetic code is universal.
Unfortunately, when DNA from higher eukaryotes was tried in such systems,
expression of the foreign genes was not obtained. In order for eukaryotic genes to be
expressed in E. coli they must be modified in such a way that their organisation
resembles prokaryotic genes. In order for a eukaryotic gene to be transcribed within a
prokaryotic cell, it is necessary to place the eukaryotic gene downstream of the
prokaryotic promotor. Most plasmid expression vectors utilise either the promotor of
the lac or of the trp operons from E. coli. Many of the vectors contain enough of the
lacZ gene to encode a peptide of 6-galactosidase. The lac operon is negatively
regulated by the lac repressor, and can be derepressed by addition of an inducer, such
as isopropyl B-D-thiogalactoside (IPTG). Genes can be directed to express their
products either in the cytoplasm or, by incorporating a leader sequence before the
coding sequence, the proteins may be secreted through the cell membrane. The level
of expression in the cytoplasm is greater than the secreted protein. However, many of
the polypeptide products located in the cytoplasm are insoluble and aggregated and
specific solublization procedures are needed (Marston, 1988). Problems associated
with the instability of the recombinant proteins due to host proteases were overcome
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by adopting fusion protein expression strategies which also gave good translation
initiation. The G-galactosidase system has been used extensively as a fusion protein
expression system. Recently this fusion protein expression strategy has been
improved further by including a signal peptide which can be cleaved with specific
proteases (Moks et al. 1987). Furthermore, the protein of interest can be selectively
attached to a fusion protein which can bind to a specific ligand which can then be used
on the basis for an affinity column purification procedures (Guan etal. 1987).
ZP from mammalian species has been difficult to isolate in large quantities
either due to the difficulty in collecting it from the ovary or because of the paucity of
the ovarian material itself (human, primate ovary). Producing ZP3 by genetic
engineering is an alternative approach. Mouse ZP3 and hamster ZP3 genomic DNA
have been transfected into the embryonal carcinoma cell lines of mouse origin and
expressed successfully (Kinloch et al. 1991). The recombinant mouse ZP3 produced
was biologically active, and could bind to mouse sperm and induce the acrosome
reaction. Moreover, the amount of recombinant ZP3 generated was large enough to
perform biochemical analyses. Mouse ZP3 cDNA transfected into rodent and primate
cell lines also generated biologically active ZP3 with differing molecular mass
Mr=60,000-70,000; (Beebe et al. 1992). Schwoebel et al (1992) have expressed rabbit
ZP2 and ZP3 cDNAs in bacteria and the recombinant ZP proteins produced (rec55)
were immunogenic in cynomologus monkeys when conjugated to either protein A or
keyhole limpet haemocyanin. In this context, production of recombinant marmoset
ZP3 would be very useful to use as an antigen in contraceptive vaccine development.
A commercially available protein expression and purification system has been used to
clone the marmoset ZP3 cDNA. Using this system (pMAL™ vector) the gene was
inserted downstream from the malE gene, which encodes a maltose binding protein
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(MBP), and results in the expression of an MBP fusion protein achieved (Guan et
al. 1987).
5.2 Materials and Methods
5.2.1 Ligation of DNA Fragment with Low Melting Agarose Gel
DNA, digested with particular restriction enzymes, was run on a 2% Nusieve
(Flowgen; Nusieve GTG agarose; FMC Bioproducts, High Wycombe, Bucks, UK)
agarose gel and then the fragment was sliced out of the gel for further ligation. The
agarose slice containing the DNA was melted at 68°C for 10 minutes and then placed
at 37°C in a water bath until the addition of the ligation reaction mix. Water was
added, approximately 3 times the volume of the melted agarose used for the ligation
reaction, but not exceeding a volume of 30gil. The lOx ligase buffer volume was
l/10th of the volume of the ligation reaction mixture and 1 unit of T4 DNA ligase per
10p.l of the ligation mixture was added. The vector was added to obtain a molar ratio
of insert to vector of 5:1 (Dumais & Nochumson, 1987).
5.2.2 Subcloning in the pMAL™-c Vector
Marmoset ZP3, exon 1-6 in the PCR 1000 vector, was digested and opened with Sacl
and Sail restriction enzymes. The digested DNA was run on a 2% Nusieve agarose
gel and the digested fragment was sliced out for further ligation. Similarly, the
marmoset ZP3 exon 4-8 in the PCR 1000 vector was digested with Sacl and Sail
restriction enzymes and run on a Nusieve agarose gel (Flowgen; Nusieve GTG
agarose; FMC Bioproducts, High Wycombe, Bucks, UK) and the fragment was sliced
from the gel for further ligation. The two agarose gel DNA fragments were melted at
68°C for 10 minutes and then kept at 37°C before adding to the ligation mixture. The
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ligation mixture contained: agarose gel ofmarmoset ZP3 exon 1-6 in PCR 1000 vector
opened with Sacl and Sail restriction enzymes (2|il), agarose gel of marmoset ZP3
exon 4-8 fragment digested Sacl and Sail from PCR 1000 vector agarose gel (10|il),
10 x ligation buffer (5|il), T4 DNA ligase (l|il, 4 Units) and water (32|il). The ligation
reaction was carried out at room temperature overnight. The following day the
ligation mix was once again melted at 68°C for 5 minutes and then electrotransformed
in XL1-B cells. White colonies of putative positive clones were grown in LB media
and mini-plasmids were prepared using Magic Mini-Prep columns (Promega,
Southampton, UK). The plasmid preparations were digested with Kpnl restriction
enzyme and verified on agarose gels for positive plasmids carrying the marmoset ZP3
cDNAs.
The PCR 1000 vector carrying the marZP3 was digested with EcoRl
restriction enzyme and run on 2% Nusieve agarose gel (Flowgen, FMC Bioproducts,
High Wycombe, Bucks, UK) and the 1.3kb fragment sliced out of the gel for the
ligation reaction. The pMALc™-c vector (New England Bio lab, Herts, England) was
digested with EcoRl restriction enzyme and then the vector was dephosphorylated
with calf intestine alkaline phosphatase. The EcoRl cut plasmid DNA was mixed
with 5(il, 10 x calf intestine alkaline phosphate buffer, calf intestine alkaline
phosphatase (4 units) and water to make a total volume of 50(tl. The reaction was
carried out at 37°C for 60 minutes. The reaction was stopped with l|il of 0.5M EDTA
and then the calf intestine alkaline phosphatase activity was heat destroyed at 75°C for
10 minutes. The dephosphorylated plasmid DNA was phenokchloroform extracted
twice and then ethanol precipitated.
The Nusieve agarose slice containing the marZP3 fragment, digested with
EcoRl, was melted at 68°C for the ligation reaction as described (Section 5.2.1). The
dephosphorylated pMALc™ vector was added to the ligation mixture and the reaction
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was carried out overnight at room temperature. The following day the ligation product
was electrotransformed with JM105 cells. White colonies were grown in LB medium
and the purified mini-plasmid was digested with restriction enzyme Pstl to determine
whether marZP3 was present in the right orientation.
5.2.3 Analysis of Recombinant mar ZP3 Protein
Plasmid carrying mar ZP3 was grown in 5ml LB medium with ampicillin (50|ig/ml) to
about 2 x 108/ml. A 1 ml sample was spun in a microcentrifuge for 2 minutes and the
pellet was resuspended with 50(_tl of protein gel SDS-PAGE sample buffer. Inducer,
IPTG, was added to the remaining culture to a final concentration of ImM and the
cells were grown for another 2-3 hours. A 0.5 ml sample was centrifuged for 2
minutes and the pellet was resuspended with lOOpl of SDS-PAGE sample buffer. The
remainder of the cells were centrifuged and resuspended with 2ml of column buffer
(20mM Tris-HCl; pH 7.4; lOOmM NaCl; ImM EDTA). The sample was frozen at
-20°C overnight and thawed in cold water the following day and treated with lmg/ml
lysozyme for 30 minutes on ice. This material was then sonicated using a MSE
Soniprep 150 for 3 x 20 seconds, followed by centrifugation at 9000g for 20 minutes.
The supernatant (crude extract 1) was saved and 5j_tl was treated with 5jil SDS-PAGE
sample buffer. The pellet was resuspended with 2 ml of column buffer to create a
suspension of the insoluble matter (crude extract 2). This 'crude extract 2' was also
treated with 5pl SDS-PAGE sample buffer. All the samples were boiled for 5 minutes
and 15|il of each sample was used for 10% SDS-PAGE analysis.
5.2.4 Electrophoresis
One dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS
PAGE) was performed according to the method of Laemmli (1970) using a Protean
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electrophoresis cell (Hoeffer Scientific Instruments, Newcastle, UK.). The stacking
gel was composed of 3.6% acrylamide, pH 6.8 and the resolving gel contained 10%
acrylamide, pH 8.8. Samples from different bacterial lysates containing recombinant
marmoset ZP3 were run under non-reducing conditions. Molecular weight standards
(Rainbow markers, Amersham International, UK) were also run. Electrophoresis was
performed at a constant current of 20mA for 2 hours through the resolving gel using
Tris, glycine, 0.1% SDS as electrode buffer. Some gels were stained with Coomassie
Brilliant blue G-250 whereas others were used for Western blotting as described in
section 5.2.5. After electrophoresis the gels were stained with 0.5% Coomassie
Brilliant blue in 25% isopropanol with 10% acetic acid for 2-3 hours, destained with
25% isopropanol and 10% acetic acid for 1-2 hours and replaced with 10%
isopropanol and acetic acid overnight.
5.2.5 Western Blot
The SDS-PAGE gels were soaked in Western blot transfer buffer for 10 minutes along
with nitrocellulose membranes (Amersham Inernational, UK). Using a BioRad
transfer blot apparatus the proteins were transferred under a constant current of 0.22A
for 4 hours using 25mM Tris-HCl buffer, pH 8.3, 192mM glycine, 20% methanol.
The nitrocellulose membranes were blocked with 5% milkpowder (Marvel, Premier
Brands UK. Ltd., Stafford, UK.) containing 0.1% Tween 20 for 30 minutes followed
by a brief wash with PBS. The nitrocellulose membrane was incubated with 1/1000
anti-human ZP3 peptide 341-360 antibody overnight at room temperature (The peptide
341-360 antibody was a gift from Organon Pharmaceuticals, Oss, Netherlands). The
next day the membrane was twice washed with 0.1M PBS, pH 7.2, containing 0.1%
Tween 20 for 15 minutes. Anti-rabbit IgG conjugated with horseradish peroxidase
(Sigma) was employed as the second antibody for 1 hour. Reactivity was visualised
Cloning and Expression of Marmoset ZP3 100
by autoradiography using an enhanced chemiluminescence detection system
(Amersham International pic, Bucks, England).
5.3 Results
A schematic diagram of the appropriately digested plasmids from PCR 1000 vector
containing marZP3 exon 1-6 and 4-8 cloned into the pMAL™-c vector is presented in
Figure 5.1. The marZP3 exon 1-6 fragment was restriction enzyme digested with Sail
and SacI enzymes to create an opening at position 731nt in the mar ZP3 and the SacI
polylinker site of the PCR 1000 Vector (Figure 5.2), to insert the rest of the marZP3 4-
8 fragment digested with the same restriction enzymes (SacI and Sail). In this way a
full length mar ZP3 construct was made in PCR 1000 vector (Figure 5.3) which could
be easily subcloned in the pMAL™-c vector (Figure 5.4).
A full-length marZP3 cDNA was subcloned in the pMAL™-c vector, (New
England Biolab, Herts, England) downstream of the malE gene which encodes maltose
binding protein (MBP) and results in the expression of an MBP fusion protein. The
strong "tac" promoter and the malE translation initiation signal present upstream of the
cloned marZP3 gave high-level expression of marZP3. The pMAL™-c vectors also
contain the sequence coding for the recognition site of the specific protease factor Xa,
which allows MBP to be cleaved from marZP3 after purification.
The marmoset ZP3 cDNA, exhibiting a size of 1.3kb, was cloned at the EcoRl
site downstream from the malE gene, in the pMAL™-c vector which encodes the
maltose binding (MBP) fusion protein. The pMAL™-c vector-containing JM105 cells
were grown to an Agoo of 0.5, then induced by addition of IPTG, to stimulate a high
level of expression of the marmoset ZP3 fusion protein. The molecular weight of the
MBP is 42,000 kD, resulting in the expression of an MBP fusion protein with total
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molecular mass of 86,000 as determined by SDS-PAGE (Figure 5.5). The pMAL™-c
vector malE gene has a deletion of the signal sequence, leading to cytoplasmic
expression of the fusion protein. In this site the fusion protein was present in a soluble
and stable form as shown by SDS-PAGE. Analysis of the bacterial fusion proteins by
Coomassie blue staining separated by ID SDS-PAGE is shown in Figure 5.5. Highly
expressed fusion protein is visible in the sample (Figure 5.5) which was induced with
IPTG, compared to the uninduced control.
To determine whether or not the induced cells synthesized marZP3 fusion
protein, cell lysates were prepared and analysed on immunoblots as well as Western
blots using rabbit sera raised against a synthetic peptide of human ZP3 (peptide
sequence of 340-361) (Figure 5.6). This antibody recognizes marZP3 fusion protein in
the bacterial cell lysate that was induced with IPTG, with the expected size 86,000 kD.
By control, in the uninduced bacterial cell lysate the antibody could not detect any
peptide of similar size. The antibody also detected a number of bands both in the
uninduced and induced bacterial cell lysates. A mouse monoclonal antibody MCA7
raised against human ZP3 also recognises marZP3 fusion protein in the bacterial cell
lysate that is induced with IPTG (Figure 5.7).



























































Figure 5.1 Diagrammatic representation of marmoset exon 1-8 subcloning
in the pMALTM-c vector.
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Figure 5.2 Electrophoresis in 2% Nusieve agarose gel. Lane 1, DNA size markers, an
EcoRI and Hind III digest of lamda DNA; Lane 2, PCR 1000 vector containing mar
ZP3 exon 4-8 digested with Sacl and Sal 1 restriction enzyme producing vector band
at 3 2kb and release of insert of 600 bp as indicated by arrows; Lane 3, PCR 1000
vector containing mar ZP3 exon 1-6 digested with Sacl and Sail restriction enzyme
producing vector and mar ZP3 at 3.7kb and release of insert of 125 bp as indicated by
arrows.








Figure 5.3. Electrophoresis of subcloned mar ZP3 in PCR 1000 vector in an 0.8%
agarose gel. Lane 1, DNA size markers, an EcoRI and Hind 111 digest of lamda DNA;
Lane 2, plasmid preparation were digested with Kpnl restriction enzyme producing
vector band at 3.2kb and release ofmar ZP3 insert of 1.2kb.








Figure 5.4. Electrophoresis of subcloned mar ZP3 in pMALc™-c vector in an 0.8%
agarose gel. Lane 1, DNA size markers, an EcoRI and Hind 111 digest of lamda DNA;
Lane 2, plasmid preparation were digested with EcoRI restriction enzyme and verified
on agarose gel for positive plasmid carrying the marmoset ZP3 gene. The pMALc™-
c vector band at 6.1kb and release of mar ZP3 insert of 1.3 kb as indicated by the
arrows.



























Figure 5.5 Analysis of the bacterial fusion proteins by Coomassie blue staining of
proteins separated by ID SDS-PAGE. Molecular weight markers as indicated on left
hand side of the gel. Uninduced lane contained lysed bacterial cell before inducing
with IPTG. Induced lane contained lysed bacterial cell after inducing with IPTG. The
marmoset ZP3 fusion protein is indicated with an arrow head. Soluble lane contained
lysed bacterial cell extract solublized with Tris-HCl buffer, pH 7.4. Insoluble lane
contained lysed bacterial cell extract's pellet after solublization with Tris-HCl buffer,
pH7.4.
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Figure 5.6 Blots of lysed bacterial cell extract containing marmoset ZP3 fusion
protein probed with rabbit sera raised against a synthetic peptide of human ZP3
(peptide sequence of 340-361). This antibody recognizes marZP3 fusion protein (lane
2, indicated by an arrow) in the bacterial cell lysate that is induced with IPTG of
expected size 86,000 kD protein. In the uninduced bacterial cell lysate (lane 3) the
antibody could not detect any peptide of similar size. Molecular weight markers flan*
1) are indicated on left hand side of the gels. * S Uane







FiPiire 5 7 Blots of lysed bacterial cell extract containing marmoset ZP3 fusion
nrotein Drobed with a mouse monoclonal antibody MCA7 raised against human ZP3.
Thk intibodv recognizes marZP3 fusion protein (lane 2, indicated by an arrow) in the
hnotorial cell lvsate that is induced with IPTG of expected size 86,000 kD protein.
Molecular weightmarkers (lane 1) are indicated on left hand side of the gels.
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5.4 Discussion
The data presented in this study describe a novel bacterial expression system that is
capable of producing high levels of a soluble stable marZP3 fusion protein. The
marZP3 full length cDNA of 1.3kb was cloned downstream of the rnalE gene resulting
in a fusion protein containing marZP3 coupled with the maltose binding protein.
Extracts of E. coli JM105 contained a prominent polypeptide with molecular mass
86,000 Daltons. The fusion protein produced by this system was in a soluble form in
aqueous solutions. The fusion protein produced by this vector was not binding to the
amylose resin (affinity purification column) which might be due to change in the MBP
confirmation that was masked by mar ZP3 protein. Due to this problem an anion
exchange chromatography was used for the fusion protein purification, which is
discussed in chapter 6.2.2. Schwoebel et al (1992) have produced a rabbit ZP
recombinant protein of molecular mass 55-kD (rec55) with cro-B-galactosidase as the
fusion protein. However these fusion proteins were insoluble in the absence of urea
and prone to aggregation in aqueous solutions. It has been noted that high level
expression of fusion peptides in E. coli may result in the expressed products being
sequestered into inclusion bodies or protein aggregates (Williams et al. 1982). Rabbit
recombinant ZP protein, (rec55) was expressed in pEX plasmid in these insoluble
inclusion bodies (Schwoebel et al. 1992b). The fact that marZP3 produced with MBP
protein as the fusion protein was soluble in aqueous solution might be due to the
different type of vector employed. This fusion protein (MBP) might also help to
establish the correct 3-dimensional configuration for the protein and the formation of a
stable translation initiation complex. Embryo carcinoma cell-derived recombinant
mouse ZP3 inhibited mouse sperm-egg binding in vitro and also induced mouse
spermatozoa to acrosome react, but hamster ZP3 expressed in the same cell line was
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not biologically active, suggesting the significance of protein configuration and post
translational modification in the expression system employed (Kinloch et al. 1991).
However it should be noted that Beebe et al (1992) have shown that the full length
mouse ZP3 cDNA construct cloned in cytomegalo virus and transfected into the
mouse L-929 cell line produced mouse recombinant ZP3 with molecular wt of 60,000-
70,000. Another construct cloned in vaccinia virus promotor and transfected into the
green monkey CV-1 cell line also produced recombinant ZP3 of the same size. Both
types of recombinant glycoproteins were biologically active since they inhibited sperm
binding to the zona pellucida and induced the acrosome reaction despite presumed
differences in the glycosylation patterns achieved with these two expression systems.
The marZP3 was analysed by Western blot with antibodies produced against
the human ZP3 peptide, 340-361, in rabbits. This antibody recognizes marZP3 fusion
protein as shown in Figure 5.5. Furthermore, it suggests that prokaryote-produced
marZP3 expresses the appropriate specific antigens, since it is recognized by
antibodies. Significantly, the fact that recombinant marZP3 produced with maltose
binding protein as a fusion product is still antigenic suggests that the major epitopes on
the marZP3 protein are not masked by the maltose binding protein. Moreover, a
mouse monoclonal antibody (MCA7) generated against human ZP3 also cross reacted
with marZP3 fusion protein, indicating recognition of major marZP3 epitopes in this
fusion protein by antibodies raised in different species.
The cross reactivity between the anti-human ZP3 peptide antibody and mar
ZP3 is clearly a consequence of the similarity in amino acid sequence between human
ZP3 and marZP3 (Thillai-Koothan et al. 1993). However, the rabbit antibody against
human ZP3 peptide 341-360 also cross-reacted with a number of other peptides in the
induced and uninduced bacterial cell lysate (Figure 5.6). Nevertheless, it could not
detect any peptide of similar size to the fusion protein in the uninduced bacterial cell
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extract. The reason for the non-specific cross-reactivity is unclear. However
unabsorbed polyclonal antibodies cross reacting with prokaryotic proteins have been
noticed with a number of other expression system (Huynh et al. 1985).
The application of the expression system described in this chapter should result
in the supply of sufficient quantities of purified recombinant marZP3 for further
studies in the context of contraceptive vaccine development and the fundamental cell
biology of the ZP. The ability to generate purified recombinant material is important
since the abnormal ovarian cyclicity seen in some ZP immunization studies might
have been due to the presence of impurities in the immunogen (Gulyas et al. 1983).
This approach of producing recombinant proteins in E. coli eliminates any possible
contamination by unwanted ovarian antigens in contraceptive vaccine studies and in
this respect represents a considerable advance over the isolation of native protein for
immunization purposes.
5.5 Summary
Marmoset ZP3 cDNA, exhibiting a size of 1.3kb, was constructed and cloned
downstream from the malE gene, in the pMALc™-c vector which encodes the maltose
binding (MBP) fusion protein. The fusion protein containing mar ZP3 was soluble in
aqueous solution and the size of the fusion protein was 86 kD as expected.
Furthermore, the recombinant mar ZP3 was antigenic since it was recognized by
human ZP3 antibody suggesting that the recombinant mar ZP3 polypeptide expresses
major antigens that are shared with the human homologue.





Rapid advances in recombinant technology have made possible the cloning of almost
any gene in a suitable vector to give expression of its product in large quantities.
Following a number of planned genetic manipulation steps, the ZP3 proteins, which
are difficult to purify in large quantities in their native form, can be synthesized in E.
coli at a level in excess of 10% of the total cellular protein. Proteins produced by
micro-organisms may be intracellular, periplasmic, or secreted into the culture
medium. Proteins produced intracellularly have to be released by disruption of the
micro-organisms in order to release the protein into the appropriate buffer. The
protein can be released by enzymatic, chemical or physical means. Of all the methods
employed for this purpose, sonication is probably the most frequently used procedure
for the small-scale release of proteins.
Following cell disruption, the first step in the purification of a protein is the
removal of cell debris. The separation of solids from liquids is a key operation in
enzyme isolation, and is normally accomplished by centrifugation or filtration. The
subsequent purification of proteins by chromatography has been a standard laboratory
practice for many years. All of the available chromatographic techniques, gel
filtration, ion exchange, hydrophobic interaction, affinity, immunoaffinity, and
chromatofocusing can be used for the large-scale isolation of proteins.
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Separation by ion exchange chromatography depends upon the reversible adsorption
of charged solute molecules to an immobilised ion exchange group of opposite charge.
The ion exchanger is brought to a starting state, in terms of pH and ionic strength,
which allows the binding of the desired solute molecules. When the sample is applied,
the molecules carrying the appropriate charge displace counter ions and bind
reversibly to the gel. Substances can then be removed from the column by changing
the elution conditions, making them unfavourable for the ionic bonding of the solute
molecules, by increasing the ionic strength of the elution buffer or changing its pH.
In gel filtration, separation is based on molecular size. The stationary phase
consists of porous beads surrounded by a mobile solvent phase. When the sample is
applied, the molecules in the mixture partition between the pores in the beads and the
solvent. Large molecules are unable to enter the pores and so pass through the
interstitial spaces and elute first. Smaller molecules, which can enter the pores, are
eluted later, in decreasing order of size.
To date, it has not been feasible to isolate large quantities of native marmoset
ZP3 proteins from ovarian material for contraceptive vaccine studies. However, since
the amino acid sequences of marmoset ZP3 and human ZP3 are highly conserved
(91%), active immunization of marmosets with recombinant mar ZP3 coupled to an
immunogenic carrier such as tetanus toxoid should provide valuable information on
the way in which an homologous vaccine would behave in the human. In order to
conduct such studies large amounts of recombinant marmoset ZP3 would have to be
generated. In the studies described in this chapter marmoset ZP3 has been produced
by means of a bacterial expression system and the fusion protein has been purified by
ion exchange chromatography. The purified material has then been used to generate
antibodies in actively immunized rabbits in order obtain preliminary data on the
immunogenicity of recombinant marmoset ZP3 in vivo.
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6. 2 Materials and Methods
6.2.1 Crude Extract Preparation.
The JM105 strain E.Coli carrying marZP3 were grown in 20ml rich medium (lOg
tryptone, 5g Yeast extract, 5 g NaCl, 2 g glucose; after autoclaving sterile ampicillin
was added to 100|ig/ml) overnight at 37°C. The following day, 1 litre of rich media
was inoculated with 10ml of the overnight cell culture containing the fusion protein.
When the cells reached a density of 2x10^ cells/ml (A600 ~0.5), IPTG was added to a
final concentration of ImM and incubated for 4 hours at 37°C. The cells were
harvested by centrifugation at 4000g for 20 minutes and resuspended in 30ml lysis
buffer (20mM Tris-HCl; pH 7.4; lOOmM NaCl; ImM EDTA; ImM phenyl methyl-
sulphonyl fluoride) and stored at 20°C overnight. The next day, the sample was
thawed in cold water, lysozyme (lmg/ml) was added and the mixture incubated on ice
for 30 minutes. This material was sonicated using a MSE Soniprep 150 for 3 x 20
seconds, followed by centrifugation at 9000g for 20 minutes. The supernatant (crude
extract) was used for further purification.
6.2.2 Anion Exchange Chromatography
DEAE 52, an anion exchanger, (Whatman Laboratory Division, Maidstone, England)
was used for initial purification ofmarmoset ZP3 fusion protein. The anion exchanger
was equilibrated with buffer containing 100 mM NaCl, 20 mM Tris-HCl, 1 mM
EDTA of pH 7.4. The crude extract (30 ml) was applied to the DEAE 52 column (2.6
x 20 cm column) and eluted with gradient buffer of high ionic strength, containing 300
mM NaCl, 20 mM Tris-HCl, 1 mM EDTA pH 7.4, to lower ionic strength, 100 mM
NaCl, 20 mM Tris-HCl, 1 mM EDTA at pH 7.4, at the flow rate of lml/minute. The
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fractions were analysed on 10% SDS-PAGE and the samples containing marmoset
ZP3 were pooled.
6.2.3 Conjugation to Carrier Protein
The anion exchange-purified marmoset ZP3 fusion protein was dialysed against PBS,
pH 7.2, overnight. Marmoset ZP3 fusion protein, 2mg in 0.5ml, was mixed with 2mg
in 0.5 ml tetanus toxoid. An equal volume of 0.2% glutaraldehyde in PBS was added
to the marmoset ZP3 fusion protein and carrier tetanus toxoid and incubated at room
temperature for 1 hour. The free amino group was blocked with glycine to a final
concentration of 200mM and incubated for 1 hour. The conjugate was dialysed
against PBS overnight.
6.2.4 Immunization of Rabbits
Three New Zealand white male rabbits were used for this study. The primary
immunization consisted of 50pg marmoset ZP3 fusion protein coupled to tetanus
toxoid which was emulsified in an equal volume of Freund's complete adjuvant. An
intramuscular injection regimen was used for immunization purposes. Two
subsequent booster immunizations were performed at weekly intervals with the same
amount of antigen, emulsified with Freund's incomplete adjuvant. One week after the
last booster immunization, the rabbits were bled and analysed for their antibody titre.
6.2.5 Electrophoresis and Immunoblotting
Samples of the crude extract from the bacterial cell lysate and anion exchange purified
marmoset ZP3 fusion protein were separated by SDS-PAGE and transferred to
nitrocellulose membranes as described in sections 5.2.4 and 5.2.5. The nitrocellulose
membranes were incubated at room temperature, with 1:200 diluted rabbit sera from
the animals immunized against the marmoset ZP3 fusion protein, for 1 hour. The
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membrane was washed twice with 0.1M PBS pH 7.2 with 0.1% Tween 20 for 15
minutes. Anti-rabbit IgG conjugated with horseradish peroxidase (Sigma, MO) was
employed as a second antibody for 1 hour. Reactivity was visualised by
autoradiography using an enhanced chemiluminescence detection system (Amersham
International pic, Bucks, England).
6.2.6 Dotblot
Hybond C-Super (Amersham) nitrocellulose membranes were spotted with l[ig of
human recombinant ZP3 and marmoset recombinant ZP3 protein and air dried at room
temperature. The membranes were soaked in 5% milk powder in Tris-buffered saline,
pH 7.6 (TBS) for 1 hour. The following antibody dilutions were then prepared: rabbit
anti-recombinant marmoset ZP3 antibody was diluted to 1/500 in a blocking solution,
rabbit anti-human ZP3 peptide sequence 341-360 was diluted to 1/2500, rabbit anti-
recombinant human ZP3 diluted to 1/500 and rabbit anti-whole human ZP diluted to
1/100. 0.1% Tween-20 was then added and the mixture incubated at room temperature
for 2 hours. Washing of the membranes was performed with two brief rinses with
distilled water and a 15 minute incubation in TBS with 0.1% Tween-20 (washing
buffer) followed by an additional 3x5 minutes wash in the same washing buffer.
Goat anti-rabbit horse radish peroxide enzyme conjugate diluted to 1/1000 (Sigma) in
blocking solution was used as a second antibody with an incubation time of 1 hour at
room temperature. The membranes were washed as described earlier and developed
with enhanced chemiluminescence (ECL; Amersham) reagents.
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6.3 Results
6.3.1 Characterization of Antibodies by Immunoblots
The wet weight of the harvested bacterial cell culture was approximately 5g and was
chilled quickly in order to avoid possible degradation. Lysozyme treatment and
sonication were employed to break the cells and after centrifugation the soluble
solution was removed, which contained the recombinant marmoset ZP3. Using the
lysis conditions described in the Materials and Methods section, most, if not all, the
fusion protein containing recombinant marmoset ZP3 was present in a soluble form in
the lysate (Figure 5.5). The crude extract containing the soluble protein was applied to
the DEAE 52 ion exchange column in 100 mM NaCl, 20 mM Tris-HCl, 1 mM EDTA
at pH 7.4. The recombinant marmoset ZP3 and other E. coli proteins bound to the
DEAE-52 column and were then eluted with a linear gradient from a starting buffer
comprising 300 mM NaCl, 20 mM Tris-HCl, 1 mM ETDA at pH 7.4. Various
fractions were collected and analysed by SDS-PAGE to identify those fractions that
contained the marmoset ZP3. Figure 6.1 shows the composition of the different peaks
eluted from the DEAE-52 column fractions. Using this procedure the marmoset ZP3
fusion protein could be extensively purified in a single step. The key to this single
step purification was to use a narrow range ionic strength gradient elution buffer
(Figure 6.2). A variety of alternative chromatographic procedures were employed but
this ion exchange strategy proved the most effective. As can be seen from the
electrophoresis profiles this procedure generated an extensively purified protein which
had not been degraded due to the inclusion of multiple steps in the purification
scheme.
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Figure 6.2 Silver stained SDS-PAGE of DEAE-52 fractions of marmoset ZP3 fusion
protein. Eluted with gradient buffer of high ionic strength, containing 100-300 mM
NaCl, 20 mM Tris-HCl, 1 mM EDTA pH 7.4. Lane indicated as markers on the left
hand side contain molecular weight markers, lane indicated as crude extract contain
lysed bacterial cell extract that passed through the anion column, lanes 32- 68 contain
various fractions that eluted from the anion exchange. Lanes 50-68 contain pure
marmoset ZP3 fusion protein, as indicated by an arrow.
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Figure 6.3 Dotblot shows the cross-reactivity of different rabbit antibodies with
human (top) and marmoset ZP3 antigens (bottom) dotted onto nitrocellulose
membranes. Lane 1 probed with recombinant human ZP3 antibody; lane 2, probed
with native human ZP antibody; lane 3 probed with a synthetic peptide antibody
against human ZP3 (341-360); lane 4, probed with recombinant marmoset ZP3
antibody.
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Preliminary experiments involving the active immunization of rabbits with
recombinant marmoset ZP3 failed to produce significant antibody titre. In order to
enhance the immunogenicity of the recombinant marmoset ZP3, conjugation with
tetanus toxoid was carried out. Single step glutaraldehyde coupling was employed to
conjugate the carrier molecule. After the primary immunization and two booster
injections with conjugated recombinant protein, antibody levels could be visualised
with the immunoblot procedure. The antibody developed against recombinant
marmoset ZP3 fusion protein was found to recognize this molecule in both the crude
extract and the partially purified fusion protein in immunoblot experiments.
Rabbit antibodies to recombinant marmoset ZP3 proteins were further
characterised by immunoblotting using recombinant human and marmoset ZP3
proteins generated in CHO cells as the target. Figure 6.3 shows the cross-reactivity of
the rabbit anti-marmoset ZP3 fusion protein with human and marmoset ZP3 antigens
dotted onto nitrocellulose membranes. It was observed that the recombinant marmoset
ZP3 antibody specifically recognized both recombinant human and marmoset ZP3
generated in an alternative, CHO expression system. This antibody recognized
marmoset ZP3 more strongly than the human ZP3, as shown in Figure 6.3. An anti-
human recombinant ZP3 antibody also recognized recombinant marmoset ZP3, but the
signal was not as strong as that produced with the homologous human protein. In
contrast, the antibody produced against whole native human ZP could detect both
human ZP3 and marmoset ZP3 with equal intensity. An antibody directed against the
human ZP3 amino acid sequence 341-360 could detect recombinant human ZP3 and
recombinant marmoset ZP3, but exhibited greater cross reactivity with the former.
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6.4 Discussion
The ZP plays a critical role in sperm-egg interaction during fertilization. As such, it is
a potential target site for the development of an effective immunocontraceptive
vaccine. It is well recognized that mammalian ZP glycoproteins are complex antigens
and that their immunogenicity and antigenicity vary between species (Dunbar et
al. 1989; Millar et al. 1989). Immunization with ZP3 antigens can result in an
autoimmune oophoritis leading to the destruction of primordial and growing follicles
as well as altered reproductive cycles (Rhim et al. 1992; Skinner et al. 1984; Paterson et
al. 1992). However, immunization with a mouse ZP3 synthetic peptide containing
only a B cell epitope produced infertility without ovarian pathogenicity (Millar et
al. 1989). In light of these results, it is important to define specific antigenic domains
which may induce antibodies that interfere with different stages of fertility, e.g.,
inhibition of sperm binding and penetration, or the inhibition of follicular
development, or the disruption of oocyte maturation. In order to determine whether
the marmoset monkey would be a suitable model to study such events it is necessary to
determine how this species responds to the induction of immunity against the
homologous zona pellucida antigen. In order to facilitate such a study an investigation
has been conducted into the generation of bacterially expressed recombinant marmoset
ZP3 proteins which have then been purified and used to generate anti-ZP3 antibodies
In order to achieve this objective a full-length marZP3 cDNA was subcloned in
the pMAL™-c vector (New England Biolab, Herts, England), downstream of the malE
gene which encodes maltose binding protein (MBP) and results in the expression of an
MBP fusion protein. The strong "tac" promoter and the malE translation initiation
signal present upstream of the cloned marZP3 gave high-level expression of marZP3.
Antibodies directed against native human ZP, recombinant human marmoset ZP3
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expressed in CHO cells and a human ZP3 peptide containing the amino acid sequence
341-360 could all recognize the recombinant marmoset ZP3 polypeptide to varying
degrees.
Preliminary immunization experiments with the purified recombinant
marmoset ZP3 in rabbits indicated that this material was not immunogenic. This
might, in part be expected, because it has been established that deglycosylated ZP
proteins are less immunogenic than the native or partially glycosylated proteins
(Bhatnagar et al. 1992; Keenan et al. 1991; Millar et al. 1989). It is also likely that the
molecular nature of the recombinant ZP3 affects its antigenicity. Thus, a mouse
recombinant ZP3 fusion protein containing B-galactosidase generated a weak immune
response in female mice and did not react with the ZP in frozen sections of mouse
ovaries (Dean et al. 1989).
Rabbits immunized with the purified recombinant marmoset ZP3 fusion
protein conjugated to tetanus toxoid produced antibodies that recognized human
recombinant ZP3 on ELISA and dotblot assays. This enhanced immunogenicity of the
recombinant marmoset ZP3 after conjugation to tetanus toxoid was due the helper T
cell epitopes provided by the carrier molecule. This demonstrates the possibility of
using such recombinant ZPxarrier protein conjugates for active immunization studies
rather than the native ZP proteins and glycoproteins that have been used in the past
(Henderson et a/.1987a; Henderson et zz/. 1987b; Paterson et al. 1992). The
recombinant marmoset ZP3 antibody recognized the recombinant marmoset ZP3 and
recombinant human ZP3 on dotblot assays. These observations are of interest, and
expected, since the amino acid sequence of marmoset ZP3 and human ZP3 exhibits
91% homology. It was also interesting to note that the recombinant marmoset ZP3
antibody recognized recombinant marmoset ZP3 more strongly than the recombinant
human ZP3. An explanation for this weak reactivity could be that the antibody was
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directed towards a dominant epitope of marmoset ZP3 which might be absent in
human ZP3. The fact that recombinant human ZP3 antibody cross-reacted with the
recombinant human ZP3 more strongly than the recombinant marmoset ZP3 is also a
reflection of antigenic differences between the human and marmoset ZP3 proteins
despite their sequence homology. The anti recombinant hZP3 antibody could have
recognized a different epitope of marmoset ZP3 or the same epitope might have been
configured in a slightly different way. The fact that antibody generated against native
human ZP recognized recombinant marmoset and human ZP3 equally well suggests
that in these recombinant proteins the conformation of the ZP3 epitopes was different
from the native protein. Different antibodies to ZP have a variety of specificities
since they may target peptide, conformational, and carbohydrate portions of the ZP
structure (Drell & Dunbar, 1984; Maresh & Dunbar, 1987; Keenan et al. 1991). Thus
there are number of different levels of epitope recognition at which differences in the
antigenicity of the recombinant ZP proteins might be expressed.
The use of a recombinant ZP3 immunogen offers several experimental
advantages over previous approaches to the induction of immunity against the zona
pellucida. ZP glycoproteins manifest great heterogeneity on electrophoretic gels, so
that it is not always possible to identify or characterize different ZP proteins or
antigens by electrophoretic methods. Even enzymatic or chemical deglycosylation
procedures do not eliminate all carbohydrate structures so that some heterogeneity
remains even after such treatments. As a consequence of the presence of charged
isomers, it has been difficult to distinguish the core ZP proteins or to be certain that
these proteins have been purified to absolute homogeneity. The use of recombinant
ZP3 avoids any possible complications due to low levels of contaminating proteins
from the oocytes and granulosa cells, or from other ZP proteins. For this reason,
recombinant ZP proteins are clearly superior antigens to those raised against native
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material in terms of their purity and as such should permit more precise analysis of the
immunogenicity and antigenicity of these molecules. Against this has to be balanced
the fact that the recombinant material may not faithfully replicate the antigenic
structures expressed by the native protein.
6.5 Summary
The recombinant mar ZP3 produced in soluble form could be easily purified to
homogeneity using anion exchange column. Moreover, a construct including
recombinant marmoset ZP3 conjugated to tetanus toxoid was found to be
immunogenic. The antibodies generated using this construct recognized recombinant
marmoset and human ZP3 in dotblot assays. The use of such recombinant ZP3 in
active immunization studies would eliminate any possible complications due to low
level of contaminating proteins from the oocytes and granulosa cells. Furthermore, the
abundant availability of pure recombinant mar ZP3 will facilitate the design of large
scale studies for accessing the safety and efficacy of contraceptive vaccines that target
the zona pellucida.
7 Active Immunization ofMarmoset
with Porcine ZP3 Antigen
7.1 Introduction
Previous studies have demonstrated that active immunization with ZP preparations can
induce infertility in a variety of different animal models including bitches (Mahi
Brown et al. 1988), rabbits (Skinner et al. 1984), squirrel monkeys (Sacco et al. 1991)
and marmoset monkeys (Paterson et al. 1992). Every species examined exhibited
abnormal reproductive cycles characterized by a fall in circulating progesterone levels
(Paterson et al. 1992; Skinner et al. 1984; Mahi Brown et al. 1988). It was also found
that those animals developing the highest titres of anti-zona antibodies following the
induction of immunity with porcine ZP developed abnormal oestrous cycles
characterized by elevated oestrogen and low progestrone values suggesting a failure of
ovulation (Mahi Brown et al. 1985; Skinner et al. 1984; Sacco et al. 1991). It was
postulated that the most likely reason for this side effect lay in the impurity of zona
preparations (Gulyas et al. 1983a), and that purified ZP preparations or ZP
components specific for sperm receptor activity (ZP3) could help to overcome this
problem (Gulyas etal. 1983a; Sacco et al. 1986a).
In order to undertake such studies, the largest zona pellucida glycoprotein
(ZP1) was purified by preparative isoelectric focusing (Dunbar etal. 1989; Paterson et
al. 1992) while ZP3 was purified by a series of chromatography steps (Sacco et
al. 1983; Sacco et al. 1987; Paterson et al. 1992). Whatever the nature of the zona
components used for the induction of immunity, and irrespective of the purification
procedures employed, active immunization with these purified ZP glycoproteins was
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still associated with the eventual appearance of ovarian dysfunction. The reasons for
this pathological response to the induction of immunity against the zona pellucida
remain unclear but the issue is the subject of intense speculation since it is of major
relevance to the development of a clinically useful contraceptive vaccine.
Recent analyses of this problem suggested that the carbohydrate content of the
ZP3 glycoprotein is the main inducer of ovarian pathogenicity (Keenan et al. 1991;
Jones et al. 1992) Rabbits immunized with the partially deglycosylated porcine ZP3
constituent, ZP3a, as well as the chemically deglycosylated peptide backbones of
porcine ZP3a and ZP313, showed no significant elevations of their circulating
gonadotrophin concentrations and continued to display a normal progesterone
response to exogenous hCG administration (Keenan et alA99l). Moreover, the
ovarian histology in these animals showed no signs of the pathological changes
associated with the induction of immunity against fully glycosylated ZP3 (Jones et
al. 1992). In contrast to these findings in the rabbit, marmosets immunized with the
chemically deglycosylated peptide backbone of porcine ZP36 did exhibit ovarian
dysfunction, although this pathology took two years to manifest itself. Since this
pathology was associated with the depletion of the primordial follicle pool, this side
effect did not reverse as antibody titres subsequently declined (Paterson et al. 1992).
Using the mouse as an experimental model, important evidence has been
obtained to indicate that the disruption of ovarian function following the induction of
immunity against the zona pellucida might be due to T-cell epitopes within the ZP3
sequence. Absence of T-cell epitopes from a ZP3 peptide resulted in an immunogen
that could induce infertility without any pathological effect on the ovary (Millar et
al. 1989). Conversely, ZP3 peptides as small as 8 amino acids in length could be used
to induce ovarian pathology (oophoritis) in the absence of anti-zona antibodies
providing T-cell epitopes were present. Since adoptive transfer of CD4" T-cell lines
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derived from actively immunized animals caused oophoritis in naive recipients, in the
absence of an antibody response against the zona pellucida, T-cell mediated immunity
is clearly the mediator of ovarian pathology in this particular model (Rhim et al. 1992).
It should be noted however that these studies were conducted in a strain of mouse
(B6AF1) that is particularly susceptible to T-cell mediated autoimmune disease. The
extent to which this model applies to the ovarian pathology observed in other species
following the induction of immunity against the zona pellucida is unknown.
In view of the importance of this pathology to contraceptive vaccine
development a detailed analysis has been undertaken of this process in the marmoset
monkey. In this chapter I shall describe an analysis of both the nature and kinetics of
the pathological responses observed in marmoset monkeys actively immunized with
glycosylated porcine ZP3. This information was then used to orientate subsequent
passive immunization studies in which the importance of the humoral response to ZP3
antigens in the aetiology of ovarian dysfunction was demonstrated.
7.2 Material and Methods
7.2.1 Purification of Porcine ZP3
Porcine ovaries were collected from the slaughter house and stored at -20°C until
further processing. Porcine oocytes were obtained by mincing thawed ovaries in a
meat grinder with copious amounts of ice-cold saline (0.9%) followed by sieving of
the homogenate through nylon screens of decreasing size (500 to 75|im). The isolated
oocytes were further purified by centrifugation in a discontinuous Percoll gradient
(40%, 20%, 10% bottom-top) for 30 minutes (2000 x g, 20°C). The oocytes collected
from the 10-20% interface were washed free of Percoll with PBS (pH 7.4) and then
gently disrupted in a small glass homogenizer, after which the remnants of the oocytes
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were removed in the supematent following centrifugation. The purified ZP were then
heat solubilized at 78°C for 20 min and finally ultracentrifuged (100 000 x g, 90 min,
4°C). The resulting supernatant was dialysed against several changes of 0.1 M
ammonium hydrogen carbonate (5L). The heat solublized ZP were treated with 2%
SDS and applied to a Sephacryl S-400 column equlibrated with 25 mM sodium
phosphate buffer (pH 7.2; 0.1% SDS, 0.02% sodium azide) to obtain a ZP3-enriched
fraction. This fraction was further purified by the use of hydroxylapatite
chromatography employing a linear gradient of 10-500 mM sodium phosphate, pH
6.8, containing 0.1% SDS. Renaturation of porcine ZP3 was carried out in the
presence of 6 M guanine hydrochloride.
7.2 2 Active Immunization
Marmoset monkeys from the Primate Centre of the Medical Research Council were
used for this study. An immunization schedule was designed that would generate a
sudden surge of antibody at a defined time point so that a time-dependent analysis of
the changes in ovarian histology could be undertaken Three marmoset monkeys were
sensitized with 100 fig of purified porcine ZP3 in peanut oil and muramyl dipeptide
adjuvant, adsorbed with alum and allowed to rest for 8 months. These animals then
received a booster immunization containing the same amount of antigen in non¬
ulcerative Freund's adjuvant adsorbed on alum in order to produce a sudden
synchronized surge of anti-zona antibodies. A second group of 3 control animals
received vehicle alone.
7.2.3 ELISA Assay
Blood samples were taken weekly to monitor antibody titres using an enzyme linked
immunosorbent assay (ELISA). The ELISA plates were coated with 50 |il of a
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solution containing 10 pg/ml heat-solubilized porcine ZP in 0.1 mM bicarbonate
buffer pH 9.0 and allowed to adsorb at 4°C for 16 hours. Plasma samples (50 |Lil) were
added in doubling dilution from 1/10 to 1/20,480 and incubated at room temperature
for 2 hours. The plates were washed three times with PBS containing 0.05% Tween-
20; then 50pl of a 1/1000 dilution of goat anti-human IgG alkaline phosphatase
conjugate was added to each well and incubated for 2 hours at room temperature. The
plates were washed with PBS containing 0.05% Tween-20; then 50 pi of substrate
solution was added (1 mg/ml p-nitrophenylphosphate in 10% diethanolamine, pH 9.8)
and allowed to develop in the dark for 1 hour at room temperature. The reaction was
terminated with 50 pi 3 M NaOH, and the absorbency at 405 nm was measured on a
Microtek ELISA plate reader. The end point for the assay was an absorbency twice
that of the negative control reading. The antibody titres for each animal were
monitored on weekly blood samples.
7.2.4 Histology
A laparotomy was performed on each of the 3 treated marmoset monkeys and the right
ovary was removed 2, 4, and 8 weeks after the booster injection; the left ovary was
subsequently removed and autopsy performed 16, 24 and 32 weeks post injection. All
the ovaries were fixed in 4% paraformaldehyde in PBS pH 7.4, embedded in paraffin
and serially sectioned to generate 5pm tissue slices. Every 20th section was stained
with haematoxylin and eosin and the primordial follicles were counted by light
microscopy. Primordial follicles were defined as those structures possessing oocytes
surrounded by one layer of squamous prefollicular cells.
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7.3 Results
7.3.1 Antibody Titre
A peak in ELISA antibody titres (1:1280 to 1:10240) was attained following the initial
immunization and occurred approximately 17-20 days after the first injection (Figure
7.1). This peak was followed by a gradual decline in titre to reach basal levels at
around 220 days. All three animals had comparable antibody titres after the primary
immunization. On day 245 the first booster immunization was given and the antibody
titre rapidly reached a maximum titre of 1:3840 and this peak was once again followed
by a small decline, although the titres were subsequently maintained at 1: 640 until the
end of the study.
7.3.2 Histology
The first ovary recovered from an actively immunized animal two weeks after the
administration of a booster immunization exhibited completely normal ovarian
histology. The primordial follicle count was exceptionally high (1:9614) in this
animal and a large number of actively growing primary, secondary and Graafian
follicles were present (Figure 7.3). The ovarian sections examined from this animal
also revealed the presence of a corpus luteum. Significantly, there was no evidence of
infiltration of mononuclear cells in the ovary.
The ovarian material obtained from the marmosets at later time points revealed
a dramatic loss of primordial follicles as early as 4 weeks after the administration of a
booster injection. Only 265 primordial follicles were present in the ovary removed at
this stage although actively growing primary and secondary follicles were also
observed, as well as an apparently normal corpus luteum (Figure 7.4 and 7.5).
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This disruption of primordial follicles was progressive and was marked from 4 weeks
following the booster injection onwards. The loss of primordial follicles was also
severe in that there were very few primordial follicles present in the ovarian cortex in
the animals examined from the fourth week. There was also little time dependency in
the loss of primordial follicles, since the numbers decreased dramatically within the
first 4 weeks following the administration of a booster injection and remained low
thereafter. Histological evaluation failed to reveal any evidence of leucocyte
infiltration over this period. The ovary removed 16 weeks after the booster injection
showed (Figure 7.6) very few primordial follicles (59) compared with the ovary
removed from the same animal at two weeks (9614). Despite the dramatic loss of
primordial follicles the ovarian sections showed evidence of primary and secondary
follicles.
The autopsies performed 16, 24, and 32 weeks after the booster immunization
of the animals revealed very low numbers of primordial follicles: 59, 123, and 23,
respectively. Despite the dramatic loss of primordial follicles there were, even at these
late stages, primary and secondary follicles in the ovaries as well as luteal tissue
(Figure 7.7).




























Figure 7.1 Antibody titre of actively immunized animal analysed by ELISA. Arrows
indicate the time of booster immunization.
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Figure 7.2 Effect of active immunization on the primordial follicle population of
marmoset ovaries at different times. In the control, each animal's left and right ovary
primordial follicles counts are presented together even though the ovaries were removed
at different time to indicate there are no discrepancy in primordial follicle counts.
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Figure 7.3 Histology section of marmoset ovary immunized with porcine ZP3
antigen. Marmoset ovarian section stained with haematoxylin and eosin. The number
of primordial follicles (P) are very high even after 2 weeks of postbooster
immunization. Many primary (PR), secondary (S) and Graafian follicles (GF) are
present. (10 x)
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Figure 7.4 Histology section of marmoset ovary immunized with porcine ZP3
antigen. Marmoset ovarian section stained with haematoxylin and eosin. After four
weeks of postbooser immunization there are few primordial follicles (P) and secondary
follicles (S). (10x)
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Figure 7.5 Histology section of marmoset ovary immunized with porcine ZP3
antigen. Marmoset ovarian section stained with haematoxylin and eosin. After four
weeks of postbooser immunization there are few primordial follicles (P) and secondary
follicles (S). (25 x)
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Figure 7.6. Histology section of marmoset ovary immunized with porcine ZP3
antigen. Marmoset ovarian sections stained with haematoxylin and eosin. The ovary
removed 16 weeks after the postbooster injection showed very few primordial follicles
and there is evidence of atretic follicle (AF). (B, 25 x) High magnification of (A, 10
x).
Active Immunization of Marmoset with Porcine ZP3 Antigen 138
Figure 7.7 Histology section of marmoset ovary immunized with porcine ZP3
antigen. Marmoset ovarian sections stained with haematoxylin and eosin. The ovary
removed 24 weeks after the postbooster injection showed very few primordial follicles
and there is evidence of luteal tissue (CL). (10 x)
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Figure 7.8. Marmoset ovarian section stained with haematoxylin and eosin. The
ovaries of the control animals appeared normal with numbers of primordial, primary
(PR) and secondary follicles (S). (10 x)
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The ovaries of the control animals appeared normal with large numbers of primary and
secondary and growing follicles, and corpora lutea. (Figure 7.8) The numbers of
primordial follicles recorded in the individual ovaries were consistent for each animal
and were not influenced by the sham immunizations carried out with vehicle alone
(Figure 7.2). Thus in the control animal, number 312R, the primordial follicle count
for the right ovary was 3160 at 2 weeks and 3228 for the left ovary at 16 weeks.
Similarly the control animal, number 392R, exhibited a right ovary primordial follicle
count of 1060 at 4 weeks compared with 888 for the left ovary at 24 weeks. The
control animal number, 399R, possessed 1284 primordial follicles in the right ovary at
8 weeks compared with 1368 in the left ovary at 32 weeks.
7.4 Discussion
The potential of the ZP as an antigen for contraceptive vaccine development has been
clearly demonstrated in various animal model studies. In order to be acceptable any
contraceptive vaccine would have to be free of untoward side effects. At the present
time, there are clear problems with the use of the ZP as a target antigen in
contraceptive vaccine development due to the ovarian pathology that can occur
following the induction of immunity against this structure. Existing data indicate that
active immunization against the native ZP3 glycoprotein is associated with the
appearance of an ovarian pathology characterized by the accelerated disappearance of
primordial follicles from the ovarian cortex (Skinner et al. 1984; Keenan et al. 1991).
The development of an immune response against ZP not only affects the ovum but
also the ovarian endocrine system; and thence indirectly the hypothalamo-
hypophyseal-ovarian axis leading to changes in the circulating levels of
gonadotrophins and steroids (Skinner et al. 1984; Sacco et a/,1987; Mahi Brown et
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al. 1985). In these studies (Skinner et al. 1984; Keenan et al. 1991) a marked decrease
in primordial and developing follicles was mirrored by elevations in LH and FSH and
by a loss of hCG-induced progesterone secretion. Such disruptions of ovarian
physiology could theoretically result from humoral or cell-mediated immune responses
to ZP antigens (Shivers etal. 1981; Mahi Brown et al. 1992; Rhim et al. 1992).
The experiments discussed in this chapter reveal that the active immunization
of female marmoset monkeys with porcine ZP3 results in a profound alteration of
ovarian follicular development and a rapid depletion of the primordial follicle pool.
This reduction in the number of primordial follicles was observed as early as 4 weeks
after the induction of high titre antibodies against the zona pellucida. Despite this
reduction in the size of the primordial follicle population there were actively growing
primary and secondary follicles in these ovaries as well as corpora lutea. The
simultaneous decrease in primordial follicle counts and the presence of other growing
follicles suggest that the former must be highly susceptible to immunological damage.
Similar observations have been made in different animal models such as the rabbit
(Skinner et al. 1984), marmoset (Paterson et al. 1992), and baboon (Dunbar et al. 1989).
The aetiology of primordial follicle population depletion following the
induction of immunity against the ZP is not clear. It might be reasonable to suppose
that antibodies against ZP3 would induce an interruption of follicular development
coincident with the stage at which the ZP first appears as an extracellular matrix
between the oocyte and follicular cells. Clearly the primordial follicle does not secrete
zona pellucida antigens in a major way since, by definition, the oocyte in a primordial
follicle is not surrounded by a zona pellucida. However, whether the oocytes in such
follicles exhibit a low level of ZP antigen expression is an extremely controversial
issue. Certainly in the rabbit there is now good evidence that the 55 kD ZP antigen is
secreted by both the follicular cells and the oocyte and that low level expression is
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observed in the primordial follicles (Lee & Dunbar, 1993). However, studies of ZP3
mRNA transcription and translation in the mouse and marmoset (this study) clearly
indicate that these activities are not observable until an oocyte has been recruited from
the primordial follicle population and has entered the actively growing follicular pool.
By 8 weeks post-immunization, the number of primordial follicles was
severely reduced (187). After 16, 24, and 32 weeks of immunization the number of
primordial follicles was 59, 123 and 23 respectively. This shows that after the intial
decline in primordial follicle number observed at eight weeks, there was no further
reduction in the size of this follicle population over the ensuing 24 weeks.
Dunbar et al (1989) found histological evidence of primordial follicle depletion
196 days after the induction of immunity against the Mr=80 000 zona polypeptide in
baboons. Furthermore, in this study the complete depletion of the primordial follicle
population was noticed 32 weeks (224 days) postimmunization. The condition of the
ovary was thought to resemble premature ovarian failure in women, a phenomenon
which may have an autoimmune aetiology. Thus, it has been suggested that this form
of infertility in women may be due to the presence of antibodies that react with
granulosa cells secreting zona antigens and thereby damage this cell type (Wolgemuth
et al. 1984). However the evidence obtained in this study suggests that the granulosa
cells do not express ZP3 antigens and retain sufficient structural integrity.
The other indirect post-immunization ovarian dysfunction which has been
recorded is depressed progesterone secretion in several species, including rabbits,
(Skinner et al. 1984; Keenan et al. 1991) dogs (Mahi Brown et al. 1988; Mahi Brown et
al. 1985), baboon (Dunbar et al. 1989), and marmoset (Paterson et al. 1992). Rabbits
immunized with SIZP, ZP3, and ZP3B/EBGD showed a significant elevation of LH
and FSH and a significant decline of peak progesterone levels. In contrast, rabbits
immunized with ZP3a/EBGD, ZP3a/DG, and ZP3B/DG showed no significant
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elevations of gonadotrophins and continued to display cyclic progesterone secretion in
response to hCG (Keenan et al. 1991). Porcine ZP3 immunization in squirrel monkeys
resulted in initial steroid hormonal disturbances, but subsequently ovarian function
returned to normal in all the animals examined (Sacco et al. 1987). It has been also
suggested that the ovarian pathogenesis was due to the immunogenicity inherent in the
carbohydrate moiety of the ZP preparations and use of deglycosylated zona molecules
produced normal cyclic progesterone secretion. On the contrary, Paterson et al (1992)
used chemically deglycosylated porcine ZP3B in marmoset monkeys and observed the
appearance of ovarian pathology as evidenced by a depletion of the primordial follicle
population, appearance of follicular clusters and no evidence of growing follicles. In
the same study all the marmoset monkeys displayed cyclic progesterone secretion for a
period of 200 days which was associated with the persistence of a few primordial
follicles up to that time, which were still competent to enter the growing follicle pool.
Similarly, in the present study there was evidence of growing follicles in the actively
immunized monkey at 24 weeks postimmunization even though the number of
primordial follicles had been severely reduced.
Immunological damage to the oocytes left only the follicular clusters within
which there is evidence to suggest (Skinner et al 1984) that the intercellular junctional
complexes and cytoplasmic processes are typical of those found in normal follicular
cells (Anderson & Albertini, 1976). It would be interesting to establish the role and
fate of the follicular cluster cells remaining after the induction of immunity against the
ZP. In all the immunized animals, the ovarian sections revealed the presence of
luteinized tissue which was centrally located in the ovaries. It has been suggested that
such luteal tissue may represent the spontaneous luteinization of granulosa cells
comprising the follicular clusters (Paterson et al. 1992). Alternatively, the small
number of primary, secondary and growing follicles in the ovaries of the immunized
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follicles suggests that such luteal tissue might have a follicular origin and represent the
spontaneous luteinization of an unruptured follicle or the occurrence of ovulation.
In the present study there was no evidence of macrophage or leucocyte
infiltration or inflammation in the ovaries at 2 weeks after booster immunization,
which might suggest the absence of cell-mediated immunity. Consistent with this
observation, the next chapter (8) cite experimental evidence to suggest that humoral
immunity alone can induce ovarian damage. It has been claimed that vaccination with
a synthetic mouse zona pellucida peptide ZP3328~342 produced long-lasting
contraception with a lack of ovarian histopathology. Furthermore, it has been
suggested that the lack of ovarian histopathology was due to the absence of zona
pellucida T-cell epitopes within that specific ZP3 sequence (Millar et al. 1989)
Additional experiments involving the use of mouse zona pellucida peptides containing
T-cell epitope strongly suggested that the primary mechanism of the ovarian
histopathology in this species was T-cell mediated (Rhim et al. 1992). In the later
study, a zona pellucida peptide ZP3328"342 was found to contain both a T-cell epitope
and a B-cell epitope, and induced ovarian histopathology in the immunized animal
(Rhim et al. 1992). Thus, in this murine model both T-cell and humoral responses
were potentially important instrument in the induction of ovarian histopathology.
Further studies will be needed to determine whether such T-cell mediated response
play any role in the ovarian pathology observed in actively immunized primates.
7.5 Summary
Existing data indicated that active immunization against the native ZP3 glycoprotein
was associated with the appearance of an ovarian pathology characterized by the
accelerated disappearance of primordial follicles. This reduction in the number of
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primordial follicles was observed as early as 4 weeks following a booster injection and
almost complete depletion of the primordial follicle population was noticed after 32
weeks (224 days) postimmunization. The evidence obtained in this study suggests that
the granulosa cells are intact following the destruction of the primordial follicles.
8 Passive Immunization ofMarmoset
with Anti-Porcine ZP3
8.1 Introduction
The passive administration of anti-ovarian, anti-egg, or anti-zona pellucida antisera to
animals has been shown to induce infertility through mechanisms that involve the
disruption of sperm-zona interaction during fertilization (Sacco, 1979; Aitken et
al. 1981b). Thus, in the initial studies, antibodies raised against aqueous extracts of
ovarian tissue were found to prevent the binding of spermatozoa to the ovum and the
antigens responsible for this block were found to reside in the zona pellucida (Sacco &
Shivers, 1973a; Garavagno et al. 1974). This hypothesis was substantiated when
mechanically isolated zona pellucida were used to generate antibodies that could block
in vitro fertilisation in laboratory rodents (Tsunoda & Chang, 1977; Tsunoda &
Chang, 1978) by preventing sperm binding to the zona pellucida. Passive
immunization with antibodies raised against homologous ovarian antigens in a second
species could induce infertility in a variety of animal models such as the hamster
(Oikawa & Yanagimachi, 1975), mouse (Jivek & Pavlok, 1975), and rat (Tsunoda &
Chang, 1976b). For example, the injection of rabbit anti-hamster ovarian antigen
antibodies into female hamsters was associated with the deposition of antibodies on
the surface of the zonae pellucidae and an inhibition of fertility that spontaneously
reversed after approximately four oestrous cycles. These results emphasize that short-
term exposure of a given host to high titre anti-zona antibodies does not irreversibly
damage the ovarian tissue but induces a temporary period of reversible infertility.
Dean and East (1986) have demonstrated that passive immunizations in the mouse
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with antibodies specific for either ZP2 or ZP3, and active in the suppression of
fertilization in vitro, will also inhibit fertilization in vivo. It appears that these
particular antibodies did not preclude sperm binding but rather prevented sperm
penetration of the zona pellucida through their capacity to cross-link and, hence,
stabilize this structure (Dean & East, 1986). The ability of monoclonal antibodies
directed against single epitopes on the ZP to block fertilization in vivo has also been
confirmed in a number of other studies (Isojima et al. 1984; Koyama et al. 1985; East et
al. 1985).
The prolonged periods of infertility observed following the induction of
passive immunity against the ZP appear to be due to the ability of these antibodies to
bind to the zonae pellucidae surrounding follicular as well as ovulated oocytes. As a
result, the ova liberated from the ovary over six or seven successive cycles will have
been affected by the anti-zona antibodies. Ova collected from passively immunized
animals possess an immunoprecipitate on the outer surface of the zona pellucida and
an increased resistance to solublization (Tsunoda & Chang, 1976b; Tsunoda & Chang,
1976a; Tsunoda & Chang, 1978). Such observations suggest that the inhibition of
both sperm-egg recognition and sperm penetration of the zona pellucida are involved
in the mechanisms by which these antibodies disrupt fertility following passive
administration.
One of the major problems encountered in the induction of active immunity
against the ZP is the disruption of normal ovarian function that has been observed in
dog (Mahi Brown et al. 1982), rabbits (Skinner et al. 1984) and primates (Paterson et
al. 1992; Sacco et al. 1991; Upadhyay et al. 1989). Thus, cynomolgus monkeys
immunized with porcine ZP failed to ovulate and also some animals showed massive
loss of large antral follicles (Gulyas et al., 1983). Similarly, after active immunization
of female rabbits with porcine ZP glycoprotein, there is an interruption of follicular
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development which coincides with (i) the stage at which the ZP first appears as an
extracellular matrix between the oocyte and follicular cell (Wood et al. 1981) and (ii) a
loss of the ability to ovulate in response to hCG administration (Sacco et al. 1986). In
this species, there is a noticeable reduction in ovarian size and weight as early as 7
weeks after primary immunization (Skinner et al. 1984). Histopathological analysis of
the ovaries of such animals has revealed an increase in the number of follicles with
atretic oocytes and complete disappearance of growing follicles as well as corpora
lutea within 30 weeks post-immunization. The number of primordial follicles present
in long-term (40-48 weeks) immunized animals was also reduced. This decrease was
accompanied by an increase in the number of oocyte-free follicular cell clusters. This
whole effect appeared to be due to a humoral immune response rather than a cell-
mediated response, since there was no sign of macrophage or leucocytic infiltration or
inflammation in the ovaries even at the earliest time points (e.g. 2-21 days) examined
after the induction of immunity (Skinner et al. 1984).
In a further study employing the mouse as an animal model, a synthetic ZP
peptide containing B-cell, but not T-cell epitopes, coupled to a carrier protein
produced long-lasting contraception without any ovarian histopathology (Millar et
al. 1989). A later experiment indicated that a synthetic peptide derived from the mouse
ZP3 sequence comprising a 15-amino acid peptide, ZP3 328-342, could elicit a form
of ovarian pathology, oophoritis, in B6AF1, BALBc/By, and A/J mice. This synthetic
peptide contained both B-cell and T-cell epitopes, suggesting that both epitopes may
be involved in autoimmune oophoritis in mice. Moreover, adoptive transfer of the
ovarian pathology by lymph node cells and two CD4 T+ cell lines derived from mice
immunized with peptides ZP3 330-342 and ZP3 328-340 strongly suggested that T-
cells were involved in induction of oophoritis. While such results clearly implicated a
cell-mediated immune reaction is this mouse model, it should be emphasized that the
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lymphocytic infiltration that characterizes the oophoritis observed under such
conditions, has not been observed in the other species in which ovarian pathology has
been induced by active immunization against ZP antigens.
Thus, while the murine studies suggest that the lack of ovarian histopathology
or cellular cytotoxicity observed in animals actively immunized with ZP3 peptides
may reflect the absence of zona pellucida T-cell epitopes in such vaccines, this
generalization may not hold true for other species, including primates (Millar et
al. 1989). The present study was therefore carried out to define the relative importance
of B-cell and T-cell ZP3 epitopes in ovarian pathogenicity. Instead of the complicated
analysis of different polypeptide fragments of ZP3, adopted by Miller et al (1989) we
have addressed this question by determining whether the ovarian pathology recorded
in marmosets actively immunized against porcine ZP3 can be transmitted to recipients
by the passive transfer of antibody. If this is the case, then it would strongly suggest
that humoral immune responses generated through B-cell epitopes are responsible for
the induction of ovarian pathology in this primate model, rather than the T-cell
epitopes implicated in the murine studies.
8.2 Material and Methods
8.2.1 Passive Immunization
Four sets of sexually mature female marmoset twins from the Medical Research
Council, Edinburgh, Primate Colony were used for this study. The experimental
protocol made use of the fact that marmosets generally produce twins that are
immunologically tolerant of each other owing to antigen exchange that occurs due to
the exchange of cells through the placental circulation (Wislocki, 1939). One member
from each of 3 sets of twins was actively immunized with porcine ZP3 while the other
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member served as a recipient (Active immunization procedure for generation of
antisera for this study was same as in Chapter 7.2.2). 2.5ml of antisera, possessing an
antibody titre of >1/10,000, from the actively immunized member of each set of twins
was transferred to its partner on day 0 and the same amount was also transferred on
day 1. In this way, 3 animals received the passive transfer of anti-porcine ZP3
antibodies from an actively immunized co-twin while the 4th set of twins served as the
controls, each animal receiving a reciprocal transfer of serum from its partner using
exactly the same protocol as was employed for the treated animals.
8.2.2 Histology
One ovary from each animal was removed by laparotomy and unilateral oophorectomy
and the second removed at autopsy 4 weeks later. The timing of the initial
hemicastration was staggered to occur at weekly intervals. Thus, if the passive
administration of the antisera/control sera was given as T=0, ovaries were removed
from the first animal on weeks 1 and 4, from the second animal on weeks 2 and 5, and
from the third on weeks 3 and 6. In the two control marmoset monkeys, one ovary was
removed from each animal one week before the induction of passive immunity while
the remaining ovaries were removed at autopsy on weeks 3 and 6, respectively. The
purpose of using such a staggered approach was to obtain as much information on the
rate at which the ovarian pathology occurred as possible.
All the ovaries were fixed in 4% paraformaldehyde in buffered saline,
embedded in paraffin and 5 |im sections were obtained. Every 20th section was
stained with haematoxylin and eosin and the primordial follicles were counted using
the light microscope. For each ovary the total number of sections obtained varied
from 800-1000 and around 50 sections (every 20th) were counted from each ovary.
Passive immunization of Marmoset with Anti-Porcine ZP3 151
Primordial follicles were identified on the basis of the presence of an oocyte
surrounded by squamous pre-follicular cells.
8.2.3 ELISA Assay
Blood samples were taken at weekly intervals to monitor antibody titres using an
enzyme linked immunosorbent assay. The assay was performed as described in
section 7.2.2.
8.3 Results
In this study the role of humoral immune responses in mediating the ovarian pathology
observed in response to the induction of immunity against porcine ZP3 was
investigated using a simple passive immunization approach. As indicated in the
Introduction, twins were selected for this study in order to avoid any possible
anaphylactic shock due to the large volume of serum administered to each animal and
the risk of complications due to the presence of immunological differences between
the host and the recipient. The consequences of administering 5.0 ml of a very high
titre anti-porcine ZP3 antibody on primordial follicles integrity is illustrated in Figure
8.1.
Within one week of the passive transfer of anti-ZP3 antibodies to the marmoset
monkey, the ovarian histology appeared normal exhibiting a large number of
primordial follicles in the ovarian cortex and an actively growing follicle population
including primary, tertiary and Graafian follicles (Figure 8.2). In all respects the ovary
removed from the passively immunized animal at this time appeared to be the same as
the control animal and contained very similar numbers of primordial follicles (7617 vs.
7948 for the immunized and control animals respectively.; Figure 8.1 and Figure 8.7).
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Figure 8.1 Effect of passive immunization on the primordial follicle population of
marmoset ovaries at different times.




Figure 8.2 Histology section of marmoset ovary after passive transfer (one week) of
porcine ZP3 antibody. Marmoset ovarian section stained with haematoxylin and
eosin. The ovarian histology appeared normal exhibiting large number of primordial
follicles (P) in the ovarian cortex and evidence of primary , secondary (S) and
Graafian follicle (GF). (B, 25 x) High magnification of (A, 10 x).
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Figure 8.3 Marmoset ovarian section stained with haematoxylin and eosin. Two
weeks after the passive transfer of anti-ZP3 antibodies the primordial follicle (P)
number had started to decline and there were secondary follicles (S) also present.
(10 x)
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Figure 8.4 Marmoset ovarian section stained with haematoxylin and eosin. Three
weeks after the passive transfer of anti-ZP3 antibodies number of primordial follicles
(P) observed had declined further. (10 x)
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Figure 8.5 Marmoset ovarian section stained with haematoxylin and eosin. Five
weeks after the passive transfer of anti-ZP3 antibodies the number of primordial
follicles observed had declined and growing follicle was present (G). (10 x)
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Figure 8.6 Marmoset ovarian section stained with haematoxylin and eosin. Control animal
after 6 weeks of study appeared normal exhibiting large number of primordial follicles (P)
in the ovary. (10 x)






















Figure 8.7 Antibody titre of passively immunized animal, analysed by ELISA.
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Two weeks after the passive transfer of anti-ZP3 antibodies the primordial follicle
number (5020) had started to decline but still there was an actively growing follicle
population (Figure 8.3).
Thereafter the number of primordial follicles decreased progressively with time
(Figure 8.4) such numbers recorded three, four, five and six weeks after the induction
of passive immunity were 4190, 3370, 1839 and 1009 respectively. There was no
evidence for the infiltration of mononuclear cells of lymphoid origin into the passively
immunized animals at any stage. Five weeks after the passive transfer of anti-ZP3
antibody the number of primordial follicles observed had declined although a
fe
population of actively growing follicles was also present (Figure 5).
The antibody titres for the passively immunized animals were monitored by an
enzyme linked immunosorbent assay. After the transfer of the anti-ZP3 antibodies to
the marmosets, the antibody titre detectable in the recipients was in the range 1/1920-
1/2560 (Figure 8.7). The antibody titres subsequently started to wane within three
weeks of antibody transfer.
8.4 Discussion
It has been demonstrated in a number of animal models that ZP3 is highly
immunogenic and able to disrupt fertility either by inhibiting the fertilization process
directly or by interfering with the viability and development of the primordial follicle
population (Mahi Brown et al. 1988; Bamezai et al. 1988; Sacco, 1979; Sacco et
al. 1983; Aitken & Richardson, 1980; Paterson & Aitken, 1989). Many of these
studies, particularly those employing porcine ZP antigens, have resulted in the
induction of ovarian pathology in a variety of animal models including rabbits, dogs,
Passive immunization of Marmoset with Anti-Porcine ZP3 160
squirrel monkeys, bonnet monkeys and marmosets (Skinner et al. 1984; Mahi Brown et
al. 1988; Sacco et al. 1991; Paterson et al. 1992).
In such cases, histopathological examination of the ovaries revealed decreased
numbers of primordial follicles, as well as developing follicles and corpora lutea
(Mahi Brown et al. 1985; Sacco et al. 1987; Skinner et al. 1984; Paterson et al. 1992;
Upadhyay et al. 1989). Obviously, either humoral or cell-mediated immune responses
to ZP antigens could theoretically have damaging effects on the ovary (Shivers et
al. 1981; Mahi Brown et al. 1992; Rhim et al. 1992). In this study, the role of humoral
immune responses in the induction of ovarian pathology has been examined. Porcine
ZP3 antibodies from marmoset monkeys transferred to a co-twin did not produce any
untoward side effects on the normal health of the animals. Moreover, examination of
the ovaries for infiltrates of inflammatory cells did not yield any positive finding.
However, scrutiny of the ovaries revealed a dramatic loss of primordial follicles which
occurred in a relatively short period of time.
Active immunization with glycosylated, wild-type glycoproteins has
previously been found to produce profound effects on the ovarian histology of
immunized animals such as rabbits (Skinner et al. 1984), bitches (Mahi Brown et
al. 1988), squirrel monkeys (Sacco et al. 1991; Keenan et al. 1991) and bonnet monkeys
(Upadhyay et al. 1989). These data indicated that glycosylated ZP proteins were
highly immunogenic and produced severe disruptions in normal ovarian function.
Keenan et al (1991) recently reported that ovarian malfunction in rabbits is dependent
on the immunological response to the ZP38 component of porcine ZP3 and that
carbohydrate determinants were probably of critical importance in the
pathophysiology of ovarian damage (Millar et al. 1989). However, Paterson et al
(1992) have used the deglycosylated peptide core of porcine ZP3J3 in marmoset
monkeys and have generated antibody titres similar in magnitude to those recorded
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with glycosylated ZP3, and yet still recorded a profound effect on ovarian pathology.
In contrast, synthetic peptides representing portions of the murine ZP3 molecule which
is homologous to porcine ZP3J3, have been reported to be immunogenic in mice when
conjugated to a macromolecule carrier and have generated antibodies that had anti-
fertility effects without any ovarian pathology (Millar et al., 1989). Furthermore, it
has been suggested that the lack of ovarian histopathology was due to the absence of
zona pellucida T-cell epitopes within that specific ZP3 sequence (Millar et al. 1989)
Additional experiments involving the use of mouse zona pellucida peptides containing
T-cell epitopes strongly suggested that the primary mechanism of the ovarian
histopathology in this species was T-cell mediated (Rhim et al. 1992). In the latter
study, a zona pellucida peptide ZP3328-342 was found to contain both a T-cell epitope
and a B-cell epitope, and induced ovarian histopathology in the immunized animals
(Rhim et al. 1992). Thus, both T-cell and humoral responses were potentially
important mediators of ovarian histopathology. Nevertheless, this study has never
ruled out that antibody alone could cause ovarian pathology.
The present experiment suggests that the presence of anti-zona antibodies per
se was sufficient to induce ovarian histopathology, as evidenced by a loss of
primordial follicles. The cellular mechanisms underlying the ovarian pathology
observed in the marmoset did not appear to involve the same T-cell mediated response
that characterizes oophoritis in the mouse, and was not associated with the same
lymphocytic infiltration. To this extent, the ovarian pathology observed in the
passively immunized marmosets reflects that observed in other species actively
immunized with porcine zona antigen, such as the rabbit or squirrel monkey, where the
loss of ovarian function is not associated with any overt leucocytic infiltration.
It is, of course, possible that any leucocytic infiltration was extremely short-lived and
was not resolved with the frequency of sampling employed in this study. For example,
Passive immunization of Marmoset with Anti-Porcine ZP3 162
a short term inflammatory reaction within the ovary might have been sufficient to
create an acute phase of oxidative stress during which the primordial follicles became
damaged. The fact that X-irradiation of the ovary causes the selective demise of the
primordial follicle population (Lacassagne et al. 1962) suggests that the resting oocyte
is particularly susceptive to oxidative stress, since such treatment affects biological
tissues through the creation of hydroxyl radicals due to the heterolytic fission of water.
Apparently the somatic components of the primordial follicles are much more resistant
to the radicals generated on irradiation, since they persist in the ovaries as small
islands of follicular cells that appear identical to the follicular clusters that accumulate
in the ovary following the induction of immunity against the zona pellucida. Clearly
further, more detailed studies will be required in order to resolve whether a transient
leucocytic infiltration is in fact a feature of the ovarian pathology observed in the
passively immunized marmoset.
A final possibility is that the antibodies inflict a direct attack on the primordial
follicles because these cells are competent to express zona pellucida antigen. Clearly
the primordial follicle does not excrete zona pellucida antigen in a major way since, by
definition, the oocytes in a primordial follicle is not surrounded by a zona pellucida.
However, whether the oocyte in such follicles exhibit a low level of ZP antigen
expression in a possibility that cannot be excluded. Certainly, in the rabbit there is
now good evidence that the 55 kD ZP antigen is secreted by both the follicular cells
and the oocyte and that expression is observed in the primordial follicles (Lee &
Dunbar, 1993). However studies of ZP3 mRNA transcription and translation in the
mouse and marmoset clearly indicate that these activities are not detectable until an
oocyte has been recruited from the primordial follicle population. Preliminary
analysis of ZP3 antigen expression in the marmoset monkey (Thillai Koothan,
unpublished observation) do indicate the presence of traces of immunoreactive
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material in follicles that are apparently at the primordial follicle stage, judging from
the flattened appearance of the prefollicular cells. Clearly, further, more detailed
illustrated studies will be required to resolve this important point.
8.5 Summary
Examination of the ovaries of marmosets passively immunized against porcine ZP36
revealed a dramatic loss of primordial follicles within a relatively short period of time.
This experiment suggests that the presence of anti-zona antibodies per se is sufficient
to induce ovarian histopathology, as evidenced by the loss of primordial follicles. The
cellular mechanisms underlying the ovarian pathology observed in the marmoset did
not appear to involve the T-cell. Moreover, the fact that passive transfer of porcine
ZP3 antibodies to marmoset monkeys was sufficient to eliminate large numbers of
primordial follicles suggests that antibody-dependent cell-mediated cytotoxicity
(ADCC) might be involved in this primate model.
9 General Discussion
This thesis focuses on the marmoset homologue of the human sperm receptor protein
that has been cloned, sequenced and expressed by means of a bacterial expression
system and used to immunize rabbits in an endeavour to initiate an analysis of
immunogenicity and antigenicity of recombinant marmoset ZP3. The second part of
the thesis deals with the ovarian pathology observed after active and passive
immunization with porcine ZP3 and its antibody, respectively.
The zona pellucida is an acellular glycoprotein shell that covers the oocyte and
provides functionality in terms of sperm binding, the induction of the acrosome
reaction, and the prevention of polyspermy (Wassarman, 1990; Wassarman, 1988b).
The zona pellucida is comprised of three to five sulphated glycoproteins, depending
on the species, which are secreted to form an extracellular coat around the developing
oocyte. The human zona pellucida glycoproteins have apparent molecular weights of
Mr=90-110,000, Mr=64-76,000, and Mr=57-73,000 (Shabanowitz & O'Rand, 1988a).
The ZP3 molecule serves as a sperm receptor and, because of its important biological
function, has been studied extensively as a candidate antigen for contraceptive vaccine
development. Heteroimmunization with glycosylated, partially deglycosylated or
completely deglycosylated ZP proteins induce antibodies that inhibit or reduce
fertility in several species (Millar et al. 1989; Sacco et al.1987; Paterson et al. 1992).
In vitro studies with anti-zona antibodies suggest that the prevention of sperm-zona
interaction was either through a process of steric hindrance or by direct interaction
with the ZP3 domain that binds to the sperm surface (Sacco et al. 1984; Aitken et
al. 1982) depending on whether the antibodies were raised against homologous or
heterologous zona antigens. In addition, anti-zona antibodies can bind to target sites
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in the ovary in vivo and can interrupt follicular growth at the time the extracellular ZP
matrix is synthesized, as well as deplete the primordial follicle population (Skinner et
al. 1984; Paterson et al. 1992). The precise definition of the nature of the
immunological response to the various epitopes presented by the ZP is crucial in
defining an approach to contraceptive vaccine development that does not interfere
with other aspects of ovarian function (Rhim et al. 1992).
While the induction of immunity against heterologous zona antigens has
generated interesting information, such studies may not accurately reflect the
consequences of developing immunity against a homologous peptide. The ideal
protocol for the evaluation of a contraceptive vaccine would be one in which an
animal model, such as the marmoset monkey, was immunized with homologous ZP3
peptides that exhibited perfect sequence homology with human ZP3. In order to
develop such a model the primary amino acid structure of marmoset ZP3 would have
to be elucidated and compared with its human counterpart. The present study was
designed to achieve this objective.
The introduction of the polymerase chain reaction (PCR) has facilitated many
molecular biology procedures like amplification of DNA from a single DNA
molecule, rapid sequencing, amplification of small amounts ofmRNA by reverse PCR
or cDNA amplification, as well as cloning. The purpose of this section of the research
was to use such molecular biology techniques to clone and sequence the marmoset
ZP3 gene and thence determine the primary amino acid structure of this molecule. In
the following sections I shall review the principal findings described in this thesis
beginning with the structure and expression of the marmoset ZP3 gene and then
discuss the use of this animal model in studies designed to elucidate the behaviour of
anti-zona vaccines in vivo. Finally, the prospects for generating a contraceptive
vaccine that targets the ZP3 molecule will be considered.
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Structure ofMarmoset ZP3 gene
Mar ZP3 has a single open reading frame 1272 nucleotides in length, which gives rise
to a polypeptide core of 424 amino acids, with a calculated molecular mass of 46815.
On the basis of the hydrophobicity plot (Kyte & Doolittle, 1982) and amino acid
homology, a signal peptide of 22 amino acids could be identified, the four amino acids
near the cleavage site sharing the "-3, -1 rule" for predicting signal sequence cleavage
sites (Von Heijne, 1986). The primary amino acid structure of marZP3 was found to
exhibit a high degree of homology (91%) with the human ZP3 (huZP3) sequence and
more than 60% homology with the mouse and hamster sequences. Since it has been
demonstrated that the zona pellucida confers relative species specificity to sperm-egg
interactions, the high degree of preservation of the encoded human and mouse zona
proteins was somewhat unexpected. Nevertheless the existence of this conserved
sequence is of great value to the development of a contraceptive vaccine since it
permits the use of epitopes in an animal model such as the marmoset that share exact
sequence homology with the human.
One consequence of such similarities in the amino acid sequence is that
marZP3 also shares with the other species in which this molecule has been
characterized a second broad hydrophobic domain near the carboxyl terminus, the
function of which is currently unknown. Hydrophobic domains like these are
typically present in membrane-spanning regions of proteins. The hydrophobic
domains in marmoset ZP3 may play an important role in the intracellular trafficking
of these secreted proteins or in their interactions with the extracellular matrix. Similar
hydrophobic domains have also been recorded in the carboxyl terminus of other zona
proteins in the mouse (ZP2 and ZP3), human (ZP2 and ZP3) hamster (ZP3) and rabbit
(Liang et al. 1990; Ringuette et al. 1988; Chamberlin & Dean, 1990; Kinloch et
al. 1990; Schwoebel et al. 1991).
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Another highly conserved feature of the ZP3 molecule is the number and location of
the cysteine residues; the human, marmoset, mouse and hamster ZP3 sequences all
possessing 15 cysteine residues at identical sites. The mouse, human and hamster ZP3
genes contain eight exons each. The coding sequences of the mouse and human ZP3
genes are 74% homologous, and they encode for 424 amino acid peptides that are
67% identical (Chamberlin & Dean, 1990). As indicated overleaf, the primary amino
acid structure of marZP3 was found to exhibit a high degree of homology (91%) with
the huZP3 sequence and more than 60% homology with the mouse and hamster
sequences. The hamster gene encodes a 422 amino acid protein that is 81% identical
to mouse ZP3. The 745 amino acid human ZP2 protein is 60% identical to that of its
murine counterpart, although the human protein has 745 amino acids compared with
713 amino acids in mouse ZP2. The first 300 bp of the 5' flanking regions of human
ZP2 and mouse ZP2 are highly conserved. Furthermore, comparison of the 5' flanking
sequences of mouse ZP2, mouse ZP3, human ZP2 and human ZP3 genes have
identified five conserved DNA elements. One, element IV, contains a 12 bp domain
that is 75% identical among the four genes. These data suggest that a common
transcription factor binds to the ZP promoter region and may be involved in the co¬
ordinated expression of the ZP gene (Liang & Dean, 1993).
Oocyte-specific expression
The expression of the ZP3 gene is restricted to growing oocytes and is not detected in
other tissues. Once oocyte growth has commenced, increasing amounts of ZP3
transcripts are detected in the ova of primary and secondary follicles. The amount of
ZP3 expression declines dramatically in the fully grown and ovulated eggs, at least in
the mouse. It has been observed in ovulated or fertilized ova that the size of the ZP3
mRNA is approximately 200 nt shorter than in growing oocytes. Since the poly(A)
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tail length of ZP3 is 200 nt this has led to the notion that the zona mRNAs, like other
maternal messages, undergo deadenylation and degradation during meiotic maturation
and ovulation.
The first 300 bp upstream of the initiation site of mouse and human ZP2 genes
are 70% identical. The TATAA box at position -31 bp and a CCAAT box at position
-65 bp in the mouse and human are present at comparable positions. Examination of
the upstream regions of human ZP3 indicates that these molecules do not share long
stretches of sequence identity but possess five short conserved DNA sequences
located at comparable distances from the transcription initiation site. It has been
demonstrated that one of these, element IV, is necessary and sufficient for reporter
gene expression driven by mouse ZP2 and ZP3 promoters microinjected into oocytes
(Millar et al. 1991).
In contrast, evidence was presented that an oocyte specific, -60,000 kD
protein called OSP-1 binds to the sequence 5'-GATAA-3' within the first 100 bp of
mouse ZP3 promoter. The OSP-1 molecule is present only in growing oocytes but not
in ovulated eggs or two-cell embryos. Nothing is known about the mechanisms that
restrict gene expression to the female germ line. However the fact that the expression
of zona genes is restricted to the growth phase of oogenesis suggests that their
transcription could be used as a marker for investigating the molecular mechanisms
governing gene activation in the oocyte.
Recombinant ZP3 proteins
All previous studies concerning the structure and function of ZP glycoproteins has
involved the isolation of native ZP from the ovaries of different animal species.
Obtaining ZP material by this procedure was very cumbersome and time consuming.
It has not been possible to isolate large quantities of ZP protein from the ovaries of all
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mammalian species, particularly the human, for contraceptive vaccine development.
The abnormal ovarian cyclicity seen in some ZP immunization studies might also
have been due to the presence of impurities in the immunogen (Gulyas et al. 1983).
The approach described in this thesis which involves the production of recombinant
proteins in E.coli eliminates any possible contaminants from ovarian components in
contraceptive vaccine studies.
Marmoset ZP3 has been cloned, sequenced and expressed by means of a
bacterial expression system and has been used to immunize rabbits in an endeavour to
initiate an analysis of the immunogenicity and antigenicity of the recombinant
marmoset ZP3 protein. The bacterially-expressed recombinant marmoset ZP3 fusion
protein was 86,000 Da as determined by SDS-PAGE and was soluble in aqueous
solution. In contrast, the rabbit recombinant 55 kD ZP protein expressed as a cro-B-
galactosidase bacterial fusion protein formed aggregates and was insoluble in the
absence of urea (Schwoebel et al. 1992). The reasons for this difference could include
the different vectors and fusion proteins employed in expressing the protein or it could
be that the recombinant 55 kD protein possesses a unique hydrophobic nature and is
prone to form aggregates.
Soluble recombinant marmoset ZP3 was purified by single-step DEAE-52
anion exchange chromatography. Earlier attempts to generate antibodies against this
purified material were not successful. This might have been anticipated since it had
already been established that deglycosylated ZP proteins are less immunogenic than
the native or partially deglycosylated structures (Yurewicz et al. 1987; Keenan et
al. 1991; Bhatnagar et al. 1992). Moreover, it has been suggested in independent
studies that antibodies directed against carbohydrates of the ZP are involved in the
immunogenicity of ZP proteins (Sacco et al. 1986). The fusion protein was therefore
conjugated to tetanus toxoid in order to enhance its immunogenicity and in this way
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an antibody was successfully generated that recognized the recombinant marmoset
ZP3 in the immunoblot.
Native mouse ZP3 obstructs sperm binding to the zona pellucida of ovulated
eggs in a dose-dependent manner. This obstruction has been attributed to a class of
3.9-kD O-linked oligosaccharide side chains containing a terminal galactose residue
which appears to be critical for sperm binding (Bleil & Wassarman, 1988). After
spermatozoa have bound to the ZP, ZP3 induces the sperm acrosome reaction and ZP2
binds to the acrosome-reacted sperm in the secondary phase of sperm-zona
interaction (Mortillo & Wassarman, 1991). Embryonal carcinoma cells transfected
with the mouse ZP3 gene product inhibited the binding of spermatozoa to ovulated
eggs and induced sperm to acrosome-react in vitro. On the other hand the hamster
ZP3 gene product did not exhibit either sperm receptor or acrosome reaction inducing
activity. It was suggested that the embryonal carcinoma cells glycosylate mouse ZP3
and hamster ZP3 genes differently, despite the fact that the primary amino acid
structures are very similar (81%) to one another (Kinloch et al. 1991). In contrast, the
data from Beebe et al (1992) have unequivocally demonstrated that the mouse
recombinant ZP3 expressed in different cell lines such as rodent or primate cells
exhibited the biological activities associated with native ZP3.
Recombinant marmoset ZP3 polypeptide may not exhibit sperm binding and
acrosome inducing properties since prokaryotes lack the glycosylation apparatus, but
the polypeptide could still be used for contraceptive vaccine development. Some
experimental evidence supports the notion that normal ovarian function may be
maintained following immunization with certain deglycosylated (ZP3a/DG;
ZP36/DG) and partially deglycosylated (ZP3a/EBGD) ZP antigens. Antibodies
directed against epitopes involving carbohydrate residues on the ZP3 molecule
induced major endocrine disturbances, removal of approximately 30-92% of the
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carbohydrate (i.e. ZP3a/EBGD; ZP3a/DG; ZP3B/DG) generated zona antigens that
caused no such adverse effects.
Histological observations on the ovaries of rabbits actively immunized with
partially deglycosylated ZP3a-EBGD or chemically deglycosylated ZP3a-DG were
much more promising since no ovarian pathologies were observed throughout the
study (Jones etal. 1992).
Collectively such data support the investigation of recombinant ZP3
polypeptides as the basis for contraceptive vaccine development since such molecules
can be generated in large amounts in a purified form, free of ovarian contaminants.
Moreover, any future vaccine is likely to depend on the synthesis of small peptides
encoding linear continuous epitopes that are defined by the amino acid sequence.
Under such circumstances it is important that non-glycosylated recombinant peptides
are used in the vaccine engineering process, even if the antigenicity of such molecules
has to be enhanced by conjugation to carrier molecules.
Ovarian Pathology
Antibodies to the ZP have a contraceptive effect by reducing fertility in a number of
animal species. Earlier studies suggested that the inhibition of fertility was due to a
disruption of sperm binding to the ZP through the ability of anti-zona antibodies to
interfere with the sperm receptor function of ZP3. Further studies demonstrated that
with some zona antigens the contraceptive effect was associated with the destruction
of primordial follicles, failure of ovulation and abnormal reproductive cycles which
ultimately rendered the immunized animals sterile (Paterson et al. 1992). The reasons
for the primordial follicle destruction and associated loss of oocytes are not clear since
the oocytes contained within primordial follicles do not express ZP antigens. The
absence of mononuclear lymphocytes in the ovaries of animals actively and passively
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immunized with ZP3 or anti-ZP3 antibodies suggested a lack of cell mediated immune
response involvement, in an animal model involving the use of porcine zona antigens
to immunize rabbits (Skinner et al. 1984). Similarly, immunization of mice with rat
zonae pellucidae had a significant impact on ovarian follicular development, even
though there was no visible evidence of an active inflammatory response (Mahi
Brown et al. 1992). On the other hand, the use of a T-cell proliferation assay indicated
an involvement of the cellular compartment of the immune system in dogs actively
immunized with porcine zona antigens (Mahi Brown et al. 1992). In the marmoset,
active or passive immunization against porcine ZP3 induced ovarian pathology in the
absence of any overt leucocytic response. A similar absence of leucocytic infiltration
has been observed in the ovaries of bitches (Mahi Brown et a/. 1988), and rabbits
(Skinner et al. 1984; Jones et al. 1992) actively immunized with porcine ZP3.
However, in all these studies, it is not possible to rule out the possibility that a short
lived leucocytic infiltration did occur before the initial observations of the histological
normality of the ovaries was undertaken.
The most convincing evidence for a role for cell-mediated immunity in the
ovarian pathology observed following the induction of active immunity against ZP3
has come from studies on mice. However the results of such experiments appear to be
very strain dependent. Thus, immunization of mice with mouse ZP3 328-343 peptide
produced only infertility in NIH mice without any ovarian disease. Interestingly, the
same peptide (ZP3 328-343) contains the seven amino acid binding site of an anti-ZP3
monoclonal antibody that causes infertility in female mice (East et al. 1985).
Immunization with mouse ZP3 peptides representing amino acid sequences 183-196,
206-221, 336-351 and 371-398 did not induce oophoritis, whereas the peptide
containing mouse ZP3 amino acid sequence 328-343 was a potent inducer of
oophoritis in B6AF1 mice. Indication of mild focal infiltration of lymphoid cells
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confined to the interstitial spaces began on day 6 of the immunization protocol. On
day 10 the disease prevalence was 85%, ovarian follicles were infiltrated by
inflammatory cells and the largest antral follicles had inflammatory cells among
granulosa cells, adjacent to the ZP and inside the oocytes (Rhim et al. 1992). The fact
that the mouse ZP3 peptide 328-343 could elicit oophoritis in some strains of mice
(B6AF1, A/J) but not others, indicated that the susceptibility to this side effect is
under genetic control. A unique feature of the peptide is that it contained both a T-cell
epitope and a B-cell epitope. Consequently, both T-cell epitope and antibody
involvement are implied in the pathogenesis of murine oophoritis. Nevertheless, since
the passive transfer of lymph node cells and two CD4+ T-cell lines derived from mice
immunized with peptides ZP3 330-342 and ZP3 328-340 induced oophoritis in the T-
cell recipients, in the absence of anti-ZP3 antibodies, we must conclude that the
primary mechanism responsible for ovarian dysfunction in this model was T-cell
mediated. As yet the significance of the B-cell epitope in the mouse ZP3 328-343
peptide in the induction of ovarian pathology has not been determined. Moreover, the
fact that passive transfer of porcine ZP3 antibodies to marmoset monkeys was
sufficient to eliminate large numbers of primordial follicles suggests that antibody-
dependent cell-mediated cytotoxicity (ADCC) might be involved in this primate
model. Cells with cytotoxic potential, which posses Fc receptors for IgG, may bind to
and lyse target cells coated with antibody of the relevant class. Natural killer cells
(NK) might play a role in the so called ADCC model. This possibility could be ruled
out by an experiment involving the passive transfer of univalent ZP3 antibodies and
then assessing the ovarian status of the immunized animals. Such an experiment is
currently being undertaken.
The future of contraceptive development based upon the ZP as a candidate
antigen is dependent upon the elimination of the ovarian pathology and associated
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irregularities in reproductive cyclicity and hormonal profiles. It seems that anti-ZP
antibodies selectively destroy the oocytes in the primordial follicles that secrete the
ZP but leave the pre-follicular cells intact. The follicular cells later developed into
follicular clusters and could still produce steroid hormones as long as they remained
viable in the ovary. Epitope mapping of ZP antigens that are exclusively associated
with mature oocytes but not the primordial or developing follicles should facilitate the
rational design of contraceptive vaccines that selectively induce antibodies which
would attack the mature antral follicles only. Since the zona pellucida significantly
increases its binding affinity for spermatozoa in the final stages of oocyte maturation
there is every reason to believe that antigenic changes do occur in the zona pellucida
in concert with the final stages of oocyte maturation. Such changes in binding affinity
are presumably mediated by post-translational alterations to the ZP3 oligosaccharide
side chains rather than modifications to the peptide core. In light of such
considerations it is possible that in addition to the search for epitopes in the
polypeptide backbone of ZP3 a detailed analysis of the carbohydrate structures
associated with the zona pellucida could provide new insights into the way in which
contraceptive vaccines might be engineered.
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